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Abstract 
 
Background and Purpose:  There are over three millions Canadians living with chronic 
lung disease.  Chronic lung disease is burdensome and debilitating to individuals and the 
health care system.  Pulmonary Rehabilitation serves as a comprehensive intervention for 
individuals living with chronic lung disease.  It improves overall quality of life, slows 
disease progression, enhances self-management abilities, and reduces hospitalizations and 
health care visits.  The purpose of this practicum project was to develop relevant 
evidenced-based education modules to be utilized for teaching clients/families with 
chronic lung disease in a Provincial Pulmonary Rehabilitation Program.    
Development of Resource: An integrative literature review and consultation with key 
stakeholders was conducted to gather literature and information related to chronic lung 
disease, pulmonary rehabilitation, and client/family education.  Ten education topics 
emerged, which guided the development of ten relevant evidence-based education 
modules to be utilized as a teaching resource.  Pender’s Health Promotion Model (2006) 
and Knowles Adult Learning Theory (1970, 1984) served as a theoretical framework. 
Various teaching aids/activities were incorporated to augment the module information. 
Conclusion:  The education modules will assist to improve client outcomes and 
confidence by enhancing self-management abilities.  They will also serve as a resource to 
nurses working in the Pulmonary Rehabilitation setting, for education delivery.  
Ultimately, it is hoped that the developed modules will be utilized for teaching 
clients/families with chronic lung disease in a Provincial Pulmonary Rehabilitation 
Program.     
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The Development of Education Modules for Teaching Clients/Families with Chronic 
Lung Disease in a Provincial Pulmonary Rehabilitation Program 
In Canada, there are currently over three million individuals living with chronic 
lung diseases (Public Health Agency of Canada, 2012).  The conditions are known to be 
burdensome and to cause debilitation.  It is estimated that chronic lung disease will 
become the third leading cause of death by 2030 (World Health Organization, 2007).  
Financially, chronic lung diseases are estimated to cost the Canadian health care system 
12 billion dollars annually and are associated with increased mortality rates, hospital 
admissions, and readmissions (Public Health Agency of Canada; Canadian Thoracic 
Society, 2010).  The physical and psychosocial burden to individuals living with chronic 
lung diseases far outweighs that of the financial impact.  Pulmonary rehabilitation serves 
as a secondary prevention “evidence-based, multidisciplinary, and comprehensive 
intervention for patients with chronic respiratory diseases who are symptomatic and often 
have decreased daily life activities” (American Association of Cardiovascular and 
Pulmonary Rehabilitation (AACVPR), 2011, p.1).   It encompasses patient assessment 
and goal setting, self-management education, supervised exercise, psychosocial support, 
and outcome measurement.  The ultimate goals of pulmonary rehabilitation are to 
optimize functional capacity and reduce or alleviate symptom, to encourage self-
management and active participation, and to decrease dependence on the health care 
system (Nici et al., 2006; Moamary et al., 2014; Ries et al., 2007).  The program is aimed 
at clients and families living with various chronic lung diseases.  The term chronic lung 
disease refers to respiratory conditions such as, chronic obstructive pulmonary disease 
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(COPD), which also encompasses chronic bronchitis and emphysema, pulmonary 
fibrosis, asthma, lung cancer, pulmonary hypertension, and tuberculosis.  
Although pulmonary rehabilitation does not provide a cure to chronic lung 
disease, various benefits are seen through participation in such programs including: 
optimal symptom management including a decrease in shortness of breath, improved 
overall quality of life, an increase in functional and exercise ability, an increase in energy 
level, support in managing anxiety and depression, and improvement in measurable items 
such as blood pressure, weight, and cholesterol levels (Capital Health, n.d; National 
Institute of Health, 2010).  It is recognized and recommended as an essential component 
of medical care for those living with chronic lung disease (AACVPR, 2011).    
Until January of 2017, pulmonary rehabilitation programming was not available to 
residents of Prince Edward Island (PEI) living with chronic lung disease.  Based on 
current recommendations, an obvious need existed within the province.  Pulmonary 
rehabilitation programming, in a community setting, was initiated but lacked an 
established education curriculum.  An informal needs assessment was conducted with the 
Acting Chronic Disease Prevention and Management Manager, who oversees the 
Provincial Pulmonary Rehabilitation Program, in which the development of educational 
modules was identified as a current need.  The Manager also served as the contact person 
for the practicum project, Based on this need, I proposed to developed education modules 
for teaching clients/families with chronic lung disease within the Provincial Pulmonary 
Rehabilitation Program.   
I currently work as the registered nurse within the Provincial Pulmonary 
Rehabilitation Program and therefore had a personal interest in the practicum project.  
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This, along with the identified need, provided rationale for the project.  Health PEI (2013) 
indicated that the financial costs associated with managing chronic disease in the province 
are crippling and it is only realistic to question the sustainability.  They further indicated 
that through enhancement of community-based services disease could be better managed, 
decreasing the likelihood of exacerbations and hospitalizations.  The practicum project is 
an excellent example of a community-based secondary prevention program.  The 
previously discussed benefits to pulmonary rehabilitation signify the importance of the 
project to the particular population.  It will have a positive contribution on the overall 
effectiveness of the Pulmonary Rehabilitation Program in the province.  The program has 
the potential to empower individuals, making them better equipped to be active 
participants in their own health care.  
Practicum Goal and Objectives 
The overall goal of this practicum project was to develop relevant evidenced-based 
education modules to be utilized for teaching clients/families with chronic lung disease in 
a Provincial Pulmonary Rehabilitation Program.  It is hoped that the developed modules 
will help education delivery in a group setting, while also maximizing program benefit for 
clients/families in the setting.  The following list describes the practicum project’s 
objectives:  
1. Gather current evidence and relevant information related to chronic lung disease, 
pulmonary rehabilitation, client/family education, Pender’s Health Promotion 
Model (2006), and Knowles Adult Learning Principle (1970, 1984) through the 
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conduction of a comprehensive literature review and consultation with key 
stakeholders.   
2. Develop content for educational modules for a 12 week Pulmonary Rehabilitation 
Program, based on a previously conducted literature review and consultation with 
key stakeholders.  
3. Disseminate current evidenced-based findings and research to classmates, faculty, 
and stakeholders and gain support for implementation of the practicum project 
from stakeholders.  This will be achieved through a presentation of the practicum 
project and production of the final practicum report. 
4. Demonstrate increased awareness and knowledge related to the advanced nursing 
practice competencies research, leadership, and consultation.  This will be 
achieved through integration of these competencies throughout the development 
of the practicum project.   
Overview of Methods 
Prior to the development of the education modules an integrative literature review 
was conducted, followed by consultation with identified key stakeholders.  Literature 
critically appraised through the integrative literature review and information gathered 
through consultation would ultimately guide the content of the education modules.   
Integrative Literature Review 
The purpose of the conducted literature review was to examine the topics of 
pulmonary rehabilitation, chronic lung disease, and client/family education.  A document 
describing the completed Integrative Literature Review in detail, with summary tables, 
can be found in Appendix A.  Literature detailing a description of the background, 
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benefits, and relevance of pulmonary rehabilitation was obtained and critically appraised 
in order to present rationale for the development of the proposed education modules.  
Recommended education topics, to be included within pulmonary rehabilitation 
programming, were specifically examined and noted through the review.  The importance 
of a theoretical framework was recognized through the practicum project.  Aligning with 
this, both Pender’s Health Promotion Model (2006) and Knowles Adult Learning 
Principles (1970, 1984) were explored through the conducted integrative literature 
review.  Both the CINAHL and PubMed databases, assessed though the Memorial Health 
Sciences Library website, as well a subsequent Internet search of grey literature were 
utilized to conduct the review.   
Consultation with Key Stakeholders  
Consultation was recognized as an essential component of the practicum project.  
Backer et al. (1992) referred to consultation as a process in which one seeks advice or 
information from another, providing an overall benefit to a service or product.  It is 
assumed that the consultant, or individual being approached for advice or information, 
has an expertise and/or unique knowledge base related to a particular topic.  The purpose 
of consultation was to gather information related to pulmonary rehabilitation and 
education topics to be included within the developed education modules.  The completed 
Consultation Report can be found in Appendix B.  It was also intended that through 
consultation the practicum project would be introduced to key stakeholders, ultimately 
assisting with gaining approval for implementation of the education modules within the 
Provincial Pulmonary Rehabilitation Program post development.  Prior to consultation, a 
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consultation plan was developed.  The plan identified eight key stakeholders for 
consultation, six of which participated in a consultation interview including a 
Respirologist, the Acting Chronic Disease Prevention and Management Manager, a 
Registered Respiratory Therapist, a patient representative sitting on the Cardiac and 
Pulmonary Rehabilitation Program Advisory Board, and two Registered Nurses working 
within established Pulmonary Rehabilitation Program in Atlantic Canada.  An Interview 
Guide for Key Stakeholders, found within the Consultation Report in Appendix B, was 
developed for developed for consultation to ensure all stakeholders were asked identical 
questions.  Stakeholders provided suggestions related to education topics to be considered 
for incorporation within the Pulmonary Rehabilitation Program, identified strategies of 
how individual patient learning needs and goals could be incorporated into education to 
maximize patient benefit, and addressed barriers to education through consultation.  
Summary of Literature Review 
Through the conducted integrative literature review it was identified that there are 
currently over three million individuals currently living with chronic lung disease in 
Canada (Public Health Agency of Canada, 2012).  The term chronic lung disease refers to 
respiratory conditions such as, chronic obstructive pulmonary disease (COPD), which 
also encompasses chronic bronchitis and emphysema, pulmonary fibrosis, asthma, lung 
cancer, pulmonary hypertension, and tuberculosis. The reality of living with chronic lung 
disease is burdensome and causes debilitation to both the individuals living with the 
conditions and the health care system.  Individuals often report experiencing extreme 
shortness of breath while doing simple tasks associated with day-to-day living and are 
often left feeling breathless (World Health Organization, 2007).  Chronic lung disease has 
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a significant economic impact on the Canadian health care system, costing approximately 
12 billion dollars annually (Public Health Agency of Canada). Chronic lung diseases are 
the leading cause of hospital admissions and are associated with higher rates of 
readmission when compared to all other chronic diseases (Canadian Thoracic Society, 
2010).  The World Health Organization (2007) estimates that chronic lung disease will 
become the third leading cause of death by 2030.  In fact, COPD is the only chronic 
condition that is still associated with an increasing mortality rate in Canada (Canadian 
Thoracic Society, 2010).  
Pulmonary rehabilitation serves as a secondary prevention “evidence-based, 
multidisciplinary, and comprehensive intervention for patients with chronic respiratory 
diseases who are symptomatic and often have decreased daily life activities” (AACVPR, 
2011, p.1).  It is considered to be comprehensive and holistic, encompassing patient 
assessment and goal setting, self-management education, supervised exercise, 
psychosocial support, and outcome measurement.  Pulmonary rehabilitation is 
recommended as an essential component of medical management for those living with 
chronic lung disease.  Its ultimate goal is to improve the overall physical and 
psychological health status of individuals living with chronic lung disease (AACVPR, 
2011; Collins et al., 2014).  
It was discovered through the integrative literature review that Canadian specific 
education guidelines for pulmonary rehabilitation do not currently exist (Camp et al., 
2015).  However, suggestions from established Canadian programs, such as Living Well 
with COPD: A Plan of Action for Life (2017), developed in partnership by McGill 
University Health Center and the Quebec Health Ministry, and guidelines developed by 
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associations, such as the AACVPR (2011) provided suggestions in relation to various 
education topics.  Educations topics included: normal pulmonary anatomy and 
physiology, pathophysiology of chronic lung disease, description and interpretation of 
medical tests, breathing strategies, secretion clearance, medications, respiratory devices, 
benefits of exercise and maintaining physical activities, activities of daily living, eating 
right, irritant avoidance, early recognition and treatment of exacerbations, leisure 
activities, coping with chronic lung disease, energy conservation, oxygen therapy, anxiety 
and panic control, sexuality related to lung disease, and end of life (AACVPR, 2011; 
Moamary et al., 2014; Camp et al., 2015). Wilson, O’Neill, Reilly, MacMahon, and 
Bradley (2007) detailed the patient perspective in relation to pulmonary rehabilitation 
education, adding the suggested topic of welfare and benefits systems.  Similarly, the 
Living Well with COPD (2017) program suggested management of breathlessness, energy 
conservation, overview of action plan and management of an exacerbation, COPD 
medication and appropriate use of inhalation devices, management of stress, anxiety, and 
depression, and continuing exercise and self-management strategies as topics to be 
including within education in the program.   
Emerging from the integrative literature review was also the concept of self-
management education (Moamary et al., 2014).  Self-management education encourages 
clients to be active participants in their care and in turn make healthy behavioral changes.  
In addition, it was identified that education topics should be tailored to individual client 
needs and goals (Nici et al., 2006).  
The importance of a theoretical framework was recognized through the practicum 
project.  Through the integrative literature review, Pender’s Health Promotion Model 
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(2006) and Knowles Adult Learning Principles (1970, 1984) were explored.  Pender et al. 
(2006) defined health promotion as “behavior motivated by the desire to increase well-
being and actualize human health potential” (p. 7).  This definition aligned with the 
underlying goals of pulmonary rehabilitation, which include optimizing functional 
capacity and alleviating symptoms and encouraging active participation.  Pender further 
identified three constructs through her Health Promotion Model including: individual 
characteristics and experiences, behavior specific cognition and affect, and behavioral 
outcomes.  These constructs aligned with the concept of self-management education 
previously identified through the integrative literature review.  Knowles (1970) identified 
that adults can learn and that it is the responsibility of the educator to foster this ability to 
learn.  As adults were the intended population for the education modules, the question of 
how health care professionals can effectively educate adults became important.  Knowles 
(1970, 1984) identified various characteristics, significant to adult learning, including: 
self-concept, unique experience, readiness to learn, orientation to learning, and motivation 
to learn, that would ultimately be incorporated into the development of the education 
modules.  It was determined that both Pender’s Health Promotion Model (2006) and 
Knowles Adult Learning Principles (1970, 1984) were applicable to the topic of 
pulmonary rehabilitation. 
Summary of Consultations 
Eight key stakeholders, including seven health care professionals and one patient 
representative, were selected and approached for consultation prior to the development of 
the education modules.  An e-mail of invitation for consultation, which can be found in 
Appendix B, was sent to all key stakeholders.  The e-mail was utilized to introduce the 
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practicum project, identify the rationale for the project, and identify a recommendation 
for implementation and evaluation of the education modules after completion.  Six of the 
eight identified stakeholders agreed to participate in consultation.  An Interview Guide for 
Key Stakeholders, located within Appendix B, was developed for use during the 
consultation interviews to collect qualitative data from key stakeholders.  The guide 
contained four open-ended questions and was developed to ensure that all stakeholders 
were asked identical questions during interview.  All stakeholders were asked the initial 
three questions, and only key stakeholders representing an established Pulmonary 
Rehabilitation Program were asked the fourth question.  The methods of face-to-face 
interview, telephone interview, and electronic distribution of the interview questions were 
utilized for data collection.  It was determined that approval by a Health Research Ethics 
Review Board was not required for consultation due to the nature of the project.  Implied 
consent was assumed from the stakeholders based on agreement for participation.  
Participant confidentiality was protected during the project.   
Once interviews were completed, thematic analysis was utilized to categorize and 
analyze collected data.  Chesney (2015) identified that thematic analysis allows themes to 
emerge from data rather than having collected data be assigned to pre-defined themes.  
This was thought to be important as pre-defined themes, or identified topics to be 
included within pulmonary rehabilitation education, were identified through the 
conducted integrated literature review.  The overall goal of consultation was to collect 
additional relevant information based on stakeholder experience and expertise.  After 
familiarities of data were ensured, data were assigned an initial code based on the topic 
that emerged from the particular piece of data.  Coding of similar topics were categorized 
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into themes and assigned a representing name.  Once assigned to a theme, all data were 
reviewed to ensure they had been assigned to an appropriate theme.  Nine themes, 
representing education topics, emerged from the collected data including: nutrition, 
managing breathing and energy conservation, physical activity, anatomy and physiology, 
understanding lung disease, stress and anxiety, environmental factors, pulmonary 
medications, and moving forward. Stakeholders were also asked how individual patient 
learning needs and goals can be best incorporated into educational content.  Three themes 
emerged from the analyzed data including individual characteristics, patient goal setting, 
and teaching strategies.  Additional data was collected related to strategies that could be 
utilized to maximize patient benefit, related to education.  Four themes emerged from the 
data including teaching methods, teaching strategies, utilization of multidisciplinary staff, 
and physical environment.    
Unfortunately, due to a family emergency one key stakeholder, a Respirologist 
and Acting Medical Lead for the Provincial Pulmonary Rehabilitation Program, was 
unable to participate in consultation during the allotted time.  The stakeholders did 
subsequently complete the interview electronically at a later date.  Results of this 
consultation interview can be found in Appendix C.  Due to the delay in data collection, 
the resulting information from this interview was not analyzed or categorized with other 
data but was considered during the development of the education modules.   
Summary of Resource 
Following the completion of the integrative literature review and consultation, ten 
evidenced-based education modules were developed to be utilized as a teaching resource 
within a group setting.  It was intended that the modules be utilized with clients/families 
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living with chronic lung diseases, while attending the Provincial Pulmonary 
Rehabilitation Program.  
Module Topics  
Ten module education topics emerged from the integrative literature review and 
consultation, which ultimately guided the development of the modules, including:  
• Module 1: Orientation/Keeping A Healthy Lifestyle  
• Module 2: Understanding Lung Disease 
• Module 3: Lung Disease Anatomy and Physiology  
• Module 4: Managing Breathing, Energy Conservation, & Environmental Factors 
• Module 5: Puffers and Device Use  
• Module 6: Additional Pulmonary Medications 
• Module 7: Self Management & Signs of Acute Exacerbation  
• Module 8: Navigating the Health Care System & Test and Interventions  
• Module 9: Stress & Anxiety  
• Module 10: Moving Forward  
The identified topics are comprehensive and holistic, addressing physical, mental, and 
social aspects of health, while also promoting self-management education for the 
participants.   
Development   
The modules were developed to contain all necessary information and resources 
required for a registered nurse to utilize while facilitating a one-hour group education 
session on the particular topic.  Beyond the integrative literature review, each module 
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required extensive examination of current evidence, best practice guidelines, and current 
available resources related to the module topic for development.  Each module was 
created with the same format to assist with ease of familiarity for the presenter.      
Each of the ten education modules contains:  
• A module description 
• A list of participant learning objectives 
• Teaching aids/activities to be utilized throughout the module including: handouts, 
videos, models, and/or participant activities  
• Content relevant to the module topic  
• Potential questions to aid with facilitation of group discussion  
• A list of key messages for participants/family members 
• An associated PowerPoint presentation  
Contained within the content section of each module is information pertinent to both the 
presenter and participants.  Content would be utilized to familiarize the presenter with 
each topic and also within a group education session.  Tips for participants and applicable 
resources or services, related to the module topic, available in Prince Edward Island were 
also provided in the content.  Developed PowerPoint presentations parallel content within 
each module, but were developed specifically for the participants, incorporating concepts 
within Knowles Adult Learning Principles (1970, 1984).  Utilization of language within 
each module was selected with cognisance placed on reading level, as well as ease of 
understanding and comprehension.   Various medical terms were utilized throughout the 
modules, which due to the nature of the project was unavoidable.  It is recognized that 
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these terms may present a challenge to some clients/family members.  Every effort was 
made to define or explain terms as simply as possible.   
Theoretical Framework  
The importance of a theoretical framework was recognized through the practicum 
project.  Pender’s Health Promotion Module (2006) and Knowles Adult Learning 
Principles (1970/1984) served as a theoretical framework during the development of the 
education modules.   
Pender’s Health Promotion Model.  Pender’s model was selected due to its 
applicability to both the underlying goals of pulmonary rehabilitation and of the 
practicum project.  Pender et al. (2006) defined health promotion as “behavior motivated 
by the desire to increase well-being and actualize human health potential” (p. 7).  
Pender’s definition aligns with the underlying goals of pulmonary rehabilitation including 
optimizing functional capacity and alleviating symptoms and encouraging active 
participation.    
Pender identified three constructs through her Health Promotion Model including 
individual characteristics and experiences, behavior specific cognition and affect, and 
behavioral outcomes.  The model identifies that patients will have individual 
characteristics and experiences that will define the knowledge they currently have, and 
will potentially influence the way they learn or process information.  This emphasized the 
importance of tailoring education to individual patient needs and/or experiences and 
utilizing patient goal setting in curriculum development.  This was reflected during the 
development of the education modules through the incorporation of facilitated group 
discussions, providing opportunity for participants to share their unique experiences and 
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knowledge.  It was also reflected through facilitating the development of individualized 
participant SMART goals for the program.  Behavior specific cognition and affect refers 
to variables that are essential for intervention.  Nursing actions can influence modification 
of these variables.  Delivery of pulmonary rehabilitation education is an example of a 
nursing action that will potentially influence behavior modification.  Self-management 
behavior modification is the ultimate goal of pulmonary rehabilitation.  Pender’s model 
serves as a tool in facilitating patients to the phase of developing health-promoting 
behaviors, which is the ultimate goal of pulmonary rehabilitation education.  It would be 
expected that through participation at pulmonary rehabilitation, clients/families would 
develop behavioral outcomes.  This could also be described as the development of health-
promoting behaviors through self-management education gained from attendance at 
pulmonary rehabilitation.     
 Knowles Adult Learning Principles.  Adult Learning Principles, described by 
Knowles (1970/1984) provided a theoretical foundation for adult learning during the 
development of the education modules.  This was important as the modules were intended 
for an adult population.  Knowles identified various characteristics significant to adult 
learning that were incorporated into the development of the modules including self-
concept, unique experience, readiness to learn, orientation to learning, and motivation to 
learn.  Modules were developed to allow time for facilitated group discussion in order to 
provide opportunity for participants to share unique experiences and knowledge.  The 
ultimate goal of pulmonary rehabilitation is to promote self-management behavior 
aligning with both self-concept and readiness/motivation to learn.  Self-concept refers to 
the idea that adults are self-directed and feel a responsibility for their own learning.  An 
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introduction was provided for each module to ensure participants were aware of the 
intended purpose.  Handouts provided throughout the modules also served as tools to 
foster these characteristics.  Feedback was requested throughout the modules from 
participants and time was allotted for group discussion and questions.  Orientation to 
learning signifies that adults are often problem or performance centered while learning.  
This aligns well with the concept of self-management education.  Various 
demonstrations, tips, and strategies are provided throughout the modules aimed at 
problem solving, troubleshooting, or performing a particular task, such as administration 
of medication devices or breathing techniques to elevate or manage shortness of breath.  
Related to motivation, Knowles (1970) indicated that adults learn best if they perceive 
education to be personally relevant.  This to was taken into consideration during the 
development of the modules.  Information provided within the content of each module 
encompassed various chronic lung diseases to ensure relevance for all participants.  It was 
of great importance during the module development to be inclusive of various chronic 
lung diseases to reach as many clients/families as possible.  
While serving as a theoretical framework, Pender’s Health Promotion Module 
(2006) and Knowles Adult Learning Principles (1970, 1984) also enhanced the quality 
and relevance of the developed education modules.  Both were determined to align 
closely with the underlying concept and goals of pulmonary rehabilitation.   
Discussion of Advanced Nursing Practice Competencies 
The Canadian Nurses Association defined advanced nursing practice (ANP) as 
“an umbrella term describing an advanced level of clinical nursing practice that 
maximizes the use of graduate educational preparation, in-depth nursing knowledge and 
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expertise in meeting the health needs of individuals, families, groups, communities and 
populations” (Canadian Nurses Association, 2008, p.9).  They further described four 
competencies related to advanced nursing practice: clinical, research, leadership and 
consultation/collaboration.  The opportunity to demonstrate various ANP competencies 
was possible throughout the practicum project.     
Clinical Competency 
Clinical competency provides opportunity for a clinician to develop an expertise 
in an area of nursing for utilization with patients and families (Canadian Nurses 
Association, 2008).  Various components of clinical competency are identified by the 
Canadian Nurses Association (2008) including decision making, education, assessment, 
intervention, and managing client health concerns.  Due to the nature of this practicum 
project and the fact that there was not a required clinical placement, the competency was 
not demonstrated.  Clinical competency could be demonstrated post completion of the 
practicum project through implementation of the developed educational modules with 
clients and families in the clinical setting or pulmonary rehabilitation.  
Research Competency 
Through the role of ANP, current research is examined and utilized (Canadian 
Nurses Association, 2008).  For this project the overall goal was to develop relevant 
evidenced-based education modules.  Research skills were demonstrated through critical 
appraisal and the synthesis of information of current evidence and data during the 
conduction of the integrative literature review.  Following the development of the 
education modules, the practicum project was presented to faculty and fellow classmates.  
This provided an opportunity to disseminate current evidenced-based findings and 
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research.  It is hoped that post completion of the practicum project the developed 
education modules will be utilized within the Provincial Pulmonary Rehabilitation 
Program.  This will contribute to nursing practice, while helping to facilitate health 
related behavioral change among the population of individuals living with chronic lung 
diseases.  
Leadership Competency    
ANP requires nurses to be leaders in their workplace, creating change and 
improving outcomes of care (Canadian Nurses Association, 2008). Leadership is evident 
throughout the practicum project.  The project serves as an example of a nursing led 
secondary prevention strategy, aimed at improving the overall health and well-being of 
individuals living with chronic lung diseases.  The practicum advocates for better health 
outcomes, though enhanced self-management education.  The practicum project was 
based on an identified educational need and identified a gap in current health care 
delivery.  Educational modules were developed by a registered nurse and were intended 
for utilization by registered nurses working within the Provincial Pulmonary 
Rehabilitation Program.  Leadership was displayed throughout the practicum project as it 
provided opportunity to advocate for a specific population and has the potential to initiate 
change at the individual and community level.  The practicum project further provided 
opportunity to assist colleagues as a goal of the project was to assist with ease of 
education delivery for staff, through a developed resource.  It is ultimately hoped that the 
Provincial Pulmonary Rehabilitation Program in Prince Edward Island will utilize the 
developed education modules.   
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Consultation and Collaboration Competency       
Consultation is essential to ANP (Canadian Nurses Association, 2008).  Initial 
consultation was seen through the identification of a contact person for the practicum 
project.  The contact person served as a resource throughout the project and identified a 
need for the development of the educational modules.  Formal consultation was 
conducted with various health care disciplines through the practicum project.  
Consultation provided an opportunity to engage others and gather information related to 
pulmonary rehabilitation and the development of the education modules.  Prior to the 
implementation of the developed modules it is assumed that the quality of developed 
resource will be assessed through consultation with key stakeholders.  Consultation was 
also seen through gaining input from other established Pulmonary Rehabilitation Program 
during consultation.  Due to the developmental nature of the practicum project, 
collaboration was not demonstrated.  
Next Steps 
 Following the completion of the practicum project, the plan is that the developed 
education modules will be implemented and utilized within the Provincial Pulmonary 
Rehabilitation Program.  Prior to implementation, approval of the education modules will 
be required from the Acting Chronic Disease Prevention and Management Manager, 
Acting Medical Leads for the Program, and the Cardiac and Pulmonary Rehabilitation 
Program Advisory Board.  The Acting Chronic Disease Prevention and Management 
Manager identified a need for the developed education modules and all were involved 
with the practicum through consultation, expressing support for the project.  It is assumed 
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that approval for implementation will be easily gained.  Front line staff in the setting will 
require time to gain familiarity with the modules prior to implementation.  
 Evaluation of the developed education modules will be essential following 
implementation.  It is proposed that the education modules be piloted within the 
Provincial Pulmonary Rehabilitation Program during a 12-week cycle of the program.  
An evaluation tool will need to be selected and/or developed for this purpose.  At that 
point, it would be suggested that the tool be utilized with front line staff, clients/families 
participating in the Program, the Program Lead, the Acting Chronic Disease Prevention 
and Management Manager, and the Acting Medical Leads for the Program.  Following 
evaluation, the education modules would be edited appropriately.        
Conclusion 
 Through the practicum project the topic of chronic lung disease was explored in 
great detail, highlighting the overall impact on both individuals living with the conditions 
and the health care system.  It was easily identified that chronic lung disease presents 
significant challenges requiring intervention.  Pulmonary rehabilitation serves as a 
secondary prevention intervention aimed at optimizing functional capacity and reducing 
or alleviating symptoms, encouraging self-management and active participation, and 
decreasing dependence on the health care system.  Through the conduction of an 
integrative literature review and consultation with key stakeholders relevant literature and 
information related to pulmonary rehabilitation, chronic lung disease, and client/family 
education was obtained, ultimately guiding the development of an educational resource.  
 The overall goal and objectives of this practicum project were met.  Ten relevant 
evidenced-based education modules were developed intended for utilization of teaching 
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clients/families with chronic lung disease in a Provincial Pulmonary Rehabilitation 
Program.  An integrative literature review and consultation with identified key 
stakeholders was conducted, which guided the development of the education modules.  
The practicum project was disseminated to faculty and fellow classmates and various 
ANP competencies were displayed throughout the project.   
 It is ultimately hoped that implementation of the developed education modules 
within the Provincial Pulmonary Rehabilitation Program will improve the overall 
health/wellness and self-management abilities of individuals living with chronic lung 
disease in Prince Edward Island.  The resource will assist in advance nursing practice 
within the setting and with education delivery.  Steps for both implementation and 
evaluation have been identified within this report.  This practicum project has provided 
opportunity for both personal and professional growth.  Extensive knowledge related to 
chronic lung disease and pulmonary rehabilitation has been gained that I will utilize day 
to day while working with clients/families in clinical practice.  I have genuinely enjoyed 
the course work associated with this practicum project and will be forever grateful for 
these opportunities.   
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Integrative Literature Review 
 There are over three million individuals currently living with chronic lung disease 
in Canada (Public Health Agency of Canada, 2012a).  The term chronic lung disease 
refers to respiratory conditions such as, chronic obstructive pulmonary disease (COPD), 
which also encompasses chronic bronchitis and emphysema, pulmonary fibrosis, asthma, 
lung cancer, and tuberculosis.  Several terms currently exist referring to respiratory 
conditions.  For the purpose of this literature review the term chronic lung disease will be 
used which also represents the terms chronic respiratory disease and chronic pulmonary 
disease.   
The reality of living with chronic lung disease is burdensome and debilitating to 
both individuals living with the conditions and the health care system.  Individuals often 
report experiencing extreme shortness of breath while doing simple tasks associated with 
day-to-day living and are often left feeling breathless (World Health Organization, 2007).  
Ries et al. (2007) described chronic lung disease as disabling and indicated an association 
between chronic lung disease and increased mortality.  In fact, COPD is the only chronic 
condition that is still associated with an increasing mortality rate in Canada (Canadian 
Thoracic Society, 2010).   Chronic lung disease has a significant economic impact on the 
Canadian health care system, costing approximately 12 billion dollars annually (Public 
Health Agency of Canada).  COPD is the leading cause of hospital admission and is 
associated with higher rates of readmission when compared to all other chronic diseases 
(Canadian Thoracic Society, 2010).  To support the importance of intervention by various 
health care disciplines, the World Health Organization (2007) estimates that chronic lung 
disease will become the third leading cause of death by 2030.  Also noteworthy is the fact 
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that several conditions encompassed by chronic lung disease are in fact degenerative, 
indicating the potential for a gradual decline over time (Canadian Thoracic Society).  
Early intervention has the potential to slow this process and provide an overall benefit to 
individuals living with chronic lung disease.  The American Association of 
Cardiovascular and Pulmonary Rehabilitation (AACVPR, 2011) indicated that pulmonary 
rehabilitation demonstrates a secondary prevention intervention aimed at improving the 
quality of life of those living with chronic lung disease.  
The AACVPR (2011) recognizes and recommends pulmonary rehabilitation as an 
essential component of medical care for those living with chronic lung disease.  
Pulmonary rehabilitation includes exercise training and education, delivered by 
multidisciplinary health care professionals, with the goal of improving the overall 
physical and psychological health status of individuals living with chronic lung disease 
(Collins et al., 2014).  Pulmonary rehabilitation has been found to have a substantial 
impact on the overall quality of life of individuals living with chronic lung disease, 
regardless of age, sex, or current lung function (Roman et al., 2013).   
Until recently, pulmonary rehabilitation programming was not available to 
residents of Prince Edward Island (PEI) living with chronic lung disease.  Based on 
recommendations discussed above, an obvious need existed within the province in order 
to better assist and manage the care of individuals living with chronic lung disease.  
Pulmonary rehabilitation programming was initiated in the province in January 2017.  
The program is new and currently lacks an established education curriculum.  The 
proposed practicum project seeks to develop evidenced-based education modules to be 
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utilized by multidisciplinary staff for client and family teaching within the Provincial 
Pulmonary Rehabilitation Program.     
The purpose of this integrative literature review is to examine the topic of 
pulmonary rehabilitation, with a specific focus on recommendations of education topics 
to be incorporated into pulmonary rehabilitation programming. Literature appraised 
through this review will be utilized in the development of education modules for the 
Provincial Pulmonary Rehabilitation Program in the province of PEI.  A detailed 
description of pulmonary rehabilitation, from reviewed literature, as well as background 
and topic relevance will be discussed, in order to present an argument for the 
development of the pulmonary rehabilitation education modules.  Pender’s Health 
Promotion Model, first developed in 1982 (Pender, Murdaugh, & Parsons, 2006), and 
Knowles Adult Learning Principles (1970), will also be reviewed in relation to providing 
a framework for the development of the education modules.  Literature summary tables 
can be found in Appendix A detailing all relevant research studies discussed in the 
following integrative literature review.  The Critical Appraisal Tool Kit, developed by the 
Public Health Agency of Canada (2014) was used for critical appraisal of reviewed 
quantitative research studies.  Guidelines related to critical appraisal of qualitative 
research, provided by Moralejo (2016), were utilized for a reviewed qualitative study.         
Description of Search Strategy 
 An extensive literature search was conducted utilizing both the CINAHL and 
PubMed databases, accessed through the Memorial Health Sciences Library website.  The 
search was initiated within the CINAHL database using the search terms “pulmonary 
rehabilitation”, yielding 2971 results.  The search results were limited to academic 
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journals that had been published within the past five years in English.  This yielded 532 
results, 78 of which were deemed relevant to pulmonary rehabilitation.  A second search 
was completed utilizing the CINAHL database for the search terms “pulmonary 
rehabilitation” and “education”.  This yielded 41 results of which 11 were deemed 
relevant to pulmonary rehabilitation.  Six of the 11 results had been found with the 
previous search, leaving five additional results.  A search was then conducted utilizing the 
same search terms and narrowing criteria on the PubMed database, yielding 4541 results.  
Due to the large number of results, the search term “education” was added to narrow 
results, yielding 231 results, 54 of which were deemed relevant to pulmonary 
rehabilitation.  Despite being relevant to pulmonary rehabilitation, not all results were 
selected for utilization within the following integrative literature review.  For example, 
articles describing online or telehealth rehabilitation, studies pertaining to adolescents and 
children, and studies post rehabilitation were excluded.    
 Journal articles and books describing Pender’s Health Promotion Model (HPM) 
and Knowles Adult Learning Principles (1970, 1984) were also obtained during the 
following literature search. A search was conducted on the CINAHL database with the 
search terms “Pender” and “Knowles” utilizing the field author.  Various unrelated results 
were obtained from this search.  Another search was then completed also utilizing the 
search term “pulmonary rehabilitation”.  No studies were found specifically relating to 
either of the researchers and pulmonary rehabilitation, which was expected.  It was hoped 
that primary sources could be obtained detailing Pender’s HPM and Knowles’ adult 
learning principles.  This was not found on the CINAHL or PubMed databases.  A 
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primary source detailing Pender’s HPM was obtained from the University of Prince 
Edward Island Library and a copy of Knowles work was obtained via the Internet.     
 A subsequent Internet search of grey literature was also conducted in order to 
obtain relevant statistics and educational resources applicable to pulmonary rehabilitation.  
Various relevant resources were found and are included within the following integrative 
literature review.    
Background of Chronic Lung Disease  
Historically, chronic lung disease has been documented as far back as the 1600’s 
(Ebner, 2015).  Medical terminology has varied over the course of several centuries but 
the fundamentals of findings remain the same.  Physician documentations from several 
centuries ago have clearly documented alterations in lung size, inflammation to the 
mucous membranes, breakdown of lung tissue, and air trapping (Ebner, 2015; Heffner, 
2013).  Despite various advancements in pulmonary health, in relation to both knowledge 
and modern equipment, much of current practice still relies on historical developments.  
Of great significance to pulmonary health and wellness is Dr. Rene Laennec.  Through his 
development of the stethoscope in 1816, Dr. Laennec revolutionized pulmonary medicine 
and is know historically as the father of chest medicine (Vatanoglu-Lutz & Ataman, 
2016).  Today, over 200 years later, the stethoscope is widely utilized by health care 
providers, in various setting, on a daily basis.  
Globally, the World Health Organization (2009) estimates hundreds of millions of 
individuals living with chronic lung disease worldwide, accounting for approximately 4 
millions deaths annually.  The prevalence of lung disease is ever increasing in society.  
The Public Health Agency of Canada (2012b) estimates that approximately 770 000 
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Canadians are living with chronic lung disease.  While not curable, chronic lung disease 
is often preventable requiring education related to tobacco prevention, diet and lifestyle 
factors, and effects of air quality.  The financial impact of lung disease impacts both the 
health care system and individual families greatly (World Health Organization, 2009).    
Description of Pulmonary Rehabilitation and Topic Relevance 
Pulmonary rehabilitation has been widely discussed by various disciplines, 
including nursing, respiratory therapy, physiotherapy, and medicine, in reviewed 
literature.  Reviewed literature recommends pulmonary rehabilitation as an essential 
component of treatment for individuals living with chronic lung disease (Moamary, 
Aloriny, & Al-Hajjaj, 2014; Roman et al., 2013; Lan et al., 2013).  Pulmonary 
rehabilitation is designed for all patients with stable chronic lung disease that are living 
with associated symptoms, known to be at times disabling to the individuals (Ries, 2008).  
Pulmonary rehabilitation has been found to decrease dyspnea, enhance exercise tolerance, 
and improve overall health related quality of life (Rochester et al., 2015; Lan et al., 2013; 
Nici et al., 2006).  According to AACVPR (2011):  
Pulmonary Rehabilitation is an evidence-based, multidisciplinary, and 
comprehensive intervention for patients with chronic respiratory diseases who are 
symptomatic and often have decreased daily life activities.  Pulmonary 
rehabilitation includes patient assessment and goal setting, self-management 
education, exercise training, psychosocial support, and outcome measurement (p. 
1).   
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This definition highlights three important characteristics of effective pulmonary 
rehabilitation programming: multidisciplinary, individualized, and attention to physical 
and social function (Ries et al., 2007).    
The underlying goals of pulmonary rehabilitation are the following: (a) to 
optimize functional capacity and reduce or alleviate experienced associated symptoms, 
(b) to encourage active participation, and (c) to decrease dependence on the health care 
system, ultimately saving health care dollars (Nici et al., 2006; Moamary et al., 2014).  In 
addition, pulmonary rehabilitation provides opportunity for patients to be actively 
involved in striving to achieve their highest level of functionality possible (Ries et al., 
2007).   
Pulmonary Rehabilitation in Canada  
Aligning with AACVPR, the Canadian Thoracic Society (2010) recommended 
pulmonary rehabilitation for all individuals living with chronic respiratory disease.  The 
Society also indicated that pulmonary rehabilitation decreases dyspnea and optimizes 
functional status for individuals living with lung disease.  Despite documented benefits to 
pulmonary rehabilitation public access to these programs in Canada is low.  Specific to 
COPD, it is estimated that only about one percent of individuals living with the chronic 
condition in Canada have access to pulmonary rehabilitation (Camp et al., 2015; Roman 
et al., 2013).  Established programs in the country cannot meet current demand with an 
estimated national capacity of only approximately 10 000 patients annually.  Of specific 
personal interest and supporting rationale for the current integrated literature review and 
resulting proposed practicum project, Camp et al., in association with the Canadian 
Thoracic Society, produced a document report describing access to pulmonary 
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rehabilitation programs in Canada.  Background data in the report indicated that in 2005 
there was no access to pulmonary rehabilitation for Canadian residents in the territories, 
Newfoundland and Labrador, or PEI.  Camp et al. indicated in the 2015 report that at the 
time there were 155 facilities across the country offering pulmonary rehabilitation 
programming, stating that rehabilitation was offered in all provinces but still no access 
was available in the territories.  The report indicated that pulmonary rehabilitation 
programs were identified through a list obtained by the Canadian Lung Association 
website.  The only program listed on the site for PEI is a program that is no longer in 
place in the province.  In 2016, government funding was secured for a pilot pulmonary 
rehabilitation program.  Based on findings from the pilot, permanent funding for a 
Provincial Pulmonary Rehabilitation Program was secured.  The Program was initiated in 
two locations across the province in January 2017.  Literature appraised through this 
integrative review will be utilized in the development of education modules for the 
above-mentioned  
Program.              
Various delivery methods are currently incorporated into pulmonary rehabilitation 
programs within Canada including community based, hospital-based outpatient, hospital-
based inpatient, telehealth, and home based (Camp et al., 2015; Rochester et al., 2015).  
Moamary et al. (2014) described community based pulmonary rehabilitation programs to 
be more cost effective in comparison to hospital-based programs.  The Pulmonary 
Rehabilitation Program for which the proposed education modules are intended for is 
community-based for the province of PEI.     
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Benefits of Pulmonary Rehabilitation 
There are several benefits to pulmonary rehabilitation and they are described in 
reviewed nursing literature.  A report by Rochester et al. (2015), in association with the 
American Thoracic Society, indicated pulmonary rehabilitation is important to improve 
health related qualify of life (HRQOL), muscle strength and endurance, exercise capacity, 
functional capacity, and emotional function.  They identified indicated that pulmonary 
rehabilitation reduces hospitalizations, healthcare visits, and symptoms of dyspnea.  Also 
noteworthy, pulmonary rehabilitation has been shown to enhance knowledge, self-
efficacy, and self-management abilities (Rochester et al.). Pulmonary rehabilitation 
guidelines developed by AACVPR (2011) states that pulmonary rehabilitation provides 
the most benefit, in relation to symptom management, exercise tolerance, and overall 
quality of life, to patients when compared to other treatment options.  Based on the 
integrative integrated literature review, there is a paucity of information related to 
pulmonary rehabilitation for clients/families.  Based on the literature review, research 
evidence describing the benefits of pulmonary rehabilitation was critically analyzed and 
will be presented below  
A quantitative research study conducted by Jacome and Marques (2014) explored 
the benefit of pulmonary rehabilitation pertaining to various health domains including 
dyspnea, functional balance, muscle strength, exercise tolerance, emotional state, and 
health related quality of life (HRQOL).  In support of relevance for the study, these 
authors identified that at that time no research was available that specifically examined 
the effects on pulmonary rehabilitation on the above mentioned health domains.  Twenty-
six participants attended a 12-week pulmonary rehabilitation program.  Various outcome 
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measures were assessed for example, pre and post intervention utilizing both medical 
testing and questionnaire.  Following data analysis, no impact was noted related to 
participant lung function.  This would be an expected finding as there is no cure for 
chronic lung disease.  The study did find a statistically significant improvement in 
participant dyspnea (p < 0.003), functional balance (pre 7.8 seconds and post 6.7 seconds; 
p < 0.001), and muscle strength (pre 2.3-4.1 kg and post 3.6-6.7 kg; p < 0.001).  In 
addition, the participant pre and post exercise tolerance was also assessed, utilizing a Six 
Minute Walk Test (6MWT).  Results found a mean improvement of 32 meters (p < 
0.001).  While Jacome et al. (2014) described a benefit of pulmonary rehabilitation in 
relation to various health domains, the results are not generalizable due to a small sample.   
Researchers Lan et al. (2013) also identified a further gap in available research 
related to pulmonary rehabilitation.  Although it is known that the overall benefit of 
pulmonary rehabilitation varies among individuals, they further hypothesized that all 
individuals, regardless of the severity of lung disease, benefit from pulmonary 
rehabilitation.  They conducted a quantitative study to investigated the benefit of 
pulmonary rehabilitation among 26 participants with existing normal exercise capacity.  
Outcome measures were assessed both pre and post intervention of a 12-week pulmonary 
rehabilitation program. Results indicated a statistically significant improvement, p < 0.05 
for the following domains: HRQOL, level of exertional dyspnea, and respiratory muscle 
strength.  The researchers also noted a significant improvement (p < 0.001) in exercise 
capacity, defined by a mean increase of 101.3 ml/min and 8.2 watts on cardiopulmonary 
exercise test, despite participants having a pre intervention normal exercise capacity.  
They concluded that pulmonary rehabilitation is beneficial and appropriate for patients 
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with chronic lung disease who have a normal exercise capacity.  Therefore this study 
demonstrates the benefit of secondary prevention.  However, due to the small sample size, 
it is not generalizable to the general population.     
Through the conducted integrative literature review, two research articles were 
found that specifically addressed the topics of anxiety and depression associated with 
chronic lung disease.  Bhandari, Jain, Marolda, and ZuWallack (2013) stated that 
previous research indicates prevalence rates of anxiety and depression, associated with 
chronic lung disease, ranges from ten to 80 percent.  Although these researchers 
hypothesized that pulmonary rehabilitation decreases symptoms of anxiety and 
depression; they also identified that little is currently known regarding the ability of 
pulmonary rehabilitation to produce a clinically meaningful improvement in these 
symptoms.  A quantitative study by the researchers, encompassing a sample of 235 
participants, investigated the effect of pulmonary rehabilitation on the domains of anxiety 
and depression.  Study results indicated a statistically significant improvement (p < 
0.001) on both domains.  Rates of reported anxiety decreased from 25 to nine percent post 
intervention, while rates of depression decrease from 17 to six percent.   
In The second study, Bentsen, Wentzel-Larsen, Henriksen, Rokne, & Wahl (2013) 
reported that chronic lung disease is complex with various associated symptoms, 
including anxiety and depression for individuals.  They defined symptom as “a subjective 
experience reflecting changes in function, sensations, or cognition” (p. 541) and also 
identified the term self-efficacy through their work.  They referred to self-efficacy as the 
confidence associated with self-management.  Results of the study showed that increased 
exercise capacity, developed through a 6-week pulmonary rehabilitation program, was 
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associated with decreased levels of depression.  They further found that increased self-
efficacy occurred through pulmonary rehabilitation and it is associated with decreased 
levels of anxiety and depression.  Interestingly, the study results indicated that women 
report higher levels of anxiety as compared to men.  Therefore, Betsen et al. concluded 
that within their study, levels of anxiety and depression decreased during and post 
pulmonary rehabilitation, however results were not found to be statistically significant (p 
> 0.05).  This was in part attributed to low levels of reported anxiety and depression pre 
intervention as well as a limitation of a low response rate (41%).     
 The majority of the previously discussed reviewed research identified an 
immediate benefit to pulmonary rehabilitation, but it did not address the impact over time.  
Donesky, Citron, Hilling, Cayou, and Millie (2015) examined long-term outcomes 
following pulmonary rehabilitation for individuals.  The quantitative study by the 
researchers encompasses a large sample size of 755 participants.  The researchers found 
that approximately 65% of participants self-reported an improvement in general health for 
at least three years post pulmonary rehabilitation programming.  Participants also reported 
utilizing strategies taught in pulmonary rehabilitation and continuing an exercise regime 
at seven years post pulmonary rehabilitation.   Of great importance was data collected 
related to utilization of health care services.  Donesky et al. (2015) reported a decrease in 
emergency room visits and hospitalizations by approximately 18% one-year post 
pulmonary rehabilitation.   
While Roman el al. (2013) raised the question as to whether delivery method and 
duration have an impact on long-term benefit to pulmonary rehabilitation, study results 
indicated minimal differences when comparing three month pulmonary rehabilitation 
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programming, identified as the RHB group, versus three month programming plus nine 
month follow-up, identified as the RHBM group (CRQ emotion score RHB group 0.7 to 
0.5 and RHBM group 0.9 to 0.7, 95% CI and p < 0.05; CRQ fatigue score RHB group 0.3 
to 0.3 and RHBM group 0.5 to 0.56).  No statistical difference (p > 0.05) was found in 
relation to 6MWT or pulmonary function.  This study introduces an additional area of 
required research in which both patient benefit and program cost would be assessed 
together.  
Education in Pulmonary Rehabilitation 
Previously discussed research clearly indicates a benefit to pulmonary 
rehabilitation.  An essential component of pulmonary rehabilitation is education.  
Recommendations related to pulmonary rehabilitation education topics and delivery 
methods will be discussed below.          
Education Recommendations  
Education is a core component of pulmonary rehabilitation (Nici et al., 2006).  
Canadian specific guidelines for pulmonary rehabilitation do not currently exist (Camp et 
al., 2015).  At the present time, the Canadian Thoracic Society recommends adhering to 
guidelines produced by the AACVPR (2011).  The AACVPR indicated that education is 
an essential component of pulmonary rehabilitation.  They further identified that 
educational needs of patients should be incorporated into the initial patient assessment.  
Education addressing specific patient needs should subsequently be incorporated into 
delivered materials.  This idea was supported through recommendations of tailored 
education to individual patient needs and incorporation of patient determined goals into 
pulmonary rehabilitation programming (Moamary et al., 2014;  Nici et al.).   
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Although specific guidelines for pulmonary rehabilitation do not currently exist 
within Canada, programming related to COPD education does exist with the program 
Living Well with COPD: A Plan of Action for Life (2017), with the first edition 
implemented in 1998.  The program was developed in partnership by McGill University 
Health Center and the Quebec Health Ministry and provides evidenced-based education 
known to improve the overall quality of life of patients.   
Only one study was found pertaining to the implementation of the Living Well 
with COPD Program in a Canadian pulmonary rehabilitation setting.  Cosgrove, 
MacMahon, Bourbeau, Bradley, and O’Neill (2013) described this program as well 
structured, evidenced-based, and to promote self-management behaviors.  They reported 
that the program has been widely utilized but not specifically in the pulmonary 
rehabilitation setting.  A quantitative study by these researchers adapted the program for 
education within the pulmonary rehabilitation setting and subsequently evaluated the 
effectiveness of the programming.  The adapted program encompassed six educational 
topics:  
• Management of breathlessness 
• Energy conservation 
• Overview of action plan and management of an exacerbation 
• COPD medication and appropriate use of inhalation devices 
• Management of stress, anxiety, and depression 
• Continuing exercise and self-management strategies  
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Educational sessions were also adapted to be delivered in 30 to 45 minutes.  Study results 
indicated that the adapted education materials were well accepted by both patients and 
health care providers.  Approximately 98% of the 57 participants rated the educational 
materials as good or excellent.  Feedback obtained from the study lead to further adaption 
of materials and additions of topics such as, healthy eating and smoking cessation into the 
programming.  The Understanding COPD Questionnaire (2012) was utilized to measure 
the effectiveness of educational programming.  Statically significant results (p < 0.001) 
were observed on all five domains of the questionnaire post intervention.  The mean 
change (%) was calculated for each domain resulting in the following: About COPD 
domain 23.78, Managing Symptoms domain 26.64, Accessing Help and Support domain 
32.14, Section A Total 26.75, and BCKQ 10.64.   Overall the researchers concluded that 
the Living Well with COPD program could be adapted and used for the delivery of 
excellent quality and consistent education sessions within a pulmonary rehabilitation 
setting.  This study was of specific personal interest as the pilot program for the 
Pulmonary Rehabilitation Program in PEI based the educational component of the 
program on resources obtained from the Living Well with COPD Program.   
Recommended Education Topics 
   The following list describes education topics recommended by the AACVPR 
(2011):  
• Normal pulmonary anatomy and physiology  
• Pathophysiology of chronic lung disease  
• Description and interpretation of medical tests 
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• Breathing strategies  
• Secretion clearance 
• Medications 
• Respiratory devices  
• Benefits of exercise and maintaining physical activities  
• Activities of daily living  
• Eating right  
• Irritant avoidance  
• Early recognition and treatment of exacerbations 
• Leisure activities  
• Coping with chronic lung disease  
• End of life planning  
The previously listed educational topics are supported in the research conducted by 
Moamary et al. (2014) and Camp et al. (2015).  Recommended topics by these 
researchers parallel those by AACVPR but require the addition of energy conservation, 
oxygen therapy, anxiety and panic control, and sexuality related to lung disease.   
 AACVPR (2011) and Moamary et al. (2014) further recommended education to 
be in the form of self-management education for individuals.   Through self-management 
education patients learn by doing rather than simply sitting listening to a traditional 
lecture.  Patients are encouraged to be active participants and as a result develop both 
knowledge and self-confidence.  Self-management education promotes problem solving, 
goal setting, and healthy behavioral changes.  Such education equips patients with the 
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knowledge and skills required to partake in problem solving, followed by action when 
faced with an acute exacerbation of their disease.  This is turn promotes early 
intervention, decreases the likelihood of a hospital admission, and ultimately decrease 
incidence of mortality (Moamary et al., 2014; Nici et al., 2006).  A review by Osadnik et 
al. (2015) identified behavioral modification as a goal of pulmonary rehabilitation 
education.  The authors suggested that self-management education is required in order to 
stimulate behavioral modification.  Self-management education promotes long-term, 
sustainable, health-promoting behaviors that will ideally extend beyond completion of a 
pulmonary rehabilitation program.  Associated chronic lung disease risk factors such as 
smoking, obesity, poor nutrition, non-compliance with medications, and inactivity can be 
addressed through self-management education with the hope of enlisting behavioral 
modification among clients in the program.         
Osadnik et al. (2015) raised the concern that research has been conducted 
indicating the benefit of exercise training in relation to pulmonary rehabilitation but little 
research currently exists pertaining to education and sustainability.  While clearly 
indicating that education promotes knowledge and confidence related to disease self-
management, the authors also questioned the benefit of education, related to method of 
delivery, indicating that traditional didactic teaching methods typically do not benefit 
patients.  A lack of research related to pulmonary rehabilitation education was identified 
through this review and presents itself as an area for future research.  
 There is currently a lack of research that explores the benefit of structured 
education in pulmonary rehabilitation programming (Casey et al., 2013).  In an attempt to 
expand such knowledge, the Pulmonary Rehabilitation in Nurse-led Environment 
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(PRINCE) study was conducted (Casey et al., 2013; Casey, Murphy, Cooney, Mee, & 
Dowling, 2011).  Through the PRINCE study it was recognized that pulmonary 
rehabilitation is a key component of care for individuals living with chronic lung disease 
and that primary healthcare nurses are essential to the delivery of successful pulmonary 
rehabilitation programming (Casey et al., 2011).  Education developed and delivered 
through the PRINCE study was defined as structured education.  In comparison to 
unstructured education, structured education is more effective in fostering self-
management behaviors in individuals living with chronic disease (Casey et al., 2013).  
Structured education is delivered by a trained educator, has a pre-planned and structured 
curriculum, is comprehensive and flexible in scope, and incorporates the expressed 
individual needs of patients participating in the program (Casey et al., 2011).  Also of 
significance, structured education should incorporate principles of adult learning, be 
readily accessible, and utilize various teaching methods.  Structured patient education was 
based on eight topics during the PRINCE study including:  
• Setting the scene  
• Managing medications and oxygen   
• Introduction to exercise 
• Managing breathlessness 
• Knowing and managing your symptoms  
• Recognizing and managing acute exacerbations  
• Managing stress and anxiety   
• Where to now (Casey et al, 2011)  
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The qualitative study utilized the Chronic Respiratory Questionnaire, developed in 2001, 
in order to measure disease specific quality of life post structured education intervention.  
Statistically significant results (p < 0.01) were observed, for individuals of the 
intervention group, in relation to the overall score on the Chronic Respiratory 
Questionnaire, with an adjusted mean pre and post difference of 1.11.  Results also 
indicated a significant increase of calculated dyspnea scores, with an adjusted mean 
difference of 0.49, as well as physical scores, with an adjusted mean difference of 0.37 
(Casey et al., 2013).  A noted limitation of the study was the exclusion of patients 
classified as having severe COPD.  Further research, incorporating the previously 
mentioned population would enhance the study’s generalizability to the population.         
The Patient Perspective 
 During the literature search, only one article was found detailing the patient’s 
perspective in relation to pulmonary rehabilitation education.  The qualitative study, 
conducted by Wilson, O’Neill, Reilly, MacMahon, and Bradley (2007), explored the 
identification of topics patients felt should be included in pulmonary rehabilitation 
education.  Purposive sampling was utilized to obtain patients to participate in focus 
groups discussing educational needs and preference of delivery methods.  Interestingly, 
patient identified education topics were similar to those recommended by AACVPR 
(2011) and Moamary et al. (2014).  Six education topics, identified by patients in the 
focus groups, include:  
• Disease education  
• Management of breathlessness and the physical impact of COPD  
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• Management of an exacerbation  
• Medication  
• Psychosocial support  
• Welfare and benefits system  
Recommendations reviewed did not incorporate the patient identified topic of welfare and 
benefits system.  Patients in the study identified a significant cost associated with chronic 
lung disease and further identified difficulty and frustration associated with accessing 
assistance from publicly funded programming.   
 Wilson et al. (2007) addressed the patient perspective in relation to education 
delivery.  They found that patients prefer a group environment and enjoy the social 
support associated with a group setting, that education utilized should be accurate and 
credible, however, presented in layman’s terms, and that patients would like supplemental 
information supporting education presented during pulmonary rehabilitation.  Preference 
of frequency of programming varied from multiple times per week to monthly sessions.  
Overall participants expressed the idea that if the education was perceived to be beneficial 
they would attend it.  A location with adequate parking, close to the facility, was also 
identified as important to patients (Wilson et al., 2007).  
 There was limited reference to the role of the family in relation to pulmonary 
rehabilitation in the reviewed literature.  While Momary et al. (2014) suggested a benefit 
to family participation in pulmonary rehabilitation programming, Marques et al. (2015) 
indicated that family involvement in pulmonary rehabilitation programming is typically 
minimal.  They reported that family involvement promotes collaborative care, helps build 
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an effective support system for patients, and increases the competence and confidence of 
family in relation to assisting their loved ones to manage chronic lung disease.  A 
qualitative study by Marques et al., involving 35 patient and 35 family member 
participants, indicated that patients want their family members to participate in pulmonary 
rehabilitation programing.  Patients in the study indicated that family member 
participation would result in an increase in knowledge by their loved one and would also 
provide opportunity to enhance relationships.  The researchers indicated that further 
research is required to examine long-term benefits of family participation in pulmonary 
rehabilitation and associated economic costs.       
Theoretical Framework 
 A theoretical framework is an essential component to evidence-based professional 
practice and nursing research (Nilsen, 2015) through validation of work and facilitation of 
implementation.  For the purpose of the proposed practicum project, Pender’s Health 
Promotion Model (2006) and Knowles Adult Learning Principles (1970) will be utilized 
as a theoretical frameworks.    
Pender’s Health Promotion Model 
 Dr. Nola Pender’s Health Promotion Model (HPM) was first introduced to nursing 
literature in 1982 and was further developed and revised in 1996 (Pender et al., 2006).  
The revised HPM can be found in Appendix B.  Pender et al. (2006) defined health 
promotion as “behavior motivated by the desire to increase well-being and actualize 
human health potential” (p. 7).  They further referred to person as an individual with 
unique characteristics and experiences that can be influenced by the environment.  
Individuals seek environments that are health promoting.  The environment has a social, 
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cultural, and physical component.  Health and illness are separate entities that can coexist.  
Illness represents a discrete event, acute or chronic in nature, that can hinder or facilitate 
health.  “Health can still be an aspiration to those with a chronic illness, and health can be 
achieved despite being diagnosed with a disease” (Pender et al., p. 19).   
The HPM examines factors that influence health behaviors and incorporates an 
individual’s interpersonal and physical environment.  The model seeks to illustrate 
processes that motivate individuals to engage in health promoting behaviors.  
Acknowledged within the HPM is the idea that individuals have unique characteristics 
and experiences that in turn influence their actions or behaviors.  The model also 
describes behavior specific variables that can be modified through nursing action.  These 
variables represent health promoting behaviors that result from intervention.  There are 
three underlying constructs of the HPM (Pender et al., 2006):  
• Individual characteristics and experiences refer to the unique traits of an 
individual that influences their actions.  Within the model actions are linked to 
health behaviors.  Particular characteristics or experiences may be perceived as 
more relevant or significant depending on the desired health behavior.  Prior 
related behaviors and personal factors encompass this construct.    
• Behavior specific cognition and affect refers to variables that are essential for 
intervention.  The HPM identifies the fact that nursing actions can influence 
modification on these variables.  Both the concepts of perceived benefits and 
barriers to action, as well as perceived self-efficacy and encompassed within this 
construct.   
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• Behavioral outcomes or the health-promoting behavior is the outcome of the 
HPM.  A developed health-promoting behavior ultimately leads to improved 
health, functional ability, and overall quality of life.  A commitment to a plan of 
action is required to develop a health-promoting behavior.  Competing demands 
may at times influence an individual’s plan of action, ultimately affecting the 
probability of successfully developing a health-promoting behavior.     
Pender’s HPM (2006) has be widely utilized in nursing research and literature, 
speaking to the model’s applicability (Alkhalaileh, Khaled, Baker, & Bond, 2011).  
Identification of health promoting behaviors and direction for intervention are provided 
through the model.  However, the HPM has not been utilized as a theoretical framework 
in the pulmonary rehabilitation setting.  This presents an area for future development and 
research.  Concepts contained within the HPM are applicable to pulmonary rehabilitation 
and provide a theoretical framework that will be utilized during the development of the 
proposed education modules.  The model identifies that patients will have individual 
characteristics and experiences that will define the knowledge they currently have, and 
will potentially influence the way they learn or process information.  This emphasizes the 
importance of tailoring education to individual patient needs and utilizing patient goal 
setting in curriculum development, as previous discussed within this literature review.  
Delivery of pulmonary rehabilitation education is a multidisciplinary action that will 
potentially influence behavior modification.  The model serves as a tool in facilitating 
patients to the phase of developing health-promoting behaviors, which is the ultimate goal 
of pulmonary rehabilitation education.     
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Principles of Adult Learning 
 Throughout the integrative literature review, education was clearly identified as an 
essential component of pulmonary rehabilitation programming.  As the intended 
population for this review was adults, the question of how health care professionals can 
effectively educate adults becomes important.  Work by Malcolm Knowles (1970) is 
recognized within nursing literature to have provided a theoretical foundation for adult 
learning (Mitchell & Courtney, 2005).  Work by Knowles, related to principles of adult 
learning, identified various characteristics as significant to adult learning (Knowles, 1970; 
Knowles, 1984):  
• Self-concept refers to the idea that as individuals move from childhood to 
adulthood they develop a personal self-concept, which moves away from 
dependence and towards self-direction (Knowles, 1970).  Adult learners feel a 
sense of responsibility for their own learning.  They require acceptance, respect, 
and support in the classroom setting.  Adults have the ability to convey their own 
personal learning needs.         
• Adults have personal and unique experience that influences their learning 
(Knowles, 1970).  Adults often utilize their experience to define their identity.  
Theses experiences serve as a foundation for new learning and enable adults to 
contribute to education. Experience is associated with the development of habits, 
which may cause adult learners to be at times closed-minded.     
• A readiness to learn is developed throughout the lifespan (Knowles, 1970).  Adult 
readiness to learn is often dependent on their personal social roles.        
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• Orientation to learning refers to the time perspective that is associated with 
learning (Knowles, 1970).  Adults associate immediacy of application with 
learning, and engage in learning based on a need related to their current life 
situation.  Adult learners tend to be problem or performance centered.      
• Adults are motivation to learn (Knowles, 1984).  Motivation to learn is typically 
internal.  Adults learn best if they perceive education to be personally relevant.       
Knowles (1970) identified that adults can learn.  It is the responsibility of the 
educator to foster this ability to learn.  Adults typically have been away from formal 
education for a period of time.  This may result in loss of confidence in one’s ability to 
learn.  Adult learners also present with physiological changes, as a result of aging, that 
may impact learning (Knowles, 1970).  Conditions or environments of learning should 
recognize these changes.  
Knowles work provides guidelines and principles to be incorporated into the 
development of education modules to be utilized in the pulmonary rehabilitation setting.   
Conclusion 
Chronic lung disease is a disabling condition, associated with various symptoms 
that can create barriers in an individual’s overall quality of life.  Therefore, evidence has 
shown that An pulmonary rehabilitation can play a valuable role in an individual’s well-
being.  Examples include: decreasing dyspnea associated with chronic lung disease, 
enhancing exercise tolerance, and improving overall health related quality of life 
(Rochester et al., 2015; Jacome and Marques, 2014; AACVPR, 2011).  Pulmonary 
rehabilitation is widely recommended as essential to the treatment and management of 
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chronic lung disease in individuals (AACVPR).  Education delivered through pulmonary 
rehabilitation programming promotes self-management, which in turn facilitates health-
promoting behavior modification.  This encourages active participation by individuals, 
allowing them to take control of their disease.  Pulmonary rehabilitation has also been 
identified to financially benefit the health care system through decreased utilization of 
resources.       
Benefits of pulmonary rehabilitation were well documented through the current 
literature review.  Despite this, various gaps in research were observed, presenting areas 
for future development and research.  Multiple reviewed studies were in fact contributors 
of new knowledge to pulmonary rehabilitation literature.  Standardized education 
guidelines specific to pulmonary rehabilitation in Canada do not currently exist.  This 
presents a challenge related to educational curriculum development.  It is currently 
suggested that guidelines developed by AACVPR (2011) be utilized for the development 
of pulmonary rehabilitation curriculum.  Several topics applicable to pulmonary 
rehabilitation education have been identified through this review and will be utilized 
during the development of pulmonary rehabilitation education modules.  Of importance is 
the fact that the patient perspective of key educational topics parallels that of current 
existing literature.  Pender’s HPM (2006) and Knowles Adult Learning Principles (1970), 
are relevant to the topic of pulmonary rehabilitation education and will serve as a 
theoretical framework during the development of education modules relevant to this 
literature review.  
 In closing, the integrated literature review indicates benefits of pulmonary 
rehabilitation to both individuals living with chronic lung disease and the health care 
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system.  Essential to pulmonary rehabilitation is the delivery of quality, evidenced-based 
education by multidisciplinary health care professionals.  The preceding step to education 
delivery is the development of pulmonary rehabilitation education modules.  The 
proposed practicum program seeks to develop such education modules.  Ultimately, it is 
hoped that these modules will be implemented within the Provincial Pulmonary 
Rehabilitation Program in PEI, and serve as a resource to both multidisciplinary staff in 
the setting as well as clients and family members of the Program.      
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Appendix A 
 
Table 1 
 
Literature Summary Table  
 
Author, Name, 
Date, 
Objective 
Sample and 
Setting 
Design and 
Methodology 
Key Results and 
Findings 
Strengths/Limitations Conclusion and 
Rating 
Jacome & 
Marques (2014).  
 
Impact of 
Pulmonary 
Rehabilitation in 
Subjects with 
Mild COPD 
 
Objective: to 
assess the effects 
of pulmonary 
rehabilitation 
(PR) on lung 
function, 
dyspnea, 
functional 
balance, muscle 
strength, 
exercise 
tolerance, 
emotional state, 
and HRQOL  
Setting: Two primary 
care centers 
 
Participants: 26 
participants, 16 male 
and ten female, mean 
age 67.8yrs  
 
Inclusion Criteria:  
• Diagnosis of mild 
COPD 
• > 18yrs of age 
• Clinically stable 
for 1 month prior 
to study  
Exclusion Criteria: 
• Severe 
psychiatric, 
neurologic or 
musculoskeletal 
condition 
• Unstable 
cardiovascular 
disease 
Design: Quantitative; 
analytic uncontrolled 
before-after  
 
12 week PR program 
with exercise training 
and education  
 
Socio-demographic 
and clinical data 
obtained to 
characterize sample 
 
Outcome measures 
obtained to assess 
lung function, 
dyspnea, functional 
balance, muscle 
strength, exercise 
tolerance, emotional 
state, and HRQOL 
pre and post PR 
program.    
Level of significance 
set at < 0.05 
 
PR program had no 
effect on lung 
function  
 
Reduction in dyspnea 
observed (p < .003) 
and improvement in 
functional balance and 
muscle strength 
observed (p <.001) 
 
6MWT distance 
improved by ~32m 
 
Statistical significant 
not observed related 
to depression, anxiety, 
stress, or HRQOL 
despite a noted 
improvement in 
scores   
Strengths: 
• Approval obtained 
from institutional 
ethics committee 
• Participant informed 
consent obtained 
prior to data 
collection 
 
Limitations: 
• No control group 
• Small sample size 
• Same health care 
providers delivered 
PR program and 
conduction evaluation 
of study  
 
Strength of 
Design: 
Weak  
 
Quality of Design:  
Medium  
 
Identified as first 
study to examine 
effects of PR on 
various health 
domains.   
 
Study significant 
to nursing practice, 
provides rationale 
for future research 
on the topic.  
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Table 2 
 
Literature Summary Table  
 
Author, Name, 
Date, Objective 
Sample and Setting Design and 
Methodology 
Key Results and 
Findings 
Strengths/Limitations Conclusion 
and Rating 
Lan et al. (2013). 
 
Benefits of 
Pulmonary 
Rehabilitation in 
Patients with COPD 
and Normal 
Exercise Capacity  
 
Objective: to 
investigate the 
effects of PR in 
patients with 
normal exercise 
capacity on 
HRQOL, exercise 
capacity, dyspnea, 
and muscle strength  
Setting: out-patient 
pulmonary rehabilitation 
program 
 
Participants: 26 
participants  
 
Inclusion Criteria: 
• Diagnosis of COPD 
and Normal exercise 
capacity 
• Stable from 
exacerbations 
• Maximal O2 uptake 
of 85% during 
exercise test 
• Ability to mobilize 
independently  
 
Exclusion Criteria: 
• Use of oral 
corticosteroids 
• History of other 
lung disease 
• Cardiovascular 
impairment  
Design: 
Quantitative; 
analytic 
uncontrolled 
before-after 
 
12-week PR 
program, 
participants 
attended twice 
weekly  
 
Outcome 
measures 
obtained to 
assess PFT, 
respiratory 
muscle strength, 
exercise stress 
test, and HRQOL 
pre and post 
intervention.  
Level of significance 
set at < 0.05 
 
Participants displayed 
an 8.4% improvement 
in exercise capacity 
post PR despite 
having a normal 
exercise capacity pre 
PR.   
 
Statistically 
significant (p < .001) 
improvements in all 
domains of the St. 
Georges Respiratory 
Questionnaire were 
observed post PR.  
 
Improvement was 
noted in related to 
respiratory muscle 
strength (p < .05) and 
level of exertional 
dyspnea (p = .01) 
Strengths: 
• Study identified gap in 
current research 
• Ethics approval 
obtained from 
associated hospital and 
medical foundation  
• Informed consent 
obtained from all 
participants 
 
Limitations: 
• Small sample size  
• Assessment of exercise 
capacity not assessed 
within study design pre 
PR  
• Lung function not 
assessed within study 
design  
• Participants recruited 
from single clinic  
 
Strength of 
Design:  
Weak  
 
Quality of 
Design: 
Medium  
 
Identified as 
first study to 
examine effect 
of PR on 
individuals with 
normal exercise 
capacity 
 
Topic requires 
further study  
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Table 3  
 
Literature Summary Table  
 
Author, Name, 
Date, Objective 
Sample and Setting Design and 
Methodology 
Key Results and 
Findings 
Strengths/Limitations Conclusion 
and Rating 
Bentsen et al. 
(2012).  
 
Anxiety and 
Depression 
Following 
Pulmonary 
Rehabilitation 
 
Objective: to 
evaluate changes 
in anxiety and 
depression post 
PR and to 
identify 
predictive factors  
Setting: 6-week outpatient PR 
program; study part of a larger 
study projected to incorporate 
a total of four studies   
 
Participants: 100 participants 
diagnosed with moderate to 
severe COPD invited to 
participate, 54 of which 
completed PR program; mean 
age 66.1yrs; 99% current or 
ex-smokers 
 
Inclusion Criteria: 
• >35yrs  
• Symptoms including 
breathlessness, chronic 
cough, and sputum 
production  
• FEV1/FEC <70% and 
FEV1 <80% predicted 
• Able to read Norwegian 
Exclusion Criteria:  
• Long-term oxygen 
treatment 
• Unstable heart disease 
Design: Quantitative; 
analytic uncontrolled 
before-after; 
longitudinal   
 
Theoretical framework 
Bandura’s Social 
Cognitive Theory  
 
Prior to intervention 
all participants 
assessed by physician  
 
Outcome measures 
obtained to assess 
exercise capacity and 
lung function. 
 
Questionnaires utilized 
to assess 
anxiety/depression, 
self-efficacy, and 
demographics 
Anxiety and 
depression tended 
to decrease 
immediately post 
PR but results were 
not statistically 
significant  
 
Females reported 
higher anxiety rates 
(p < .019)  
 
Individuals with 
better exercise 
capacity reported 
decreased levels of 
depression (p < 
.049)  
 
Self-efficacy 
decreased anxiety 
(p < .001) and 
depression (p < 
.005) 
Strengths: 
• Questionnaires valid 
and reliable.  
• Ethical approval and 
informed consent 
obtained  
• Longitudinal design 
with four repeated 
measurements 
 
Limitations: 
• Completion rate 54% 
• PR program only six 
weeks in duration  
• Pre levels of 
anxiety/depression 
reported as low, may 
speak to minimal 
change observed  
 
Strength of 
Design: 
Weak  
 
Quality of 
Design: 
Medium 
 
Study 
applicable to 
nursing 
practice.  
Serves as a 
framework for 
future research.  
Significant 
topic due to 
rates of anxiety 
(eight-37%) 
and depression 
(16-88%) 
identified in 
previous 
research.   
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Table 4 
 
Literature Summary Table  
 
Author, Name, 
Date, Objective 
Sample and 
Setting 
Design and 
Methodology 
Key Results and 
Findings 
Strengths/Limitations Conclusion and 
Rating 
Bhandari et al. 
(2013).  
 
Comprehensive 
Pulmonary 
Rehabilitation 
Results in Clinically 
Meaningful 
Improvements in 
Anxiety and 
Depression in 
Patients with 
Chronic Obstructive 
Pulmonary Disease  
 
Objective: to 
examine clinically 
meaningful 
improvement in 
anxiety and 
depression post 
pulmonary 
rehabilitation  
Setting: hospital 
based pulmonary 
rehabilitation center 
 
Participants: 366 
patient records 
retrospectively 
reviewed, 235 
records indicated 
completion of PR 
program and had 
post rehabilitation 
outcome data   
 
Inclusion Criteria: 
• Clinical 
diagnosis of 
COPD 
• FEV1 <80% 
predicted 
 
Exclusion Criteria: 
• Not identified  
 
Design: 
Quantitative; 
analytic inadequate 
interrupted time 
series    
 
Outcome measures 
for 6MWT, number 
of unsupported arm 
lifts, Chronic 
Respiratory Disease 
Questionnaire 
(CRQ), and anxiety 
and depression 
scores assessed pre 
and post PR during 
the program  
 
Patient records, 
spanning eight yrs 
of PR program 
attendance, 
reviewed  
  
Improvement 
observed on all 
outcome measures  
 
Percentage of 
improvement… 
6MWT 18%  
Arm lifts 30% 
CRQ 22% 
Anxiety score 16% 
Depression 27% 
All improvements 
statistically 
significant (p < .05) 
 
Reported anxiety 
rate dropped from 
25 to nine percent 
post PR  
 
Reported depression 
rate dropped from 
17 to six percent 
post PR 
 
Strengths: 
• Institutional review 
board approval received 
• Large sample 
• Use of valid and 
reliable outcome 
measures  
 
Limitations: 
• Authors did not state 
whether participant 
consent was obtained 
for record review  
• Retrospective design  
• No control group 
 
Strength of 
Design:  
Weak 
 
Quality of Design: 
Medium  
 
Findings 
generalizable 
 
Study significant 
to nursing practice  
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Table 5  
 
Literature Summary Table  
 
Author, 
Name, 
Date, 
Objective 
Sample and Setting Design and 
Methodology 
Key Results and Findings Strengths/Limitation
s 
Conclusion 
and Rating 
Donesky et 
al. (2015). 
 
Additional 
Evidence for 
the Long-
Term 
Benefits of 
Pulmonary 
Rehabilitatio
n  
 
Objective:  
To evaluate 
long-term 
outcomes 
following 
pulmonary 
rehabilitatio
n 
Setting: Community 
based pulmonary 
rehabilitation program 
in San Francisco Bay   
 
Participants: 755 
participants; mean age 
71; 60% female; 85% 
diagnosed with 
moderate-severe 
COPD  
  
Inclusion Criteria:  
• Completed PR at 
the participating 
program between 
2000 and 2009 
• Completed at least 
one follow-up 
questionnaire  
Exclusion Criteria:  
• Not identified  
Design: Quantitative; 
analytic inadequate 
interrupted time series, 
longitudinal     
 
Hypothesized that ER 
visits and hospitalizations 
would decrease post PR 
 
Participants mailed a 
questionnaire at 6mths, 
1yr, and then yearly 
 
Questionnaire r/t ER 
visits, hospitalizations, 
current health, smoking, 
and adherence to 
strategies taught at PR 
designed by PR director  
 
t tests and chi-square test 
for statistical analysis; 
significance accepted at 
p< .05 
2/3 of participants reported 
improved general health for the 
first three yrs following PR, 
50% of which continued to 
report improved health at 7yrs 
following 
 
68-72% reported participation in 
regular ongoing exercise 
 
89% reported utilizing pursed-
lip breathing and energy 
conservation  
 
70% reported calling their health 
care provider at first sign of 
exacerbation 
 
ER visits reported…  
26% pre PR, decreased to      9 
% 1yr post PR 
Hospitalizations… 
28% pre PR, decreased to 10% 
1yr post PR 
Strengths: 
• Review board 
approval obtained 
from hospital and 
university 
• Large sample  
 
Limitations: 
• Unclear as to 
weather validity and 
reliability of 
questionnaire was 
assessed  
• Participant consent 
not discussed  
• Collected data was 
self reported  
• Possible bias related 
to participants who 
did not fill out 
follow- up 
questionnaires, ? 
didn’t want to 
opposed to unable  
Strength of 
Design: 
Weak   
 
Quality of 
Design: 
Medium 
 
Study 
relevant to 
both nursing 
practice and 
globally to 
the overall 
health care 
system.  
Speaks to 
patient 
benefits and 
financial 
impact of PR 
related to 
health care 
utilization.   
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Table 6  
 
Literature Summary Table  
 
Author, 
Name, Date, 
Objective 
Sample and Setting Design and 
Methodology 
Key Results and 
Findings 
Strengths/Limitations Conclusion and 
Rating 
Roman et al. 
(2013).  
 
Efficacy of 
Pulmonary 
Rehabilitation 
in Patients 
with Moderate 
Chronic 
obstructive 
Pulmonary 
Disease: A 
Randomized 
Controlled 
Trial  
 
Objective: To 
compare the 
efficacy of 
three PR 
programs with 
varying 
delivery and 
duration  
Setting: Primary care 
PR 
 
Participants: 97 
participants; recruited 
from seven primary 
care practices in Spain 
over 12 months 
 
Inclusion Criteria: 
• 35-74yrs with 
moderate COPD 
• FEV1 < .7 and 
FEV1 50-80% 
Exclusion Criteria: 
• Musculoskeletal 
conditions 
preventing 
exercise  
• Terminal illness 
 
Physician confirmed 
participant eligibility  
Design: Quantitative; 
analytic randomized 
control trial 
 
Randomized to three 
groups: RHBM group 
(3mth PR and 9mth 
follow-up), RHB (3mth 
RP and routine follow up 
with their physician or 
nurse), and control group 
(no PR; routine follow up 
with their physician or 
nurse) 
 
Outcome measures CRQ, 
PFT, exercise tolerance, 
and hospital admission 
assessed pre and post  
 
 
Extensive statistical 
analysis conducted  
 
No significant change 
noted between groups r/t 
pulmonary function or 
6MWT 
 
RHBM and RHB group 
showed significant 
improvement in CRQ 
emotion score, only 
maintained in RHBM 
group at 12mths   
 
RHBM group improved 
fatigue score  
 
Indicated minimal 
difference of improvement 
noted in exercise capacity, 
dyspnea, and HRQOL btw 
groups. Attributed to low 
attendance rates and 
reported HRQOL.  Authors 
indicated these results do 
not parallel other available 
research 
Strengths: 
• Group selection 
randomized  
• Follow up health care 
professionals blinded to 
participant’s group 
• Bias assessed and 
controlled  
• Received approval from 
ethics and research 
committee 
 
Limitations: 
• Required sample size not 
recruited 
• 50% of participants 
withdrew from study 
after randomization  
• One study location not 
centrally located 
• Program attendance rates   
 
Strength of 
Design:  
Strong  
 
Quality of 
Design: 
High 
 
Further research 
is required in 
order to fully 
understand the 
long-term effect 
of PR 
 
Requires further 
research 
identifying 
benefit to 
patients verses 
health care cost 
associated with 
12 months PR 
program 
		65	
Table 7  
 
Literature Summary Table  
 
Author, 
Name, Date, 
Objective 
Sample and 
Setting 
Design and Methodology Key Results and Findings Strengths/Limita
tions 
Conclusion 
and Rating 
Cosgrove et 
al. (2013) 
 
Facilitating 
Education in 
Pulmonary 
Rehabilitation 
Using the 
Living Well 
with COPD 
Programme 
for Pulmonary 
Rehabilitation: 
A Process 
Evaluation  
 
Objective: To 
adapt the 
LWWCOPD 
for use in PR 
and assess 
effectiveness  
Setting: PR 
programs/focus 
groups; Ireland 
 
Participants: 57 
patients and 25 
health care 
providers 
 
Inclusion Criteria: 
• Health care 
professionals 
working in PR 
• Diagnoses of 
COPD and 
participating in 
PR 
• Understanding 
of written 
English 
Exclusion 
Criteria:  
• Not identified  
Design: Quantitative; analytic 
uncontrolled before-after 
 
Six patient focus groups and one 
health care provider focus group 
utilized in process of adapting 
LWWCOPD material as well as 
current practice and research 
guidelines; identified key topics 
perceived important for 
inclusion in PR 
 
Likert scale questionnaires 
completed post each PR 
education session  
 
Outcome measure data collected 
post PR from patients (UCOPD 
and BCKQ questionnaire) and 
health care professionals 
(questionnaire r/t material use) 
 
Patient demographic data 
collected 
LWWCOPD program easily 
adaptable for use in PR  
 
Health care professionals and 
patients reported good 
acceptance of LWWCOPD 
adapted program 
 
87% of sessions rated good or 
excellent  
 
Patients suggested inclusion of 
family members in PR, 
supplemental materials, and 
requested additional sessions of 
shorter duration 
 
Patients requested topics of 
smoking cessation and healthy 
eating to be included in 
education   
 
Statistical significant 
improvement noted on all 
domains of outcome measures 
(p < .001) 
Strengths: 
• Ethics approval 
obtained  
• Written consent 
received from 
participants  
• Health care 
professionals 
attended 
training 
workshop r/t 
utilization of 
adapted 
LWWCOPD 
program 
• No evidence of 
bias 
 
Limitations: 
• First study to 
utilized 
LWWCOPD 
program  
Strength of 
Design:  
Weak  
 
Quality of 
Design: 
High  
 
Significant to 
PR 
programming 
in Canada as 
LWWCOPD is 
a Canadian 
program.  
 
Further 
research 
required in 
order to ensure 
generalizability  
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Table 8  
 
Literature Summary Table  
 
Author, Name, 
Date, Objective 
Sample and Setting Design and 
Methodology 
Key Results 
and Findings 
Strengths/Limitations Conclusion 
and Rating 
Casey et al. (2013) 
 
The Effectiveness of 
a Structured 
Education 
Pulmonary 
Rehabilitation 
Programme for 
Improving the 
Health Status of 
People with 
Moderate and Sever 
Chronic Obstructive 
Pulmonary Disease 
in Primary Care: The 
PRINCE Cluster 
Randomized Trial  
 
Objective: to 
evaluate the 
effectiveness of 
structured education 
in PR on health 
status  
Setting: 32 GP in Ireland 
 
Participants: 350 
participants of possible 
431; randomized to control 
and intervention group; 15 
month recruitment 
 
Inclusion Criteria: 
• Diagnosis of moderate 
to severe COPD based 
on spirometry 
• Extensive patient 
inclusion criteria (Figure 
1 of study)  
• GP utilizing 
computerized 
medication system, 
employing nurse & 
>2500 patients 
Exclusion Criteria:  
• Not specifically 
discussed, simply stated 
medical grounds 
Design: Quantitative; 
randomized control 
trial 
 
Various outcome 
measures utilized CRQ 
(assess 4 domains of 
health), ISWT (walk 
test), and self-efficacy 
scale pre and post 
intervention  
 
Intervention groups 
structured education 
program; control 
groups “usual care” 
 
Separate qualitative 
study conducted to 
assess “usual care” for 
control group 
  
Extensive statistical 
analysis conducted 
Intervention 
group had 
statistically 
greater change 
in total CRQ 
score, dyspnea 
score, and 
physical score 
post PR (p < 
.05) 
 
Change in self-
efficacy noted 
but not found to 
be statistically 
significant (p < 
.176) 
 
Accessibility of 
PR 
programming 
greatly 
influences 
attendance  
Strengths: 
• Bias assessed 
• Research team blinded to 
baseline data 
• Accuracy of data entry 
assessed at 99.9% 
• Various health care 
professionals delivered 
education; intensive 
training provided, 
program manual 
available, and quality 
control measures 
assessed 
 
Limitations: 
• One intervention group 
eliminated due to 
attendance r/t H1N1 
outbreak 
• ~20% of participants did 
not complete PR 
Strength of 
Design:  
Strong  
 
Quality of 
Design: 
High 
 
Study relevant 
to PR 
curriculum 
development.   
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Table 9  
 
Literature Summary Table  
 
Author, Name, 
Date, Objective 
Sample and 
Setting 
Design and 
Methodology 
Key Results and 
Findings 
Strengths/Limitatio
ns 
Conclusion 
and Rating 
Wilson et al. 
(2007) 
 
Education in 
Pulmonary 
Rehabilitation: The 
Patient’s 
Perspective 
 
Objective: To 
determine, from 
the patient’s 
perspective, what 
topics should be 
included in PR 
education and how 
education should 
be delivered; 
compared to views 
of health care 
professionals  
Setting: Respiratory 
and outpatient 
clinic in Ireland  
 
Participants: 32 
participants, of an 
invited 49 & eight 
health care 
professionals   
 
Inclusion Criteria: 
• Diagnosis of 
COPD 
• Healthcare 
professionals 
experienced in 
PR and 
management of 
patients with 
COPD 
Exclusion Criteria:  
• Not identified 
 
Design: Qualitative 
 
Purposive sampling 
 
Six patients focus groups 
and one multidisciplinary 
healthcare professional 
focus group   
 
Series of key open-ended 
questions r/t educational 
needs and delivery 
preferences utilized in 
focus groups   
 
Data analyzed utilizing 
Grounded Theory approach 
through debriefing, 
transcription, selective 
coding, and triangulation 
 
Saturation achieved during 
5th focus group 
 
Focus groups videotaped 
 
Six key topics related to PR 
education were identified: 
disease education, 
management of 
breathlessness, 
management of 
exacerbation, medication, 
psychosocial impact of 
COPD, and welfare and 
benefits system.   
 
Patients prefer education in 
a group setting, utilizing 
layman’s terms, delivered 
by a knowledgeable 
professional.    
 
Education delivery should 
be supplemented with 
written and audiovisual 
materials 
 
Accessibility and location 
of PR are relevant to 
attendance  
Strengths: 
• Healthcare 
professionals 
blinded to results of 
patient focus groups 
• Study approval 
obtained from ethics 
committee 
• Written consent 
obtained from 
participants 
• Participant 
confidentiality 
ensured 
 
Limitations: 
• Design may limit 
generalizability  
• Sensitive topics such 
as sexual 
relationships and end-
of-life not 
incorporated into 
program  
 
Study Rating:  
Strong 
  
Study unique 
in that it 
provides 
patient 
perspective in 
relation to PR 
education.  
Contributes to 
current 
knowledge r/t 
PR 
curriculum 
development.  
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Table 10  
 
Literature Summary Table  
 
Author, Name, 
Date, Objective 
Sample and Setting Design and Methodology Key Results and 
Findings 
Strengths/Limitati
ons 
Conclusion 
and Rating 
Marques et al. 
(2015).  
 
Development of a 
family-based 
pulmonary 
rehabilitation 
programme: An 
exploratory Study 
 
Objective: to 
explore the needs 
of patients and 
families related to 
PR and to 
develop, 
implement, and 
evaluate impacts 
of PR on patients 
and families  
Setting:  primary care 
center  
 
Participants: 35 patients 
and 35 family members 
(63% were spouse)  
 
Inclusion Criteria:  
• Diagnosis of COPD 
• Family member 
providing care, or 
support 
• >18yrs  
• Able to understand 
purpose of study  
Exclusion Criteria: 
• Severe psychiatric 
conditions  
• Exacerbation or 
hospitalization one 
month prior to 
program 
• Patient or family 
member refused  
Design: Mixed-methods; 
exploratory; uncontrolled before-
after  
 
Three phases to study… 
qualitative study assessing 
expectation and needs r/t family 
based PR, interviews utilizing 
open ended questions conducted; 
family based PR program 
implemented based on qualitative 
study and literature review; 
impact of family based PR 
assessed using mixed methods 
design, various outcome measures 
assessed using pre existing 
measures of which assumed to be 
valid and reliable  
 
Statistical analysis conducted, 
level of significance assumed at p 
< .05; Interviews transcribed, 
coded, and reduced to essential 
concepts and relationships 
Patients and family 
members have 
similar needs and 
expectation r/t PR 
 
Patients want 
family members to 
participate in PR  
 
Statistical 
improvement noted 
in muscle strength, 
exercise tolerance, 
and function 
balance 
 
No improvement 
was noted in 
dyspnea, 
contributed to low 
levels reported pre 
PR 
Strengths: 
• Approval 
obtained from 
ethics committee 
• Written informed 
consent obtained  
• Expands current 
research 
 
Limitations: 
• Convenience 
sampling  
• 70% of 
participants male,  
?generalizable to 
female population  
• No control group  
• In qualitative, 
saturation not 
assessed 
 
Study Rating:  
Strong  
 
Significant to 
nursing 
practice as first 
study to 
develop, 
implement, and 
evaluate family 
based PR.  
  
Researchers 
suggest further 
research to 
assess long 
term effect and 
economic cost 
of family based 
PR 
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Appendix B 
 
Figure 1. Pender’s Health Promotion Model 
 
Pender first published the revised Health Promotion Model, depicted below, in 1996 
(Pender et al., 2006, p. 50-51).   
 
 
 
 
 
 
 
Reference:  Pender, N., Murdaugh, C., & Parsons, M. (2006). Health Promotion in 
Nursing Practice (5th ed.). Upper Saddle River, NJ: Pearson. 
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Consultation Report 
In Canada, there are over three million individuals currently living with chronic 
lung disease (Public Health Agency of Canada, 2012).  The reality of living with these 
respiratory conditions is burdensome and debilitating to both individuals living with the 
conditions and the health care system.  Pulmonary Rehabilitation, which includes exercise 
training and education, is recommended as an essential component of medical care for 
those individuals.  It encourages active participation and strives to optimize functional 
capacity, reduce symptoms associated with chronic lung disease, and decreases 
dependence on the health care system (American Association of Cardiovascular and 
Pulmonary Rehabilitation, 2011; Collins et al., 2014; Nici et al., 2006).  
Until recently, pulmonary rehabilitation programming was not available to 
residents of Prince Edward Island (PEI), identifying an obvious need in order to better 
assist and manage the care of individuals living with chronic lung disease. A Pulmonary 
Rehabilitation Program was initiated in January of 2017, however, currently lacks an 
established education program.  The overall goal of the proposed practicum project is to 
develop evidenced-based education modules to be used for client/family teaching within a 
Provincial Pulmonary Rehabilitation Program.   
An integrative literature review was completed to examine the topic of pulmonary 
rehabilitation, with a focus on suggested education for individuals/families living with 
chronic lung disease.  It was discovered that Canadian specific education guidelines for 
pulmonary rehabilitation presently do not exist (Camp et al., 2015).  However, the 
Canadian program Living Well with COPD: A Plan of Action for Life (2017), developed 
in partnership by McGill University Health Center and the Quebec Health Ministry, and 
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guidelines developed by the American Association of Cardiovascular and Pulmonary 
Rehabilitation (2011) provide suggestions in relation to education topics.  In addition, it is 
also important that the education topics be tailored to individual client needs and goals 
(Nici et al., 2006) in the management of their chronic lung disease.      
For the purpose of the proposed practicum project, a consultation plan was 
developed and submitted for approval.  Once approved, the consultation plan was 
implemented with identified key stakeholders.  The following report details these 
consultations.  	
Purpose of Consultation 
The purpose of this consultation is to gather information, from key stakeholders, 
regarding education topics to be included within the proposed education modules.  
Consultation also provides an opportunity to involve key stakeholders prior to the 
development of the education modules.  Backer et al. (1992) described consultation as a 
process in which one seeks advice or information from another, providing an overall 
benefit to a service or product.  It is assumed that the consultant, or individual being 
approached for advice or information, has an expertise or unique knowledge base related 
to a particular topic.  
There are two objectives identified for the consultations with the key stakeholders:  
1. Through consultation I will introduce the proposed practicum project and its 
overall purpose to key stakeholders including: respirologists, associated 
managers within Health PEI, the PEI Lung Association, two other established 
Pulmonary Rehabilitation Programs, and a client representative.  
2. Through consultation I will obtain information in relation to suggestions for 
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the education topics that will be considered in the development of the 
education modules for the Pulmonary Rehabilitation Program.    
It is felt that both objectives were achieved through the process of consultation.   
Summary of Participants and Conducted Consultations 
Eight key stakeholders were selected and approached for consultation in 
preparation for the development of the proposed education modules.  An e-mail of 
invitation for consultation was sent to all key stakeholders.  Information contained within 
the e-mail introduced to the proposed practicum project, identified the rationale for the 
project, and identified a recommendation for implementation and evaluation of the 
education modules after completion (see Appendix A).  Key Stakeholders include:  
• Two Respirologists working in Prince Edward Island, whom are the Acting 
Medical Directors for the Provincial Pulmonary Rehabilitation Program.  
These medical specialists are experts in pulmonary health and wellness and 
are involved with all decision-making and approval of policies and procedures 
associated with the program.  This approval will ultimately be required for all 
educational content developed for the Provincial Pulmonary Rehabilitation 
Program.  To date, in particular to one of the Respirologists, no response was 
received in reply to the invitation.  A follow-up email was sent, which has also 
yielded no response.  Therefore, another contact will be made during Nursing 
6661.  Due to a family emergency, travel outside of the country was required, 
for the other Respirologist, during the time scheduled for the consultations.  
Because of this, a face-to-face interview was not possible.  At the 
Respirologist’s request, the Interview Guide for Key Stakeholders (see 
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Appendix B), was sent via e-mail.  It was indicated by the stakeholder that a 
response would be sent back electronically, which to date has not been 
received.  It is proposed that a face-to-face meeting be arranged with this 
Respirologist during Nursing 6661.   
• The Acting Chronic Disease Prevention and Management 
Manager/Physiotherapist who oversees the Provincial Pulmonary 
Rehabilitation Program.  This Manager is responsible for the approval for all 
educational content developed for the Provincial Pulmonary Rehabilitation 
Program.  The discipline of physiotherapy’s perspective is also essential.  
Therefore, as the Acting Chronic Disease Prevention and Management 
Manager is a physiotherapist by profession this perspective could be obtained 
during the same consultation.  This consultation was conducted with the 
Manager via face-to-face interview at the office of Chronic Disease Prevention 
and Management on March 20th, 2017.   
• The Registered Respiratory Therapist (RRT) working directly with the 
Provincial Pulmonary Rehabilitation Program.  Consultation was conducted 
with the RRT via face-to-face interview at the office of Chronic Disease 
Prevention and Management on March 21st, 2017.               
• The Cardiac and Pulmonary Rehabilitation Program Advisory Board play a 
role as key decision-makers in relation to the Provincial Pulmonary 
Rehabilitation Program. Two members of this Board for example, the 
Executive Director of the PEI Lung Association and a client representative 
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were identified for the consultation.  At the Executive Director’s request, a 
telephone meeting time was arranged for March 21st, 2017 for consultation.  
This was not conducted successfully as no response was received to the 
planned telephone call.  A message was left and a follow-up e-mail was sent in 
attempt to arrange another meeting time.  To date no response was received.  
A face-to-face meeting was arranged with the client representative.  Due to 
weather circumstances, the client canceled the face-to-face meeting, but the 
consultation was conducted via telephone interview on March 23rd, 2017.  
• Two Established Pulmonary Rehabilitation Programs located within Atlantic 
Canada serve as a model for proposed programming.  Consultation was 
conducted via telephone interview with a registered nursing working at the 
Capital Health Pulmonary Rehabilitation Program in Halifax, Nova Scotia and 
at the Pulmonary Rehabilitation Program, associated with the Horizon Health 
Network, in Fredericton, New Brunswick.  These consultations were 
approximately 45 minutes in duration and were conducted on March 21st, 2017 
and March 24th, 2017.        
Data Collection 
 Seven health care professionals and one client representative were identified as 
key stakeholders and included in the process of consultation.  Through consultation, 
qualitative data were obtained from five key stakeholders. Effort was made to ensure that 
the process of consultation was convenient for the stakeholders.   
The methods of face-to-face interview, telephone interview, and electronic 
distribution of the interview questions were utilized for data collection. The methods used 
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were based on factors such as stakeholder preference and physical location.  Unforeseen 
circumstances, specifically a family emergency and weather, influenced the method of 
data collection. The Interview Guide for Key Stakeholders was developed for use during 
consultation interviews.  The guide was developed to ensure that all stakeholders were 
asked the same questions during the interview.  While all stakeholders were asked the 
first three questions of the guide, stakeholders representing an established Pulmonary 
Rehabilitation Program were asked question four. Question one encompassed two slightly 
varying questions. Stakeholders representing an established Pulmonary Rehabilitation 
Program were asked “What education topics do you currently have incorporated into the 
curriculum of your program?” and all other stakeholders were asked “What education 
topics should be incorporated into the Provincial Pulmonary Rehabilitation Program?”.		
All questions contained within the Guide were open-ended.  During interview, 
stakeholders were asked the Guide questions but were also provided the opportunity to 
share any other information they felt was relevant.  Comprehensive handwritten notes 
were taken during interview with all stakeholders.    
Ethical Considerations 
Due to the nature of the proposed practicum project, review by a Health Research 
Ethics Review Board was not required.  This was determined through completion of the 
Health Research Ethics Authority Screening Tool provided within course materials for 
Nursing 6660.  The completed tool, specific to the proposed practicum project, can be 
found in Appendix C.   
Implied consent was assumed based on agreement for participation in consultation 
by key stakeholders.  Stakeholders were therefore not asked to sign a formal consent 
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form.  Several safeguards were implemented during data collection and analysis in order 
to protect the confidentiality of key stakeholders.  Personal identifiers were not linked to 
collected data. Handwritten notes were taking during each interview and labeled by 
stakeholder professional title rather than by name.  Through this report, key stakeholders 
have been identified by their associated professional title rather than by name in order to 
further maintain confidentiality.  Interviews were not audibly or visually recorded.  All 
telephone interviews were conducted in a private setting.  All e-mail correspondence with 
stakeholders was conducted through an account secured by Health PEI.  Data collected 
during consultation was stored in a locked cabinet in my home office.  Post completion of 
the proposed practicum project all collected data will be destroyed by shredder.  
Data Management and Analysis 
Through the consultation plan, it was identified that thematic analysis would be 
utilized to categorize and analyze collected data.  The consultation plan identified 
thematic analysis as an effective strategy for categorizing qualitative data.  This provided 
rationale for use of the proposed method of analysis due to the fact that all collected data 
was in fact qualitative.  It was further indicated that the method synthesizes recurrent 
patterns and linkages within collected data.  Thematic analysis allows themes to emerge 
from data rather than having collected data be assigned to pre-defined themes (Chesney, 
2015).  This was thought to be important as pre-defined themes, or identified topics to be 
included within pulmonary rehabilitation education, were identified through the 
conducted integrated literature review.  The overall goal of consultation was to collect 
additional relevant data based on stakeholder experience and expertise related to the 
development of the proposed education modules.  Pre-defined themes of the literature 
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review were not disclosed to key stakeholders in an attempt to minimize bias of collected 
data.   
After the completion of stakeholder interviews, all collected data was re-read in 
order to ensure familiarity of data.  Each segment of collected data were assigned an 
initial code based on the topic that emerged from the particular piece of data.  An 
example of this can been seen through the statement “an important topic to discuss during 
pulmonary rehabilitation is the cause of the disease”.  This statement was originally coded 
with the term cause and later assigned to the theme anatomy and physiology.  Once this 
was completed, coding of similar topics was categorized into themes and assigned a 
representing name.  Once assigned to a theme, all data were reviewed to ensure they had 
been assigned to an appropriate theme. Nine themes emerged from the analyzed data and 
will be discussed in the following section of this report.            
Handwritten notes taken during each consultation interview created a need for 
secure management of the collected data.  Security of data was maintained within a 
locked cabinet in a home office.  During the process of analysis, data was entered into an 
electronic document and kept secure on a password-protected personal computer.     
Consultation Results 
Three questions were asked to each key stakeholder during the interview process and 
a fourth question was asked to stakeholders representing an established Pulmonary 
Rehabilitation Program.  Question one of the Interview Guide for Key Stakeholders 
examined suggestions of education topics to be included within pulmonary rehabilitation 
education.  Nine themes emerged from the analyzed data.  These themes represent 
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potential topics to be included during the development of the proposed education 
modules.  
1. Nutrition: Two Healthcare professionals and a stakeholder representing the client 
perspective identified the topic of dietary or nutritional requirements to be 
included within the Pulmonary Rehabilitation Program.  Stakeholders simply 
identified the topics and did not elaborate on specific aspects or objectives, such 
as cholesterol or a low salt diet.   
2. Managing Breathing and Energy Conservation: All key stakeholders identified 
that managing breathing and energy conservation is essential within pulmonary 
rehabilitation education.  Healthcare professionals indicated that such strategies 
were currently being addressed in their programs and that clients need to be 
taught strategies to control shortness of breath and how to manage breathing.   
3. Physical Activity: Four stakeholders identified the importance of physical activity 
to individuals living with chronic lung disease.  Education should include an 
introduction to exercise, the importance of exercise, and how to balance exercise 
and shortness of breath.   
4. Anatomy and Physiology: Stakeholders identified that it is important to 
understand the cause of chronic lung disease and also how an individual’s lungs 
work.  Health care professionals identified that such sessions are included within 
our programs.  A key stakeholder also indicated that the topic of infection and its 
relation to chronic lung disease should be addressed.   
5. Understanding Lung Disease: All five stakeholders identified the importance of 
clients understanding lung disease.  Healthcare professionals indicated that clients 
		80	
require information related to tests associated with lung disease, symptoms of 
decline, and contributing factors leading to progression.  Two stakeholders 
identified that clients need to understand that lung disease is chronic and 
progressive and not curable.  Clients require support and development of coping 
strategies related to the reality of not getting better.  Data collected representing 
the client perspective indicated that understanding lung disease assists with 
effective coping.   
6. Stress and Anxiety: Stress and anxiety and their relation to lung disease were 
identified during consultation.  A stakeholder suggested incorporating meditation 
and relaxation techniques into programming, to assist with anxiety and 
depression.   
7. Environmental Factors: Two healthcare professionals addressed the topic of 
environmental factors and lung disease.  They indicated that clients should be 
aware that environmental factors influence lung disease and should be taught 
infection control practices and effective hand washing techniques.  
8. Pulmonary Medications: All key stakeholders identified education on pulmonary 
medications as important.  Extensive data was collected related to this theme.  
Stakeholders suggested providing education on medications, puffers, and device 
use.  They indicated that clients need education regarding actions plans and 
oxygen use.  The topics of current treatment management and medication 
compliance also emerged from collected data.  Stakeholders further indicated that 
other medications, such as cardiovascular or diabetic medications, should not be 
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addressed in pulmonary rehabilitation programming as it would be too time 
consuming and not relevant to all clients.   
9. Moving Forward: Finally, stakeholders described long-term plans, advanced care 
planning, and information on home exercise programs as important.   
These nine themes, representing information gathered from key stakeholders, parallel 
suggested topics of pulmonary rehabilitation education programming described within the 
integrative literature review.      
Question two of the Interview Guide for Key Stakeholders examined how individual 
client learning needs and goals can be best incorporated into educational content.  Three 
themes emerged from the analyzed data including individual characteristics, patient goal 
setting, and teaching strategies.  Key stakeholders identified that an individual’s literacy 
level influences his or her ability or capacity to learn.  Collected data suggested 
identification of literacy levels and strategies such as developing educational content at a 
grade six-literacy level.  Stakeholders further identified characteristics such as age or 
impairments such as a hearing deficit to influence capacity to learn.  All five key 
stakeholders acknowledged patient goal setting during interview.  Stakeholders identified 
that learning is individualized and that patients should be asked what they want to get out 
of education sessions or what their personals goals are.  One stakeholder identified that 
individuals come to rehabilitation for different reasons and that these reasons may 
influence their motivation to learn.  Another stakeholder identified that the goals of 
rehabilitation staff and individual patients may differ, indicating that it is the role of the 
nurse to ensure these goals align.  Various teaching strategies were identified as helpful in 
ensuring that individual patient learning needs and goals are incorporated into educational 
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content.  Stakeholders suggested that patients be encouraged to be active participants and 
to ask questions.  It was suggested that education sessions be interactive and encompass 
discussion.  Two stakeholders indicated that information related to various chronic lung 
conditions needs to be incorporated into programming and not just information related to 
chronic obstructive pulmonary disease (COPD).  Finally, stakeholders suggested that one 
on one time with patients be allotted during pulmonary rehabilitation programming, 
specifically to address topics such as puffer administration and action plans.  
Question three of the Interview Guide for Key Stakeholders examined strategies 
that could be utilized to maximize patient benefit, related to education.  Four themes 
emerged from the data including teaching methods, teaching strategies, utilization of 
multidisciplinary staff, and physical environment.  Related to teaching methods, 
stakeholders identified various approaches such as incorporating pictures into 
presentations, utilizing models for demonstration, and providing written materials or 
handouts to supplement presented materials.  Stakeholders also indicated that patients 
should be provided time for hands on demonstrations, specifically suggesting that patients 
be permitted to demonstrate self-administration of puffers.  Stakeholders suggested that 
utilization of multidisciplinary staff maximizes patient benefit.  They suggested 
incorporating staff from various professions into programming and utilizing the resources 
of various professions.  The physical environment was described to influence learning.  
Stakeholders suggested maintaining a comfortable environment through appropriate 
seating, lighting, and temperature.  It was also noted that having access to parking close to 
the education setting is important for patients with chronic lung disease.  It was noted that 
all data collected related to teaching strategies stemming from question three paralleled 
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data collected in question two, which was previously discussed.   In response to question 
three, information was collected representing the patient perspective that did not fit into 
an associated theme.  It was indicated that pulmonary rehabilitation education should 
involve both patients and their families.  The stakeholder further indicated that patients 
and family members have different learning needs and both need to be addressed.  
Throughout the interview, the stakeholder reiterated the fact that the needs of family 
members must to be considered.       
Stakeholders representing established Pulmonary Rehabilitation Programs were 
asked if they had experienced barriers to education within their programs.  Minimal data 
were collected related to barriers.  One program stated that to date no barriers had been 
experienced that had been thought to have an impact on education.  The other program 
stated that they had patients with both hearing and visual impairments enrolled in their 
program, requiring individual attention.   
Both established Pulmonary Rehabilitation Programs identified utilizing materials 
from the program Living Well with COPD: A Plan of Action for Life (2017), developed in 
partnership by McGill University Health Center and the Quebec Health Ministry, within 
their program.  It was reported that they utilized materials from BreathWorks (2007), 
developed by the Canadian Lung Association, within the educational content of their 
program.  While the program Living Well with COPD was identified through the 
integrative literature review, the BreathWorks program was not mentioned in any of the 
information.      
 Data collected through consultation will be useful during the development of the 
proposed education modules and provides support to information obtained through the 
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integrative literature review.  Both the integrative literature review and information 
gathered through consultation will guide the development of the proposed education 
modules.   
Conclusion and Consultation Implications 
 Through the process of consultation, information and advice related to suggested 
topics to be included within the Pulmonary Rehabilitation Program was gathered from 
key stakeholders. Data obtained through the interview process addressed various aspects 
of pulmonary rehabilitation education.  Stakeholders provided suggestions related to 
topics to be included within pulmonary rehabilitation education, identified strategies of 
how individual patient learning needs and goals could be incorporated into education to 
maximize patient benefit, and addressed barriers to education.  Thematic analysis was 
utilized during the data analysis and resulted in various themes emerging from collected 
data.   
 Ultimately, the integrative literature review will guide the development of the 
proposed education modules but information gathered through consultation will also be 
used to guide the development of the modules.  Themes emerging from analyzed data 
provide additional supporting evidence to information gathered through the literature 
review. The completion of these consultations prior to the development of the education 
modules will also allow involvement, input, and support from key stakeholders.  It is 
hoped that post completion of the practicum project, developed client/family educational 
modules will be approved and used by the multidisciplinary team within the Provincial 
Pulmonary Rehabilitation Program.    
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Appendix A 
_______________,  
I am a registered nursing working with the Provincial Pulmonary Rehabilitation Program.  
I am also currently enrolled in the Master of Nursing Program at Memorial University, St. 
John’s, NL.  As a partial requirement for the degree I will be completing a practicum 
project.  For my project, I have proposed to develop client/family education modules to 
be utilized by the multidisciplinary staff within the Provincial Pulmonary Rehabilitation 
Program.   
You are a key stakeholder with expertise related to pulmonary health and wellness and 
rehabilitation.  Therefore, your thoughts and opinions of the required content would assist 
in the development of these education modules for the program.  I would like to invite 
you to a meeting, at a time and location convenient for you.  
Thank you for your consideration.  I look forward to hearing from you.   
Lindsey Smith     
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Appendix B 
Interview Guide For Key Stakeholders  
1. What education topics should be incorporated into the Provincial Pulmonary 
Rehabilitation Program?  
OR 
What education topics do you currently have incorporated into the curriculum of your 
program?  
2. How can individual patient learning needs and goals be best incorporated into 
educational content?  
3. What strategies could be utilized to maximize patient benefit related to the education 
component of the Provincial Pulmonary Rehabilitation Program?   
4. Have you encountered any barriers to education within your program?  
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Appendix	C	
Health	Research	Ethics	Authority	Screening	Tool	
	 Question	 Yes			 No	
1.	 Is	the	project	funded	by,	or	being	submitted	to,	a	research	funding	agency	for	a	research	grant	or	award	that	requires	research	ethics	review	 r 	 x  
2.	 Are	there	any	local	policies	which	require	this	project	to	undergo	review	by	a	Research	Ethics	Board?	 r 	 x  
	 IF	YES	to	either	of	the	above,	the	project	should	be	submitted	to	a	Research	Ethics	Board.	
IF	NO	to	both	questions,	continue	to	complete	the	checklist.	
	
r 	 r  
3.	 Is	the	primary	purpose	of	the	project	to	contribute	to	the	growing	body	of	knowledge	regarding	health	and/or	health	systems	that	are	generally	accessible	through	academic	literature?	
	
x 	 r  
4.	 Is	the	project	designed	to	answer	a	specific	research	question	or	to	test	an	explicit	hypothesis?	 r 	 x  
5.	 Does	the	project	involve	a	comparison	of	multiple	sites,	control	sites,	and/or	control	groups?	 r 	 x 
6.	 Is	the	project	design	and	methodology	adequate	to	support	generalizations	that	go	beyond	the	particular	population	the	sample	is	being	drawn	from?	
	
r 	 x 
7.	 Does	the	project	impose	any	additional	burdens	on	participants	beyond	what	would	be	expected	through	a	typically	expected	course	of	care	or	role	expectations?		 r 	 x 
LINE	A:	SUBTOTAL	Questions	3	through	7	=	(Count	the	#	of	Yes	responses)	 1	 	
8.	 Are	many	of	the	participants	in	the	project	also	likely	to	be	among	those	who	might	potentially	benefit	from	the	result	of	the	project	as	it	proceeds?		 r 		 x 
	9.	 Is	the	project	intended	to	define	a	best	practice	within	your	organization	or	practice?	 x	 r 
		10.	 Would	the	project	still	be	done	at	your	site,	even	if	there	were	no	opportunity	to	publish	the	results	or	if	the	results	might	not	be	applicable	anywhere	else?		 x 	 r 
11.	 Does	the	statement	of	purpose	of	the	project	refer	explicitly	to	the	features	of	a	particular	program,	Organization,	or	region,	rather	than	using	more	general	terminology	such	as	rural	vs.	urban	populations?		
x	 r 
12.	 Is	the	current	project	part	of	a	continuous	process	of	gathering	or	monitoring	data	within	an	organization?	 	 x	
LINE	B:	SUBTOTAL	Questions	8	through	12	=	(Count	the	#	of	Yes	responses)	 3	 	
	 SUMMARY:	Sum	of	Line	B	>	Line	A	and	therefore,	the	most	probable	purpose	is	quality/evaluation.	Proceed	with	locally	relevant	process	for	ethics	review.		 	 	
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Memorial University of Newfoundland 
School of Nursing 
Master of Nursing Program 
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Interview Guide For Key Stakeholders  
1. What education topics should be incorporated into the Provincial Pulmonary 
Rehabilitation Program?  
I would like to see interactive sessions incorporated rather than just didactic 
lectures; e.g. having patients actually use demo inhaler devices rather than just 
looking at the teacher, interactive problem solving discussions, e.g how to cope 
with severe dyspnea in a public place, instructions/demonstrations of airway 
clearance techniques e.g. use of devices etc.  
We need topics like sexual intimacy with spouses.  I think many patients may be 
too afraid/anxious to have intimacy and may not ask at the program.  
In addition to medications they are on, perhaps touching on the merits/demerits of 
over the counter and herbal remedies may be interesting to many.  
Sleep/insomnia/sleep apnea are comorbidities that we find in COPD.  Ditto acid 
reflux.  
Travel related issues including they find out from their doctors if they need oxygen 
for air travel.  
Topics to promote patient self-management skills will also be crucial.  We should 
ensure visual aids and handouts for many of these topics.  
These are by no means exhaustive!!  
OR 
What education topics do you currently have incorporated into the curriculum of 
your program?  
2. How can individual patient learning needs and goals be best incorporated into 
educational content?  
I believe this fits well with the items above.  For the patient the goals are simple-
improve quality of life, alleviate breathlessness and other respiratory symptoms 
like cough/sputum expectoration, improve exercise capacity/tolerance such that 
they can actually enjoy outdoor activities and not be afraid to leave their house, 
prevent and minimize physician office visits, ER visits and hospitalizations.  Much 
of what I discussed are items that would help.  Discussing actions plans and self 
management would minimize ER and physician visits and potentially avert 
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hospitalizations.  Adherence to and proper inhaler techniques ensures they are on 
the right treatment to improve symptoms.  Breathing techniques help ensure they 
can cope with dyspnea in the public place etc.  Having the patients demonstrate 
these activities in an interactive manner will reinforce what they learn.  
3. What strategies could be utilized to maximize patient benefit related to the 
education component of the Provincial Pulmonary Rehabilitation Program?   
At the risk of sounding like a parrot, I personally learn better when I am engaged 
interactively.  People’s attention span for didactic lectures tend to be short! 
Choosing engaging interesting topics that actually reflect the patients’ main 
concerns will garner more interest.  We can actually have patients submit topics 
they would want to learn more about.  We should ensure we cover topics that 
pertain to all chronic lung disease and not just COPD.  There will be patients with 
pulmonary fibrosis and other diseases.   
The teachers must also be quite knowledgeable and comfortable with their topics.  
They must use visual aids and other props that drive home the pertinent points.   
4. Have you encountered any barriers to education within your program?  
N/A 
 
		
	 93	
 
 
 
 
 
Appendix D 
Education Resource: Education Modules for Teaching Clients/Families with Chronic Lung 
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Resource Introduction 
 
There are currently over three million individuals living with chronic lung disease in 
Canada (Public Health Agency of Canada, 2012).  The term chronic lung disease refers to 
respiratory conditions such as, chronic obstructive pulmonary disease (COPD), which also 
encompasses chronic bronchitis and emphysema, pulmonary fibrosis, asthma, lung cancer, 
pulmonary hypertension, and tuberculosis.  The reality of living with chronic lung disease is 
burdensome and debilitating to both individuals living with the conditions and the health care 
system.  Individuals often report experiencing extreme shortness of breath while doing simple 
tasks associated with day-to-day living and are often left feeling breathless (World Health 
Organization, 2007).   
Chronic lung disease has a significant economic impact on the Canadian health care 
system, costing approximately 12 billion dollars annually (Public Health Agency of Canada, 
2012). Chronic lung diseases are the leading cause of hospital admissions and are associated with 
higher rates of readmission when compared to all other chronic diseases (Canadian Thoracic 
Society, 2010). The World Health Organization (2007) estimates that chronic lung disease will 
become the third leading cause of death by 2030.  In fact, COPD is the only chronic condition 
that is still associated with an increasing mortality rate in Canada (Canadian Thoracic Society, 
2010).   
Early intervention has the potential to slow disease progression and provide an overall 
benefit to individuals living with chronic lung disease (AACVPR, 2011).  
The American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR, 2011) 
indicated that pulmonary rehabilitation demonstrates a secondary prevention intervention aimed 
at improving the quality of life of those living with chronic lung disease. Pulmonary 
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Rehabilitation is recognized and recommended as an essential component of medical care for 
those living with chronic lung disease.  Pulmonary Rehabilitation is an evidence-based, 
multidisciplinary, and comprehensive intervention for patients with chronic respiratory diseases 
who are symptomatic and often have decreased daily life activities. (AACVPR, 2011, p. 1).”  
Pulmonary rehabilitation encompasses patient assessment and goal setting, self-management 
education, exercise training, psychosocial support, and outcome measurement (AACVPR, 2011, 
p. 1).  
 This education resource is to be utilized for teaching clients/families with chronic lung 
disease within the Provincial Pulmonary Rehabilitation Program in Prince Edward Island.  
Modules within the resource were developed based on literature and information, related to 
chronic lung disease, pulmonary rehabilitation, and client/family education, obtained through 
conduction of an integrative literature review and consultation with key stakeholders.  Pender’s 
Health Promotion Module (2006) and Knowles Adult Learning Principles (1970) served as a 
theoretical framework during the development of the education modules.  Information and 
resources contained within each module are intended to be utilized to assist with ease of 
education delivery during a one hour group education session.  Various teaching methods have 
been incorporated within each module in the hopes of addressing the various learning styles of 
participants.  This will also be useful in overcoming or addressing individual learning needs, 
deficits, and/or impairments.  The ultimate goal of education delivered through pulmonary 
rehabilitation is health promoting, self-management behavior modification.   				
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		The	module	will	provide	a	brief	orientation	to	the	program	by	defining	pulmonary	rehabilitation	and	describing	various	benefits.		It	will	then	describe	several	components	of	keeping	a	healthy	lifestyle	including	medication	compliance,	exercise,	diet,	sexual	activity,	and	smoking	cessation.		Throughout	this	module	the	term	“program	participant”	will	be	utilized	when	referring	to	both	clients	and	family	members.		A	few	potential	discussion	questions	have	been	provided	to	aid	with	facilitation	of	group	discussion.						By	the	end	of	a	group	education	session	participants	will:		1. Identify	education	and	exercise	as	components	of	pulmonary	rehabilitation.			2. Identify	two	benefits	of	attending	pulmonary	rehabilitation.			3. Develop	three	personalized	SMART	goals	to	be	achieved	by	the	end	of	the	12-week	program.				4. Take	part	in	a	group	discussion	pertaining	to	the	concepts	of	health	and	chronic	lung	disease	and	share	their	personal	definition	health.	5. Be	introduced	to	several	components	of	keeping	a	healthy	lifestyle.		6. 	Identify	two	related	key	messages	learned	during	the	module.				
It	is	intended	that	the	materials	presented	within	this	module	be	utilized	during	a	one	hour	group	education	session.		Various	aids	have	been	provided	within	the	module	to	aide	with	ease	of	education	delivery.		
v Potential	questions	for	facilitated	group	discussion			
v Visual	Aids:	PowerPoint	presentation	containing	various	pictures/graph;	whiteboard	and	markers		
v Patient	Activity	and	Handout:	Patient	SMART	Goal	Handout;	smoking	quiz	
	
Module	1:	Orientation/Keeping	a	Healthy	
Lifestyle	
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What	is	Pulmonary	Rehabilitation?			
• The	American	Association	of	Cardiovascular	and	Pulmonary	Rehabilitation	(AACVPR)	(2011)	define	pulmonary	rehabilitation	as	“an	evidence-based,	multidisciplinary,	and	comprehensive	intervention	for	patients	with	chronic	respiratory	diseases	who	are	symptomatic	and	often	have	decreased	daily	life	activities.		Pulmonary	rehabilitation	includes	patient	assessment	and	goal	setting,	self-management	education,	exercise	training,	psychosocial	support,	and	outcome	measurement.”	(p.	1)			
• Pulmonary	rehabilitation	includes:		
	
 
 and	is	delivered	by	multidisciplinary	health	care	professionals,	with	the	goal	of	improving	the	overall	physical	and	psychological	health	status	of	individuals	living	with	chronic	lung	disease	(Collins	et	al.,	2014).			
• The	underlying	goals	of	pulmonary	rehabilitation	are	the	following:	(a)	to	optimize	functional	capacity	and	reduce	or	alleviate	experienced	associated	symptoms,	(b)	to	encourage	active	participation,	and	(c)	to	decrease	dependence	on	the	health	care	system,	ultimately	saving	health	care	dollars	(Nici	et	al.,	2006;	Moamary,	Aloriny,	&	Al-Hajjaj,	2014).				
	
• Pulmonary	rehabilitation	is	an	essential	component	of	medical	care	for	those	living	with	chronic	lung	disease	(AACVPR,	2011).				
Patient	Assessment	and	Goal	Setting	
Education	
Supervised	Exercise	Psychosocial	Support	
Outcome	Measurement	
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Each	day	while	attending	pulmonary	rehabilitation,	clients/families	will	participate	in	a	one	
hour	education	session	as	well	as	a	one	hour	exercise	session,	supervised	by	multidisciplinary	
staff	including	a	Registered	Nurse,	Respiratory	Therapist,	and	Physiotherapist.		Family	
members	are	welcome	to	participate	in	all	education	sessions	but	may	not	be	able	to	
participate	in	exercise	due	to	limitations	with	the	amount	of	equipment.		Family	members	are	
welcome	to	watch	exercise	and	welcome	to	participate	in	the	daily	warm-up	and	cool-down	
lead	by	the	Physiotherapist.		Clients	will	have	their	vital	signs,	including	blood	pressure,	heart	
rate,	and	SP02,	monitored	both	pre	and	post	exercise.		Clients	will	wear	an	SP02	monitor	
during	exercise.					
Benefits	of	Pulmonary	Rehabilitation			
• Pulmonary	rehabilitation	has	been	found	to	have	a	substantial	impact	on	the	overall	quality	of	life	of	individuals	living	with	chronic	lung	disease,	regardless	of	age,	sex,	or	current	lung	function	(Roman	et	al.,	2013).				
• Pulmonary	rehabilitation	provides	the	most	benefit,	in	relation	to	symptom	management,	exercise	tolerance,	and	overall	quality	of	life,	to	patients	when	compared	to	other	treatment	options	(AACVPR,	2011).				
• Various	benefits	to	pulmonary	rehabilitation	are	described	in	current	literature	including:			
v Improved	health	related	quality	of	life		
v Improved	muscle	strength	and	endurance	
v Improved	functional	and	exercise	capacity		
v Improved	emotional	function	(reduction	in	anxiety	and	depression)	and	self-efficacy		
v Reduction	in	hospitalizations	and	health	care	visits		
v Enhanced	knowledge	and	self-management	abilities		
v Reductions	in	associated	symptoms	particularly	shortness	of	breathe		(Rochester	et	al.,	2015;	AACVPR,	2011;	Jacome	&	Marques,	2014;	Bhandari, Jain, Marolda, 
and ZuWallack, 2013)			
Patient	SMART	Goals	
	
Education presented during pulmonary rehabilitation programming should be tailored to 
individual patient needs and incorporate patient determined goals (Moamary et al., 2014;  Nici et 
al.).   
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After orientating clients/families to what pulmonary rehabilitation is and describing benefits of 
attending, facilitate clients to create three personalized SMART goals to be achieved by the end 
of the 12-week program.  At the end of this module you will find a patient handout to be utilized 
for this activity.    
 
 
                Client	goals	should	be:		
                                              
	
	
Health	and	Chronic	Lung	Disease		
 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
			
The	above	picture,	available	at	www.livingwellwithCOPD.com	represents	two	individuals	with	
the	same	chronic	lung	condition	(COPD)	but	depicts	two	varying	associated	qualities	of	life.							
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• Health	and	disease	are	two	different	concepts	that	co-exist	and	influence	each	other.		It	is	important	for	clients/families	to	be	able	to	distinguish	between	the	two.		The	World	Health	Organization	(WHO)	(1948)	defines	health	as	“a	state	of	complete	physical,	mental,	and	social	well-being	and	not	merely	the	absence	of	disease.”		The	Center	for	Disease	Control	and	Prevention	(2013)	defines	disease	as	a	condition	that	impairs	normal	functioning,	is	self-limiting,	is	associated	with	distinguishing	signs	and	symptoms,	and	with	a	duration	of	months	or	years.				
• The	reality	of	living	with	chronic	lung	disease	is	burdensome	and	debilitating	to	both	individuals	living	with	the	conditions	and	the	health	care	system.		Individuals	often	report	experiencing	extreme	shortness	of	breath	while	doing	simple	tasks	associated	with	day-to-day	living	and	are	often	left	feeling	breathless	(World	Health	Organization,	2007).		
• COPD	is	the	leading	cause	of	hospital	admission	and	is	associated	with	higher	rates	of	readmission	when	compared	to	all	other	chronic	diseases	(Canadian	Thoracic	Society,	2010).		The	World	Health	Organization	(2007)	estimates	that	chronic	lung	disease	will	become	the	third	leading	cause	of	death	by	2030.				
• Early	intervention	has	the	potential	to	slow	this	process	and	provide	an	overall	benefit	to	individuals	living	with	chronic	lung	disease.		Pulmonary	rehabilitation	demonstrates	a	secondary	prevention	intervention	aimed	at	improving	the	quality	of	life	and	overall	health	of	those	living	with	chronic	lung	disease	(AACVPR,	2011).			
	
Group Discussion Questions:  1. What does health mean to you? 	2. How	does	your	chronic	lung	disease	impact	your	day-to-day	life?					
	There	are	various	Components	of	Keeping	a	Healthy	Lifestyle:			
																												 	Image	obtained	from	www.livingwellwithCOPD.com	
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The	remainder	of	the	module	will	introduce	many	of	the	components	of	keeping	a	healthy	
lifestyle.		Remind	clients/families	that	this	is	an	introduction	and	that	all	topics	will	be	
discussed	in	detail	in	a	subsequent	education	session.							Discussion	Question:	What	do	you	do	to	stay	healthy?	
	
	
Medication	Compliance		
	
 • Compliance	is	a	term	often	used	to	describe	clients	or	patients	in	relation	to	their	adherence	to	medication	instruction.			
Approximately	50%	of	Canadians	do	not	take	their	prescription	
medications	as	prescribed!!	Medication	non-compliance	is	the	cause	of	
10%	of	all	hospital	admissions	(Canadian	Society	of	Hospital	
Pharmacists,	2017).		 	Discussion	Questions:		
 1. Is	it	important	to	take	your	medications	as	prescribed?		
 2. Why	would	someone	stop	taking	his	or	her	medications?			
 • Taking	medications	will	not	cure	chronic	lung	disease	but	will	relieve	symptoms	and	improve	overall	quality	of	life			
Tip:	If	you	cannot	remember	the	name,	dose,	and	administration	time	of	each	medication	you	take,	keep	an	updated	list	in	your	purse	or	wallet.		This	is	important	when	going	to	the	hospital	for	treatment	as	the	doctors	and	staff	working	at	the	hospital	will	not	know	what	medications	you	are	supposed	to	be	taking	and	will	rely	on	you	to	provide	this	information.		If	you	have	a	cell	phone,	another	option	would	be	to	take	a	picture	of	your	medication	list	and	then	you	will	always	have	it	with	you.				
In	following	weeks	of	the	program	we	be	covering	presentations	that	will	discuss	your	
medications	in	detail.				
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Exercise		
	
• The	WHO	(2017)	suggests…	
v 	150	minutes	of	moderate-intensity	activity	or	75	minutes	of	vigorous-intensity	activity	weekly	&	
v 	Muscle-strengthening	on	2	or	more	days			
Only	15%	of	Canadians	are	currently	meeting	activity	recommendations	
(Statistics	Canada,	2015)		
• Chronic	disease	does	not	prevent	participation	in	exercise.		Exercise	just	needs	to	be	adjusted	based	on	exercise	capacity	and	health	needs	(WHO,	2017).					Types	of	Activity:		
• Leisure	physical	activity	time		
• Transportation	
• Occupational	
• Household	chores	
• Games	or	sports	
• Planned	exercise			
• The	150	or	75	minutes	of	weekly	activity	can	be	achieved	in	bouts	of	just	10	minutes	at	a	time	(WHO).				
• Individuals	who	are	currently	inactive	should	begin	with	short	durations	and	gradually	increase	over	time.			
• Inactivity	financially	impacts	the	Canadian	health	care	system.		Statistics	Canada	(2014)	reported	that	inactivity	costs	over	5	billion	dollars	annually	correlating	to	almost	3	percent	of	the	total	health	care	costs	in	Canada.			
	
In	following	weeks	of	the	program	we	be	covering	presentations	that	will	discuss	your	exercise	
in	detail	as	well	as	strategies	to	prevent	shortness	of	breath	during	exercise.			
	
Diet		
	
• A	healthy	diet	helps	to	conserve	energy,	improves	overall	quality	of	life,	improves	physical	capacity,	and	prevents	infections	(Living	Well	with	COPD,	2017).		
• Breathlessness	and	fatigue	prevent	individuals	with	chronic	lung	disease	from	eating	well.		Shopping	and	preparing	meals	may	be	difficult	(Living	Well	with	COPD,	2017).				
Later	in	the	program	you	will	participate	in	various	education	sessions	with	a	Registered	
Dietitian	who	will	discuss	various	aspects	of	healthy	eating.				
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Sexual	Activity		
	
  A	satisfying	sex	life	is	important	to	your	overall	well-being.		Individuals	with	lung	disease	can	have	a	satisfying	sex	life	(Living	Well	with	COPD,	2017)!		
  SOB	and	fatigue	can	have	a	negative	impact	on	an	individual’s	sex	life.		
  Strategies	to	reduce	SOB…	
 v Exercise	regularly	
 v Take	bronchodilator	(Ventolin)	20-30	minutes	before	having	sex		
 v Avoid	positions	that	apply	pressure	to	your	chest	or	stomach	and	positions	that	require	the	support	of	your	arms.		(Living	Well	with	COPD,	2017)		
	
Smoking		
	
 • Smoking	is	the	leading	cause	of	chronic	lung	disease	with	approximately	50%	of	smokers	developing	COPD.		Smoking	is	further	estimated	to	account	for	ten	percent	Laniado-Laborin,	2009)of	deaths	worldwide	( .		Of	importance,	smoking	is	a	preventable	risk	factor	for	chronic	lung	disease	(CDC,	2017).			
 • Smoking,	as	well	as	exposure	to	second-hand	smoke,	has	been	found	to	have	a	negative	impact	on	overall	health	and	wellness.		Both	lead	to	the	development	of	chronic	lung	disease	and	lung	cancer,	while	also	increasing	risk	of	cardiovascular	disease	(CDC,	2017).			
• One	in	five	Canadians	smoke	(Public	Health	Agency	of	Canada,	2012).			
• Quitting	smoking	is	the	most	effective	and	economical	treatment	for	COPD	(Laniado-Laborin,	2009).		Attempts	to	quit	smoking,	even	if	not	successful,	can	preserve	lung	function.				
• Quitting	smoking	is	very	difficult	and	often	requires	multiple	attempts	and	nicotine	replacement	therapy	(NRT).		Only	about	2%	of	smokers	succeed	in	quitting	smoking	without	the	help	of	NRT	with	approximately	two-thirds	relapsing	in	the	first	48	hours	(Laniado-Laborin,	2009).			
• The	Canadian	Lung	Association	(2017)	indicates	that	the	use	of	electronic	cigarettes	potentially	has	a	harmful	effect	on	our	lungs	and	does	not	recommend	electronic	cigarettes	as	a	smoking	cessation	aid.		They	further	indicate	that	more	research	is	required	examining	the	overall	effect	of	electronic	cigarettes.				
• Cannabis	or	Marijuana	is	typically	utilized	as	an	illegal	recreational	drug	but	can	also	be	prescribed	legally	as	a	medication	treatment	for	various	chronic	conditions.		Smoking	cannabis	has	a	similar	effect	on	our	lungs	to	smoking	tobacco	(Government	of	Canada,	2016).					
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Both	the	Registered	Nurse	and	Respiratory	Therapist	working	within	the	pulmonary	
rehabilitation	program	have	taken	specialized	smoking	cessation	training	and	can	help	you	
quit	smoking!				
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
The	above	picture,	available	at	www.livingwellwithCOPD.com	represents	typical	lung	function	
decline	with	age.		Estimated	lung	function	at	age	50	and	75	years	of	a	non-smoker	is	easily	
compared	to	that	of	a	smoker.		Of	interest,	improvement	in	lung	function	can	also	be	viewed	of	
an	individual	who	quit	smoking	at	45	and	65	years.				
	
	 www.livingwellwithcopd.com)Smoking	Activity/Quiz	(obtained	from	 :		
									 	Answers:	T,	T,	F,	T		
	
Lung Function Deterioration 
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 v Education	+	Exercise	=	Pulmonary	Rehabilitation	
 v Pulmonary	Rehabilitation	improves	overall	quality	of	life.		
 v Taking	medications	will	not	cure	lung	disease	but	will	relieve	symptoms.	
 v Chronic	disease	does	not	prevent	participation	in	exercise	
 v Quitting	smoking	is	the	most	effective	treatment	for	COPD	and	will	reduce	decline	in	lung	function.			
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While	a)ending	pulmonary	rehabilita5on	you	will	par5cipate	in	both	educa5on	
sessions	and	supervised	exercise.		During	the	program	you	will	work	with	and	be	
supervised	by	mul5disciplinary	staﬀ	including	a	Registered	Nurse,	Respiratory	
Therapist,	and	Physiotherapist.			
2	
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Provide	SMART	goal	handout	and	assist	pa5ents	in	developing	personal	SMART	goals	
for	Pulmonary	Rehabilita5on.		
4	
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Discussion	Ques5on:		What	does	health	mean	to	you?		
	
Health	and	disease	are	two	diﬀerent	concepts	that	coexist	and	inﬂuence	each	other.		
It	is	important	for	clients/families	to	be	able	to	dis5nguish	between	the	two.		The	
World	Health	Organiza5on	(WHO)	(1948)	deﬁnes	health	as	“a	state	of	complete	
physical,	mental,	and	social	well-being	and	not	merely	the	absence	of	disease.”		The	
Center	for	Disease	Control	and	Preven5on	(2013)	deﬁnes	disease	as	a	condi5on	that	
impairs	normal	func5oning,	is	self-limi5ng,	is	associated	with	dis5nguishing	signs	and	
symptoms,	and	with	a	dura5on	of	months	or	years.			
5	
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Tip:	If	you	cannot	remember	the	name,	dose,	and	administra5on	5me	of	each	
medica5on	you	take,	keep	an	updated	list	in	your	purse	or	wallet.		This	is	important	
when	going	to	the	hospital	for	treatment	as	the	doctors	and	staﬀ	working	at	the	
hospital	will	not	know	what	medica5ons	you	are	supposed	to	be	taking	and	will	rely	
on	you	to	provide	this	informa5on.		Another	5p	would	be	to	take	a	picture	of	your	
medica5on	list	with	you	cell	phone	and	then	you	will	always	have	it	with	you.			
	
In	following	weeks	of	the	program	we	be	covering	presenta5ons	that	will	discuss	
your	medica5ons	in	detail.			
	
7	
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Chronic	disease	does	not	prevent	par5cipa5on	in	exercise.		Exercise	just	needs	to	be	
adjusted	based	on	exercise	capacity	and	health	needs.				
	
Types	of	Ac5vity:		
•  Leisure	physical	ac5vity	5me		
•  Transporta5on	
•  Occupa5onal	
•  Household	chores	
•  Games	or	sports	
•  Planned	exercise		
The	150	or	75	minutes	of	weekly	ac5vity	can	be	achieved	in	bouts	of	just	10	minutes	
at	a	5me.			
	
Individuals	who	are	currently	inac5ve	should	begin	with	short	dura5ons	and	
gradually	increase	over	5me.		
	
Inac5vity	ﬁnancially	impacts	the	Canadian	health	care	system.		Sta5s5cs	Canada	
(2014)	reported	that	inac5vity	costs	over	5	billion	dollars	annually	correla5ng	to	
almost	3	percent	of	the	total	health	care	costs	in	Canada.			
	
	
	
8	
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A	healthy	diet	helps	to	conserve	energy,	improves	overall	quality	of	life,	improves	
physical	capacity,	and	prevents	infec5ons	(Living	Well	with	COPD,	2017).	
	
Breathlessness	and	fa5gue	prevent	individuals	with	chronic	lung	disease	from	ea5ng	
well.		Shopping	and	preparing	meals	may	be	diﬃcult	(Living	Well	with	COPD).			
	
Later	in	the	program	you	will	par5cipate	in	various	educa5on	sessions	with	a	
Registered	Die55an	who	will	discuss	various	aspects	of	healthy	ea5ng.				
			
	
	
9	
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Answers:	T,	T,	F,	T	
	
11	
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Tobacco	is	a	preventable	risk	factor	for	chronic	lung	disease.		
	
Smoking,	as	well	as	exposure	to	second-hand	smoke,	has	been	found	to	have	a	
nega5ve	impact	on	overall	health	and	wellness.		Both	lead	to	the	development	of	
chronic	lung	disease	and	lung	cancer,	while	also	increasing	risk	of	cardiovascular	
disease	(CDC,	2017).		
	
(CDC,	2017)		
		
One	in	ﬁve	Canadians	smoke.		
	
Smoking	causes	inﬂamma5on	to	the	lungs	and	airways.			
	
Qui ng	smoking	is	associated	with	an	increased	life	expectancy.			
	
A)empts	to	quit	smoking,	even	if	not	successful,	can	preserve	lung	func5on.			
	
Qui ng	smoking	is	very	diﬃcult	and	ojen	requires	mul5ple	a)empts	and	NRT	
therapy.		Only	about	2%	of	smokers	succeed	in	qui ng	smoking	without	the	help	of	
NRT	with	approximately	2/3	relapsing	in	the	ﬁrst	48	hours.		Both	the	Registered	
Nurse	and	Respiratory	Therapist	have	taken	specialized	smoking	cessa5on	training		
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Image	obtained	from	the	Canadian	Lung	Associa5on.			
	
There	are	more	then	4000	chemicals	contained	within	a	cigare)e,	many	of	which	are	
known	to	be	cancer	causing	agents.		
	
Some	of	the	chemicals	found	in	cigare)es	include:			
“•				Carbon	Monoxide	(found	in	car	exhaust)	
	•				Arsenic	(rat	poison)	
	•				Ammonia	(found	in	window	cleaner)	
	•				Acetone	(found	in	nail	polish	remover)	
	•				Hydrogen	Cyanide	(gas	chamber	poison)	
	•				Napthalene	(found	in	mothballs)	
	•				Sulphur	Compounds	(found	in	matches)	
	•				Lead	
	•				Vola5le	Alcohol	
	•				Formaldehyde	(used	as	embalming	ﬂuid)	
	•				Butane	(lighter	ﬂuid)”		
(Canadian	Lung	Associa5on,	2017)	
	
	
13	
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Image	obtained	from	www.clipartpanda.com	
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http://www.albertahealthservices.ca/assets/info/nutrition/if-nfs-setting-smart-goals.pdf
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		This	module	will	begin	by	providing	an	overview	of	the	pulmoary	or	respiratory	system,	describing	both	the	anatomy	and	fuction.		This	will	provide	an	understanding	of	the	“normal	or	healthy”	lung	prior	to	learning	the	abnormal	associated	with	chronic	lung	disease.		Following,	a	description	of	chronic	lung	disease	and	the	associated	impact	on	both	individuals	and	the	health	care	system	will	be	discussed.		Common	symptoms	of	chronic	lung	disease	will	be	identified.				By	the	end	of	a	group	education	session	participants	will:	7. Simply	explain	the	anatomy	and	function	of	the	“healthy	or	normal”	lung.		8. Describe	chronic	lung	disease	and	identify	their	current	diagnosis.					9. Share	their	personal	impact	of	chronic	lung	disease.						
It	is	intended	that	the	materials	presented	within	this	module	be	utilized	during	a	one	hour	group	education	session.		Various	aids	have	been	provided	within	the	module	to	assist	with	ease	of	education	delivery.				
v Potential	questions	for	facilitated	group	discussion			
v Visual	Aids:	PowerPoint	presentation	with	various	pictures/graph;	whiteboard	and	markers;	lung	models		
v Video:	“The	Respiratory	System”	avaliable	at	https://www.youtube.com/watch?v=hc1YtXc_84A			 	
The	Pulmonary	or	Respiratory	System	
	
To	survive,	our	bodies	need	oxygen,	which	we	get	from	the	air	that	we	breathe	throughout	the	
day.		For	individuals	with	“healthy	lungs”,	breathing	is	often	a	passive	process	and	something	
that	we	don’t	actively	think	about	as	we	go	about	our	day-to-day	activities.		It	is	important	for	
us	to	have	an	understanding	of	the	anatomy	and	function	of	the	respiratory	system.					
	
• There	are	two	functions	of	the	pulmonary	or	respiratory	system:	ventilation	and	respiration	(Urden,	Stacy,	&	Lough,	2010).		During	ventilation,	air	moves	into	and	out	of	the	lungs	through	inspiration	and	expiration.		Ventilation	is	controlled	by	the	
Module	2:	The	“Healthy”	Lung	and	
Understanding	Lung	Disease	
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central	nervous	system.		During	respiration,	gas	exchange	takes	place	and	oxygen	is	moved	from	the	air	around	us	into	the	bloodstream	and	carbon	dioxide	is	moved	from	the	bloodstream	into	the	air.					
																								 	Image	obtained	from	www.clipartpanda.com		
• We	breathe	approximately	22	000	times	each	day,	averaging	12	to	20	times	per	minute	for	an	adult	(Canadian	Lung	Association,	2017).			
• During	inspiration,	the	diaphragm	(the	main	muscle	of	breathing)	contracts,	the	lungs	expand,	and	air	is	drawn	into	the	body	(Urden	et	al.,	2010).		Accessory	muscles,	such	as	those	that	expand	the	rib	cage	or	those	within	our	abdomen,	may	also	assist	with	inspiration.		Respiration	is	a	passive	process.		The	diaphragm	relaxes	and	air	is	expelled.				
• The	lungs	are	located	within	the	chest	and	protected	by	the	rib	cage	(Urden	et	al.,	2010).		The	normal	pulmonary	system	is	comprised	of	a	left	and	right	lung.		Each	lung	is	divided	into	segments	called	lobes.		The	right	lung	has	three	lobes	and	the	left	lung	has	two	lobes.					
• The	pulmonary	system	consists	of	the	following	(Urden	et	al.,	2010):				1. Thorax:	thoracic	cage,	lungs,	pleura,	and	muscles	of	ventilation	2. Conducting	airways:	upper	airways,	trachea,	and	bronchial	tree		3. Respiratory	airways:	bronchioles	and	alveoli		4. Pulmonary	blood	and	lymph	supply			
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											 	 	Image	obtained	from	www.lung.ca
 
 
• Air	that	we	breathe	enters	the	body	through	the	nose	or	mouth	(Urden	et	al.,	2010).		It	then	travels	through	the	pharynx	and	larynx	into	the	trachea.		The	trachea	divides	into	tubes	called	bronci.		The	right	main	and	left	main	bronchus	each	supply	a	lung.		The	bronchi	further	divide	and	eventually	form	into	bronchioles	which	are	final	division	of	the	conducting	airways.		Each	bronchiole	connects	to	several	alveoli	which	is	the	site	of	gas	exchange	(Urden).		 
        
         
 • The	pulmonary	system	has	various	built	in	protective	mechanisms	(Urden	et	al.,	2010;	Australia	Lung	Foundation,	2016).		The	nose	and	mouth	both	filter	and	warm	the	air	we	breathe.		The	nose	is	more	effective	at	this	and	serves	as	a	better	filter,	making	the	nose	the	preferred	breathing	route.		The	mouth	on	the	other	hand	allows	for	larger	amounts	of	air	to	enter	the	body.		This	is	useful	during	episodes	of	shortness	of	breath	or	during	exercise.		Both	sputum	and	tiny	hair-like	structures	called	cilia	line	the	airways.		Both	prevent	irritants	and	particles	from	entering	the	
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lungs.		The	cilia	move	in	a	sweeping	motion	and	help	move	particles	and	sputum	from	the	airways	to	the	mouth	where	they	can	be	cleared.			The	following	video,	“The	Respiratory	System”,	provides	a	review	of	the	information	previously	covered:	https://www.youtube.com/watch?v=hc1YtXc_84A		
Now	that	we	understand	the	normal	lung,	in	the	next	module	we	will	be	discussing	the	impact	
of	various	chronic	lung	conditions	on	the	lung.	
			
What	is	Chronic	Lung	Disease?	
	
The	term	Chronic	Lung	Disease	refers	to	respiratory	conditions	that	are	long	term	or	
incurable.		They	are	typically	associated	with	permanent	or	irreversible	damage	to	the	lungs.		
Symptoms	of	these	diseases	are	usually	progressive	in	nature.		During	the	last	presentation	we	
talked	about	various	factors	of	keeping	a	health	lifestyle.		Many	of	these	will	help	control	
symptoms	of	chronic	lung	disease	and	slow	disease	progression.			
	
 The	term	chronic	lung	disease	refers	to	respiratory	conditions	such	as,	chronic	• obstructive	pulmonary	disease	(COPD),	which	also	encompasses	chronic	bronchitis	and	emphysema,	pulmonary	fibrosis,	asthma,	lung	cancer,	and	tuberculosis	(Public	Health	Agency	of	Canada,	2012).				
Chronic	(long	term)	Obstructive	(partially	blocked)	Pulmonary	(lung)	Disease		
																																										
• Chronic	lung	disease	has	been	documented	as	far	back	as	the	1600’s.		Physician	documentations	from	several	centuries	ago	have	clearly	documented	alterations	in	
Chronic	Lung	Disease	
Pulmonary	Fibrosis	
COPD	
Lung	Cancer	Asthma	
Tuberculosis	
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lung	size,	inflammation	to	the	mucous	membranes,	breakdown	of	lung	tissue,	and	air	trapping	(Ebner,	2015;	Heffner,	2013).						
• The	reality	of	living	with	chronic	lung	disease	is	burdensome	and	causes	debilitation	to	both	individuals	living	with	the	conditions	and	the	health	care	system.	(World	Health	Organization,	2007).			
o Common	symptoms	include	(Living	Well	with	COPD,	2017):		
§ Shortness	of	breath		
§ Cough/mucous	production		
§ Chest	tightness	
§ Wheezing		
§ Fatigue	
§ Anxiety		
	
Pulmonary	rehabilitation	demonstrates	a	secondary	prevention	
intervention	aimed	at	improving	the	quality	of	life	of	those	living	with	
chronic	lung	disease	(AACVPR,	2011).		
• The	World	Health	Organization	(2007)	estimates	that	chronic	lung	disease	will	become	the	third	leading	cause	of	death	by	2030.			
	Discussion	Questions:		
 1. What	is	the	name	of	your	chronic	lung	disease?	
 2. What	symptoms	do	you	experience	with	your	chronic	lung	disease?		
	
Chronic	Lung	Disease	in	Canada			
• There	are	over	three	million	individuals	currently	living	with	chronic	lung	disease	in	Canada	(Public	Health	Agency	of	Canada,	2012).				
• COPD	is	the	only	chronic	condition	that	is	still	associated	with	an	increasing	mortality	rate	in	Canada	(Canadian	Thoracic	Society,	2010).			
• Chronic	lung	disease	has	a	significant	economic	impact	on	the	Canadian	health	care	system,	costing	approximately	12	billion	dollars	annually	(Public	Health	Agency	of	Canada).				 	Discussion	Questions:		1. How	does	your	chronic	lung	disease	impact	your	day-to-day	life?		2. How	has	your	life	changed	since	being	diagnosed	with	a	chronic	lung	disease?			3. What	is	the	financial	impact	of	your	chronic	lung	disease?		
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  The	pulmonary	system	has	two	functions:	ventilation	and	respiration.	
  Chronic	lung	disease:			
 u Long	term	or	incurable	
 u Associated	with	permanent	or	irreversible	damage	to	the	lungs	
 u Symptoms	are	usually	progressive.	
  Pulmonary	rehabilitation	=	secondary	prevention	intervention	aimed	at	improving	quality	of	life	
  Chronic	lung	disease	has	an	impact	on	the	individual	living	with	the	disease	and	the	health	care	system.		
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Review	Key	Messages	from	previous	module.		
2	
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Image	obtained	from	www.clipartpanda.com	
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Image	obtained	from	www.clipartpanda.com	
	
Before	we	can	learn	about	abnormal	condi?ons,	we	need	to	ﬁrst	understand	the	
anatomy	and	func?on	of	the	“healthy	or	normal”	lung.			
	
When	we	discuss	breathing	or	our	lungs	we	are	referring	to	the	pulmonary	or	
respiratory	system.		The	two	are	used	interchangeably.			
	
There	are	two	func?ons	of	the	pulmonary	system:	ven?la?on	and	respira?on	(Urden,	
Stacy,	&	Lough,	2010).		During	ven?la?on,	air	moves	into	and	out	of	the	lungs	
through	inspira?on	and	expira?on.		Ven?la?on	is	controlled	by	the	central	nervous	
system.		During	respira?on,	gas	exchange	takes	place	and	oxygen	is	moved	from	the	
air	around	us	into	the	bloodstream	and	carbon	dioxide	is	moved	from	the	
bloodstream	into	the	air.			
	
During	inspira?on,	the	diaphragm	(the	main	muscle	of	breathing)	contracts,	the	lungs	
expand,	and	air	is	drawn	into	the	body	(Urden	et	al.,	2010).		Accessory	muscles,	such	
as	those	that	expand	the	rib	cage	or	those	within	our	abdomen,	may	also	assist	with	
inspira?on.		Respira?on	is	a	passive	process.		The	diaphragm	relaxes	and	air	is	
expelled.			
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The	lungs	are	located	within	the	chest	and	protected	by	the	rib	cage	(Urden).		The	
normal	pulmonary	system	is	comprised	of	a	leU	and	right	lung.		Each	lung	is	divided	
into	segments	called	lobes.		The	right	lung	has	three	lobes	and	the	leU	lung	has	two	
lobes.				
	
Air	that	we	breathe	enters	the	body	through	the	nose	or	mouth	(Urden).		It	then	
travels	through	the	pharynx	and	larynx	into	the	trachea.		The	trachea	divides	into	
tubes	called	bronchi.		The	right	right	and	leU	main	bronchus	each	supply	a	lung.		The	
bronchi	further	divide	and	eventually	form	into	bronchioles	which	are	ﬁnal	division	of	
the	conduc?ng	airways.		Each	bronchiole	connects	to	several	alveoli	which	is	the	site	
of	gas	exchange	(Urden).					
	
The	pulmonary	system	has	various	built	in	protec?ve	mechanisms	(Urden;	Australia	
Lung	Founda?on,	2016).		The	nose	and	mouth	both	ﬁlter	and	warm	the	air	we	
breathe.		The	nose	is	more	eﬀec?ve	at	this	and	serves	as	a	be[er	ﬁlter,	making	the	
nose	the	preferred	breathing	route.		The	mouth	on	the	other	hand	allows	for	larger	
amounts	of	air	to	enter	the	body.		This	is	useful	during	episodes	of	shortness	of	
breath	or	during	exercise.		Both	sputum	and	?ny	hair-like	structures	called	cilia	line	
the	airways.		Both	trap	irritants	and	par?cles	from	entering	the	lungs.		The	cilia	move	
in	a	sweeping	mo?on	and	help	move	from	the	airways	to	the	mouth	where	it	can	be	
cleared.			
5	
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These	are	examples	of	diseases	or	condi?ons	that	fall	under	the	term	chronic	lung	
disease.			
	
The	term	Chronic	Lung	Disease	refers	to	condi?ons	that	are	long	term	or	incurable.		
They	are	typically	associated	with	permanent	or	irreversible	damage	to	the	lungs.		
Symptoms	of	these	diseases	are	usually	progressive	in	nature.		During	the	last	
presenta?on	we	talked	about	various	factors	of	keeping	a	health	lifestyle.		Many	of	
these	will	help	control	symptoms	of	chronic	lung	disease	and	slow	down	disease	
progression.			
	
The	World	Health	Organiza?on	(2007)	es?mates	that	chronic	lung	disease	will	
become	the	third	leading	cause	of	death	by	2030.			
	
Pulmonary	rehabilita?on	demonstrates	a	secondary	preven?on	interven?on	aimed	at	
improving	the	quality	of	life	of	those	living	with	chronic	lung	disease	(AACVPR,	2011).		
	
Individuals	are	most	commonly	referred	to	pulmonary	rehabilita?on	with	a	diagnosis	
of	COPD	or	Pulmonary	Fibrosis.			
	
Discussion	Ques?on:		What	is	the	name	of	your	chronic	lung	disease?			
6	
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Chronic	(long	term)	Obstruc?ve	(par?ally	blocked)	Pulmonary	(lung)	Disease		
	
Next	class	we	will	be	discussing	the	Anatomy	and	Physiology	of	various	chronic	lung	
diseases.			
7	
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Discussion:	What	symptoms	do	you	experience	with	your	chronic	lung	disease?		
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Discussion	Ques?ons:		
	
How	does	your	chronic	lung	disease	impact	your	day	to	day	life?		
	
How	has	your	life	changed	since	being	diagnosed	with	a	chronic	lung	disease?			
	
What	is	the	ﬁnancial	impact	of	your	chronic	lung	disease?		
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Image	obtained	from	www.clipartpanda.com	
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Module	3:	Lung	Disease	Anatomy	and	
Physiology		
		This	module	will	provide	a	description	of	the	disease	process	of	various	chronic	lung	conditions	including:	chronic	obstructive	pulmonary	disease,	pulmonary	fibrosis,	asthma,	pulmonary	hypertension,	cystic	fibrosis,	and	tracheomalacia.		The	module	will	also	identify	symptoms	specific	to	each	disease.		Learning	Objectives:			By	the	end	of	a	group	education	session	participants	will:				 1. Be	able	to	explain	a	basic	description	of	their	diagnosed	chronic	lung	disease.		2. State	two	common	symptoms	of	their	diagnosed	chronic	lung	disease.					
It	is	intended	that	the	materials	presented	within	this	module	be	utilized	during	a	one	hour	group	education	session.		Various	aids	have	been	provided	within	the	module	to	assist	with	ease	of	education	delivery.					
v Visual	Aids:	PowerPoint	presentation	with	various	pictures/graph;	whiteboard	and	markers;	lung	models		
v Video:	Understanding	COPD	avaliable	at:	https://www.youtube.com/watch?v=T1G9Rl65M-Q	
v Video:	Understanding	Pulmonary	Fibrosis	avaliable	at:	https://www.youtube.com/watch?v=qjDNp54o_bI	
v Handouts:	COPD	retrieved	from	www.livingwellwithCOPD.com;	Pulmonary	Fibrosis	retrieved	from	www.livingwellwithPulmonaryFibrosis.com		
	
In	the	last	module	we	discussed	the	pulmonary	system	and	the	“normal	lung”.		This	module	
will	discuss	the	impact	of	various	chronic	lung	diseases	on	the	lungs.		The	most	common	
diagnoses	for	patients	attending	pulmonary	rehabilitation	are	Chronic	Obstructive	Pulmonary	
Disease	and	Pulmonary	Fibrosis.			
	
Note:	For	the	other	conditions	discussed,	if	there	is	not	a	participant	attending	with	the	
associated	diagnosis	the	related	section	could	be	omitted.			
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Chronic	Obstructive	Pulmonary	Disease	(COPD):		
Chronic	(long	term)	Obstructive	(partially	blocked)	Pulmonary	(lung)	Disease			
• COPD	is	a	chronic	disease	characterized	by	obstruction	of	airflow	in	the	lungs.		The	
two	most	common	symptoms	of	COPD	are	shortness	of	breath	and	cough.		COPD	is	a	progressive	disease	and	symptoms	typically	worsen	over	time	(Australia	Lung	Foundation,	2016).				
• COPD	is	not	curable,	but	COPD	is	treatable.		Appropriate	diagnosis	and	treatment	improve	overall	quality	of	life	and	slows	disease	progression	(Canadian	Lung	Association,	2017).						
• COPD	is	best	diagnosed	with	spirometry	(Living	well	with	COPD,	2017)		
Note:	In	a	later	module	we	will	discuss	spirometry	and	other	tests	and	interventions	in	detail.				
• The	term	COPD	encompasses	two	conditions:	obstructive	chronic	bronchitis	and	emphysema	(Canadian	Lung	Association;	Living	well	with	COPD,	2017;	Australia	Lung	Foundation).		Individuals	may	have	one	or	both	of	these	conditions	when	diagnosed	with	COPD.				 1. Obstructive	Chronic	Bronchitis	results	in	inflammation	and	swelling	of	the	lung’s	airways,	specifically	the	bronchi	and	bronchioles.		This	inflammation	further	causes	increased	and	excessive	sputum	production	within	the	airways.		Both	inflammation	and	sputum	lead	to	airway	obstruction.		This	obstruction	makes	it	difficult	to	move	air	in	and	out	of	the	lungs	leading	to	symptoms	such	as	shortness	of	breath.			
Symptoms:	increased	sputum	production,	frequent	coughing,	wheezing,	and	shortness	of	breath	(Canadian	Lung	Association;	Living	well	with	COPD;	Australia	Lung	Foundation)		
														 											Image	retrieved	from	www.livingwellwithcopd.com	
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2. Emphysema	results	in	damage/destruction	and	stiffening	to	the	alveoli.		The	alveoli	are	the	time	air	sacs,	connected	to	the	bronchioles,	where	gas	exchange	is	conducted.		In	the	normal	lung	these	sacs	stretch	as	we	breathe	in	and	out.		The	stiffening	of	the	alveoli	leads	to	air	trapping,	in	which	your	lungs	do	not	completely	empty.		This	makes	it	difficult	to	move	air	in	and	out	and	prevents	the	exchange	of	oxygen	and	carbon	dioxide.			
Symptoms:	shortness	of	breath	and	fatigue		(Canadian	Lung	Association;	Living	well	with	COPD;	Australia	Lung	Foundation)					
																								 							Image	retrieved	from	www.livingwellwithcopd.com					
• There	are	various	causes	or	contributing	factors	that	lead	to	COPD.		The	main	cause	of	COPD,	in	80	to	90	percent	of	diagnoses,	is	smoking.		Other	causes	include:	Alpha-1	antitrypsin	deficiency,	air	pollution	such	as	dust	or	chemicals,	second-hand	smoke,	and	repeated	lung	infections	particularly	as	a	child	(Canadian	Lung	Association).						
• Alpha-1	antitrypsin	deficiency	is	a	rare	genetic	disorder.		Alpha-1	antitrypsin,	found	within	our	blood,	protects	our	lungs	from	damage.		Individuals	with	a	deficiency	are	at	risk	of	developing	COPD	due	to	exposure	to	inhaled	pollutants,	smoke,	or	dust	etc.	from	everyday	living	(Australia	Lung	Association).			
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Patients	often	express	guilt	or	shame	associated	with	smoking	and	a	diagnosis	of	COPD.		They	
may	feel	that	they	brought	this	condition	on	themselves	or	healthcare	professionals	blame	
them	for	their	current	condition.		As	healthcare	professionals	we	recognize	that,	in	relation	to	
chronic	lung	disease,	quitting	smoking	is	the	most	significant	action	one	can	do	for	their	
health.		We	must	also	recognize	that	smoking	is	an	addiction.		Centers	for	Disease	Control	and	
Prevention	(2017)	indicate	that	nicotine,	a	drug	found	in	the	tobacco	of	cigarettes,	is	as	
addictive	as	heroin,	cocaine,	or	alcohol.		It	is	also	significant	to	acknowledge	that	awareness	
related	to	the	impacts	of	smoking	and	smoking	cessation	were	not	always	as	common	as	they	
are	today.		There	was	a	time	in	our	history	when	smoking	was	the	norm.		Within	the	
Pulmonary	Rehabilitation	setting	both	the	RN	and	RT	are	trained	in	smoking	cessation	and	
serve	as	a	resource	for	participants	who	may	be	interested	in	quitting	smoking!								
Pulmonary	Fibrosis:			
• Pulmonary	fibrosis	is	sometimes	referred	to	as	interstitial	lung	disease	and	characterized	by	progressive	scarring	of	the	lungs	(Living	well	with	Pulmonary	Fibrosis,	2017).		In	order	for	gas	exchange	to	happen	within	the	lungs,	air	must	pass	through	the	interstitium	of	the	lung	to	reach	the	pulmonary	circulation.		Scarring	of	the	lungs	causes	the	interstitium	to	become	thick	and	stiff,	making	this	difficult.			
Symptoms:	shortness	of	breath,	fatigue,	non-productive	cough,	clubbing	of	the	fingernails,	and	crackles	heard	on	auscultation	of	the	lungs			(Living	Well	with	Pulmonary	Fibrosis,	2017)																					 Images	from	the	program	"Living	Well	with	Pulmonary	Fibrosis",	J.	Morisset,	D.	Nault,	A.	Savard,	M.	Sedeno,	1st	edition	(2016)	www.livingwellwithpulmonaryfibrosis.com		
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• Pulmonary	fibrosis	is	referred	to	as	idiopathic	(IPF)	when	the	cause	of	the	disease	is	unknown.		There	are	various	risk	factors	for	IPF	including:	age	>	50	yrs,	smoking,	family	history,	and	acid	reflux	(Living	well	with	Pulmonary	Fibrosis).		There	are	other	known	causes	of	pulmonary	fibrosis.		Individuals	may	also	be	diagnosed	with	pulmonary	fibrosis	related	to	hypersensitivity	pneumonitis	or	an	immune	reaction	to	an	inhaled	agent,	or	related	to	a	connective-tissue	disease	such	as	rheumatoid	arthritis.							
• There	is	no	cure	for	pulmonary	fibrosis.		Appropriate	diagnosis	and	treatment	may	slow	disease	progression.				
Although	the	anatomy	and	physiology	of	pulmonary	fibrosis	differs	from	that	of	COPD,	the	
impact	on	quality	of	life	and	symptoms	are	similar!							
Asthma:		
	
• Asthma	is	a	condition	characterized	by	constriction	and	swelling	of	the	airways,	muscle	tightening	surrounding	the	airways,	and	increased	sputum	production.		These	process	lead	to	airways	obstruction,	similarly	to	COPD.							
Symptoms:	wheezing,	chest	tightness,	shortness	of	breath,	and	cough	(Canadian	Lung	Association;	Australia	Lung	Foundation)		
• Asthma	is	a	chronic	disease	and	not	curable.				
	 	Image	obtained	from	www.lung.ca	
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Pulmonary	Hypertension:				
	
• Pulmonary	hypertension	is	a	condition	characterized	by	increased	blood	pressure	within	the	vessels	of	the	lungs.		This	increased	pressure	leads	to	narrowing	of	the	lungs	arteries,	decreasing	blood	flow	and	oxygen	concentration.		If	left	untreated,	pulmonary	hypertension	can	lead	to	heart	failure	or	mortality.			
Symptoms:	shortness	of	breath,	chest	pain,	dizziness,	fainting,	cough,	edema,	and	decreased	energy		
• Genetics	and	obstructive	sleep	apnea	are	risk	factors	for	pulmonary	hypertension.		
• Pulmonary	hypertension	is	not	curable	but	treatable.			(Canadian	Lung	Association;	Pulmonary	Hypertension	Association,	2017)		
																			 	Image	obtained	from	https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_pulmonary_hypertension.htm		
	
The	following	lung	conditions	are	not	commonly	seen	in	the	pulmonary	rehabilitation	setting.		
A	brief	description	has	been	provided	for	each	disease	in	the	event	that	a	participant	attending	
has	been	diagnosed.		If	not	applicable	they	can	be	omitted	from	group	education.			
	
Cystic	Fibrosis:			
	
• Cystic	Fibrosis	(CF)	is	a	genetic	condition	affecting	both	the	lungs	and	digestive	system.		CF	typically	leads	to	frequent	lung	infections,	destruction	of	lung	tissue,	and	ultimately	loss	of	lung	function.			
Symptoms:	cough,	increased	sputum	production,	shortness	of	breath,	wheezing,	weight	loss	and	difficulties	gaining	weight,	salty	tasting	sweat,	and	infertility		
• It	is	estimated	that	individuals	will	CF	spend	the	equivalent	of	four	months	of	full-time	work	undergoing	treatment	for	CF	yearly.			
• CF	is	diagnosed	with	a	sweat	test	or	genetic	testing.		 (Cystic	Fibrosis	Canada,	2017)		
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Tracheomalacia:			
• Tracheomalacia	is	a	condition	in	which	the	cartilage	that	supports	the	trachea	is	not	fully	developed	or	misshaped.		This	may	lead	to	a	narrowing	or	collapse	of	the	airways	during	exhalation.			
Symptoms:	stridor,	high-pitched	breathing,	cough,	frequent	infections,	and	exercise	intolerance	
  COPD	=	Chronic	(long	term)	Obstructive	(partially	blocked)	Pulmonary	(lung)	Disease		
  COPD,	Pulmonary	Fibrosis,	Asthma,	and	Pulmonary	Hypertension	are	not	curable	but	are	treatable.			
  Appropriate	treatment	improves	overall	quality	of	life	and	slows	disease	progression.		
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Review	Key	Messages	from	previous	module.		
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COPD	is	a	chronic	disease	characterized	by	obstrucDon	of	airﬂow	in	the	lungs.		The	
two	most	common	symptoms	of	COPD	are	shortness	of	breath	and	cough.		COPD	is	a	
progressive	disease	and	symptoms	typically	worsen	over	Dme	(Australia	Lung	
FoundaDon,	2016).			
	
COPD	is	not	curable,	but	COPD	is	treatable.		Appropriate	diagnosis	and	treatment	
improve	overall	quality	of	life	and	slow	disease	progression	(Canadian	Lung	
AssociaDon,	2017).					
	
There	are	various	causes	or	contribuDng	factors	that	lead	to	COPD.		The	main	cause	
of	COPD,	in	80	to	90	percent	of	cases,	is	smoking.		Other	causes	include:	Alpha-1	
anDtrypsin	deﬁciency,	air	polluDon	such	as	dust	or	chemicals,	second-hand	smoke,	
and	repeated	lung	infecDons	parDcularly	as	a	child	(Canadian	Lung	AssociaDon).			
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The	term	COPD	encompasses	two	condiDons:	obstrucDve	chronic	bronchiDs	and	
emphysema	(Canadian	Lung	AssociaDon;	Living	well	with	COPD;	Australia	Lung	
FoundaDon).		Individuals	may	have	one	or	both	of	these	condiDons	when	diagnosed	
with	COPD.			
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Image	retrieved	from	www.livingwellwithcopd.com	
	
Obstruc)ve	Chronic	Bronchi)s	results	in	inﬂammaDon	and	swelling	of	the	lung’s	
airways,	speciﬁcally	the	bronchi	and	bronchioles.		This	inﬂammaDon	further	causes	
increased	and	excessive	sputum	producDon	within	the	airways.		Both	inﬂammaDon	
and	sputum	lead	to	airway	obstrucDon.		This	obstrucDon	makes	it	diﬃcult	to	move	air	
in	and	out	of	the	lungs	leading	to	symptoms	such	as	shortness	of	breath.			
	
Symptoms:	increased	sputum	producDon,	frequent	coughing,	wheezing,	and	
shortness	of	breath	(Canadian	Lung	AssociaDon;	Living	well	with	COPD;	Australia	Lung	
FoundaDon)	
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Image	retrieved	from	www.livingwellwithcopd.com	
	
Emphysema	results	in	damage/destrucDon	and	sDﬀening	to	the	alveoli.		The	alveoli	
are	the	Dme	air	sacs,	connected	to	the	bronchioles,	where	gas	exchanges	is	
conducted.		In	the	normal	lung	these	sacs	stretch	as	we	breathe	in	and	out.		The	
sDﬀening	of	the	alveoli	leads	to	air	trapping,	in	which	your	lungs	do	not	completed	
empty.		This	makes	it	diﬃcult	to	move	air	in	and	out	and	prevents	the	exchange	of	
oxygen	and	carbon	dioxide.			
	
Symptoms:	shortness	of	breath	and	faDgue	(Canadian	Lung	AssociaDon;	Living	well	
with	COPD;	Australia	Lung	FoundaDon)	
	
8	
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Images	from	the	program	"Living	Well	with	Pulmonary	Fibrosis",	J.	Morisset,	D.	Nault,	
A.	Savard,	M.	Sedeno,	1st	ediDon	(2016)	www.livingwellwithpulmonaryﬁbrosis.com	
	
Pulmonary	ﬁbrosis,	someDmes	referred	to	as	intersDDal	lung	disease,	is	
characterized	by	progressive	scarring	of	the	lungs	(Living	well	with	Pulmonary	
Fibrosis,	2017).		In	order	for	gas	exchange	to	happen	within	the	lung	the	lungs,	air	
must	pass	through	the	intersDDum	of	the	lung	to	reach	the	pulmonary	circulaDon.		
Scarring	of	the	lungs	causes	the	intersDDum	to	become	thick	and	sDﬀ,	making	this	
diﬃcult.			
	
Symptoms:	shortness	of	breath,	faDgue,	non-producDve	cough,	clubbing	of	the	
ﬁngernails,	and	crackles	heard	on	auscultaDon	of	the	lungs	(Living	Well	with	
Pulmonary	Fibrosis,	2017)	
	
Pulmonary	ﬁbrosis	is	referred	to	as	idiopathic	(IPF)	when	the	cause	of	the	disease	is	
unknown.		There	are	various	risk	factors	for	IPF	including:	age	>	50	yrs,	smoking,	
family	history,	and	acid	reﬂux	(Living	well	with	Pulmonary	Fibrosis).		There	are	other	
known	causes	of	pulmonary	ﬁbrosis.		Individuals	may	also	be	diagnosed	with	
pulmonary	ﬁbrosis	related	to	hypersensiDvity	pneumoniDs	or	an	immune	reacDon	to	
an	inhaled	agent,	or	related	to	a	connecDve-Dssue	disease	such	as	rheumatoid	
arthriDs.						
9	
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Image	obtained	from	www.lung.ca	
	
Asthma	is	a	condiDon	characterized	by	constricDon	and	swelling	of	the	airways,	
muscle	Dghtening	surrounding	the	airways,	and	increased	sputum	producDon.		These	
process	lead	to	airways	obstrucDon,	similarly	to	COPD.							
Symptoms:	wheezing,	chest	Dghtness,	shortness	of	breath,	and	cough	
(Canadian	Lung	AssociaDon;	Australia	Lung	FoundaDon)	
	
Asthma	is	a	chronic	disease	and	not	curable.			
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Image	obtained	from	hfps://www.cdc.gov/dhdsp/data_staDsDcs/fact_sheets/
fs_pulmonary_hypertension.htm	
	
Pulmonary	hypertension	is	a	condiDon	characterized	by	increased	blood	pressure	
within	the	vessels	of	the	lungs.		This	increased	pressure	leads	to	narrowing	of	the	
lungs	arteries,	decreasing	blood	ﬂow	and	oxygen	concentraDon.		If	leh	untreated,	
pulmonary	hypertension	can	lead	to	heart	failure	or	mortality.			
	
Symptoms:	shortness	of	breath,	chest	pain,	dizziness,	fainDng,	cough,	edema,	and	
decreased	energy		
GeneDcs	and	obstrucDve	sleep	apnea	are	risk	factors	for	pulmonary	hypertension.		
	
Pulmonary	hypertension	is	not	curable	but	treatable.		
	
(Canadian	Lung	AssociaDon;	Pulmonary	Hypertension	AssociaDon,	2017)	
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	Content	and	images	from	the	program	"Living	Well	with	Pulmonary	Fibrosis",	J.	Morisset,	D.	Nault,	A.	Savard,	M.	Sedeno,	1st	edition	(2016)	www.livingwellwithpulmonaryfibrosis.com	
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Module	4:	Managing	Breathing,	Energy	
Conservation,	&	Environmental	Factors			This	module	will	identify	why	shortness	of	breath	occurs	in	chronic	lung	disease,	specifically	related	to	COPD	and	pulmonary	fibrosis.		It	also	provides	a	review	of	chronic	lung	disease	anatomy	and	physiology.		Strategies	to	manage	breathing,	as	well	as	common	environmental	factors	that	lead	to	acute	onset	of	shortness	of	breath	or	exacerbation	will	be	identified	in	the	content.				
By	the	end	of	a	group	education	session	participants	will:			 1. Describe	how	their	current	diagnosis	causes	shortness	of	breath.		2. Demonstrate	pursed-lip	breathing.			3. Demonstrate	controlled	coughing	and	huffing.			4. Share	one	environmental	factor	that	aggravates	their	disease.				
It	is	intended	that	the	materials	presented	within	this	module	be	utilized	during	a	one	hour	group	education	session.		Various	aids	have	been	provided	within	the	module	to	assist	with	ease	of	education	delivery.			
v Visual	Aids:	PowerPoint	presentation	containing	various	pictures/graph;	whiteboard	and	markers		
v Patient	Activity	and	Handout:	Lets	practice!	;	How	to	Avoid	Factors	that	Worsen	COPD	
v Model:	Lung	models		
v Potential	questions	for	facilitated	group	discussion					Chronic	Lung	Disease	Anatomy	and	Physiology	Review			Shortness	of	breath	is	a	common	symptom	of	many	chronic	lung	diseases	including	both	COPD	and	pulmonary	fibrosis.		These	are	the	two	most	common	diagnoses	of	participants	enrolled	in	pulmonary	rehabilitation.				
Let’s	review…	How	does	chronic	lung	disease	cause	shortness	of	breath?	Utilization	of	the	
provided	lung	models	may	be	helpful	during	this	review.				
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• Obstructive	Chronic	Bronchitis	results	in	inflammation	and	swelling	of	the	lung’s	airways,	specifically	the	bronchi	and	bronchioles.		This	inflammation	further	causes	increased	and	excessive	sputum	production	within	the	airways.		Both	inflammation	and	sputum	lead	to	airway	obstruction.		This	obstruction	makes	it	difficult	to	move	air	in	and	out	of	the	lungs	leading	to	symptoms	such	as	shortness	of	breath	(Canadian	Lung	Association,	2017;	Living	well	with	COPD,	2017;	Australia	Lung	Foundation,	2016).				
																																	 		Image	retrieved	from	www.livingwellwithcopd.com			
• Emphysema	results	in	damage/destruction	and	stiffening	to	the	alveoli.		The	alveoli	are	the	time	air	sacs,	connected	to	the	bronchioles,	where	gas	exchange	is	conducted.		In	the	normal	lung	these	sacs	stretch	as	we	breathe	in	and	out.		The	stiffening	of	the	alveoli	leads	to	air	trapping,	in	which	your	lungs	do	not	completely	empty.		This	makes	it	difficult	to	move	air	in	and	out	and	prevents	the	exchange	of	oxygen	and	carbon	dioxide	leading	to	shortness	of	breath	(Canadian	Lung	Association,	2017;	Living	well	with	COPD,	2017;	Australia	Lung	Foundation,	2016).		
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																												 	Image	retrieved	from	www.livingwellwithcopd.com		
• Pulmonary	fibrosis,	sometimes	referred	to	as	interstitial	lung	disease,	is	characterized	by	progressive	scarring	of	the	lungs	(Living	well	with	Pulmonary	Fibrosis,	2017).		In	order	for	gas	exchange	to	happen	within	the	lungs,	air	must	pass	through	the	interstitium	of	the	lung	to	reach	the	pulmonary	circulation.		Scarring	of	the	lungs	causes	the	interstitium	to	become	thick	and	stiff,	making	this	difficult.		This	leads	to	shortness	of	breath	(Living	Well	with	Pulmonary	Fibrosis,	2017).																						 Images	from	the	program	"Living	Well	with	Pulmonary	Fibrosis",	J.	Morisset,	D.	Nault,	A.	Savard,	M.	Sedeno,	1st	edition	(2016)	www.livingwellwithpulmonaryfibrosis.com		Managing	Breathing	and	Energy	Conservation			
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• Normal	breathing	involves	two	phases,	inspiration	and	expiration.		Inspiration	involves	the	movement	of	air	into	the	lungs,	while	expiration	involves	the	movement	of	air	out	of	the	lungs	(Urden	et	al.,	2010).		As	we	have	already	reviewed,	chronic	lung	disease	can	have	a	great	impact	on	both	of	these	phases,	leading	to	shortness	of	breath.			
																								  	Images	obtained	from:	www.clipartpanda.com					
• Shortness	of	breath	can	lead	to	anxiety,	fear,	and	exhaustion	(COPD	Foundation,	2017;	Living	Well	with	COPD,	2017).		There	are	techniques	and	strategies	that	can	be	utilized	to	manage	shortness	of	breath	such	as:		
o Pursed-lip	breathing		
o Body	positioning	and	posture		
o Coughing	techniques			
Before	discussing	materials	related	to	the	above	techniques	and	strategies,	facilitate	a	group	
discussion	to	answer	the	following	question.					Discussion	question:		What	techniques	or	strategies	do	you	currently	use	to	manage	your	shortness	of	breath?				
• A	common	and	effective	strategy	used	to	decrease	and	manage	shortness	of	breath	is	
pursed-lip	breathing	(Living	Well	with	COPD,	2017;	COPD	Foundation,	2017).		Pursed-lip	breathing	enables	individuals	to	have	better	control	over	their	breathing	and	is	helpful	in	decreasing	both	respiratory	rate	and	the	workload	associated	with	breathing.		Exhalation	should	last	twice	as	long	as	inhalation	while	pursed-lip	breathing.				
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• Pursed-lip	breathing	may	be	helpful	during	times	of	exertion	such	as	while	performing	activities	of	daily	living	or	while	exercising	(Living	Well	with	COPD,	2017;	COPD	Foundation).		During	exertion,	individuals	should	exhale	with	effort.		For	example	while	climbing	stairs	inhale	while	at	rest	or	while	standing	still	and	exhale	during	effort	or	while	climbing	up	a	step.																																																														
The	following	image,	obtained	from	www.livingwellwithCOPD.com,	depicts	the	steps	of	
pursed-lip	breathing.		Review	steps	and	demonstrate	pursed-lip	breathing	for	participants.			
	
	(Living	Well	with	COPD,	2005,	p.	11)	
	
Patient	Activity:	Lets	practice	pursed-lip	breathing!						
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• Changes	to	body	position	and	posture	can	provide	relief	to	or	reduce	oxygen	demands	of	various	accessory	muscles	and	improve	function	of	the	diaphragm	while	breathing	(Living	Well	with	COPD,	2017;	Canadian	Lung	Association,	2017).								
	(Living	Well	with	COPD,	2005,	p.	16)					
• Coughing	techniques,	for	example,	controlled	coughing	and	the	huffing,	can	be	helpful	in	reducing	shortness	of	breath	and	also	assist	in	removing	sputum	from	
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your	lung	(Cystic	Fibrosis	Foundation,	2017;	Living	Well	with	COPD,	2017;	Australia	Lung	Foundation,	2016).		Increased	sputum	production	is	commonly	associated	with	chronic	lung	disease.		It	is	also	a	risk	factor	for	infection	and	exacerbation.				
The	following	images,	obtained	from	www.livingwellwithCOPD.com,	depicts	the	steps	of	
controlled	coughing	and	huffing.		Review	steps	and	demonstrate	each	technique	for	
participants.				
	(Living	Well	with	COPD,	2005,	p.	16)	
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		 (Living	Well	with	COPD,	2005,	p.	23)		
	
Patient	Activity:	Lets	practice	coughing	techniques!										
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Environmental	Factors			
		Image	obtained	from	livingwellwithCOPD.com						
Everyday	we	encounter	various	factors	in	the	environment	that	may	
have	an	effect	on	our	breathing.		For	individuals	who	do	not	have	chronic	
lung	disease	this	is	something	that	we	often	do	not	even	think	about	or	
even	notice.		For	individuals	living	with	chronic	lung	disease	these	
factors	may	aggravate	symptoms	and	lead	to	an	acute	exacerbation	of	
their	disease.			
	Common	Environmental	Factors	include	(Living	Well	with	COPD,	2017):		
• Indoor	and	outdoor	pollutant	such	as	cigarette	smoke,	smog,	or	dust	etc.		These	factors	can	be	avoided	to	prevent	exacerbation.			
	
• Changes	in	temperature.		Unfortunately	we	cannot	avoid	changes	in	temperature	associated	with	weather.		We	can	dress	appropriately	in	layers	and	stay	in	air-conditioned	environments	when	possible.					
• Respiratory	infections.		Frequent	handing	washing	and	receiving	a	yearly	flu	shot	is	very	important	for	individuals	living	with	chronic	lung	disease.			
v Hand	washing	removes	microorganisms	from	the	hands	and	is	the	most	effective	way	to	prevent	the	spread	of	disease	and	infection	(Infection	Prevention	and	Control	Canada,	2017).		You	should	wash	your	hands	after	being	in	contact	with	another	individual	(e.g.	shaking	hands),	each	time	you	are	in	contacting	with	secretions	or	other	body	fluids	(ex.	after	covering	your	mouth	while	coughing	or	blowing	your	nose),	and	after	performing	personal	functions	(e.g.	going	to	the	bathroom).		Effective	hand	washing	can	be	done	utilizing	soap	and	water	or	an	alcohol-based	hand	rub.		If	your	hands	are	visibly	soiled	you	should	use	soap	and	water	(Infection	Prevention	and	Control	Canada)!				
• Emotions.		Breathing	techniques	can	help	manage	shortness	of	breath	associated	with	anxiety	or	stress.			
Discussion	Question:	What	environmental	factors	aggravate	your	lung	disease?			
Patient	Activity:		Distribute	the	handout	“How	to	Avoid	Factors	that	Worsen	COPD”	to	participants	and	facilitate	group	discussion.		(Obtained	from	www.livingwellwithCOPD.com)		
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In	a	previous	module	we	discussed	the	overall	impact	of	smoking	and	smoking	cessation.		Let’s	
review…		
	
Smoking		
	
 • Smoking	is	the	leading	cause	of	chronic	lung	disease	with	approximately	50%	of	smokers	developing	COPD.		Smoking	is	further	estimated	to	account	for	ten	percent	Laniado-Laborin,	2009)of	deaths	worldwide	( .		Of	importance,	smoking	is	a	preventable	risk	factor	for	chronic	lung	disease	(CDC,	2017).			
 • Smoking,	as	well	as	exposure	to	second-hand	smoke,	has	been	found	to	have	a	negative	impact	on	overall	health	and	wellness.		Both	lead	to	the	development	of	chronic	lung	disease	and	lung	cancer,	while	also	increasing	risk	of	cardiovascular	disease	(CDC,	2017).			
• One	in	five	Canadians	smoke	(Public	Health	Agency	of	Canada,	2012).			
• Quitting	smoking	is	the	most	effective	and	economical	treatment	for	COPD	(Laniado-Laborin,	2009).		Attempts	to	quit	smoking,	even	if	not	successful,	can	preserve	lung	function.				
• Quitting	smoking	is	very	difficult	and	often	requires	multiple	attempts	and	nicotine	replacement	therapy.		Only	about	2%	of	smokers	succeed	in	quitting	smoking	without	the	help	of	NRT	with	approximately	two-thirds	relapsing	in	the	first	48	hours	(Laniado-Laborin,	2009).			
v Both	the	RN	and	RT	working	with	the	program	are	trained	in	smoking	cessation	and	can	
assist	any	participant	interested	in	quitting	smoking!		
		
v Shortness	of	breath	is	a	common	symptom	of	many	chronic	lung	diseases	
v Normal	breathing	involves	two	phases,	inspiration	and	expiration.			
v Shortness	of	breath	can	lead	to	anxiety,	fear,	and	exhaustion.		Techniques	and	strategies	such	as	pursed-lip	breathing,	body	positioning	and	posture,	and	coughing	techniques	can	be	utilized	to	manage	shortness	of	breath.			
v 	Various	environmental	factors	have	an	impact	on	breathing.		
v Smoking,	as	well	as	exposure	to	second-hand	smoke,	has	been	found	to	have	a	negative		impact	on	overall	health	and	wellness.	
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Review	Key	Messages	from	previous	module.		
	
Image	obtained	from	www.clipartpanda.com	
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Image	obtained	from:	www.livingwellwithCOPD.com	
	
Obstruc)ve	Chronic	Bronchi)s	results	in	inﬂammaDon	and	swelling	of	the	lung’s	
airways,	speciﬁcally	the	bronchi	and	bronchioles.		This	inﬂammaDon	further	causes	
increased	and	excessive	sputum	producDon	within	the	airways.		Both	inﬂammaDon	
and	sputum	lead	to	airway	obstrucDon.		This	obstrucDon	makes	it	diﬃcult	to	move	air	
in	and	out	of	the	lungs	leading	to	symptoms	such	as	shortness	of	breath	(Canadian	
Lung	AssociaDon,	2017;	Living	well	with	COPD,	2017;	Australia	Lung	FoundaDon,	
2016).			
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Image	obtained	from:	www.livingwellwithCOPD.com	
	
Emphysema	results	in	damage/destrucDon	and	sDﬀening	to	the	alveoli.		The	alveoli	
are	the	Dme	air	sacs,	connected	to	the	bronchioles,	where	gas	exchange	is	
conducted.		In	the	normal	lung	these	sacs	stretch	as	we	breathe	in	and	out.		The	
sDﬀening	of	the	alveoli	leads	to	air	trapping,	in	which	your	lungs	do	not	completely	
empty.		This	makes	it	diﬃcult	to	move	air	in	and	out	and	prevents	the	exchange	of	
oxygen	and	carbon	dioxide	leading	to	shortness	of	breath	(Canadian	Lung	
AssociaDon;	Living	well	with	COPD;	Australia	Lung	FoundaDon).	
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Images	from	the	program	"Living	Well	with	Pulmonary	Fibrosis",	J.	Morisset,	D.	Nault,	
A.	Savard,	M.	Sedeno,	1st	ediDon	(2016)	www.livingwellwithpulmonaryﬁbrosis.com	
	
Pulmonary	ﬁbrosis,	someDmes	referred	to	as	intersDDal	lung	disease,	is	
characterized	by	progressive	scarring	of	the	lungs	(Living	well	with	Pulmonary	
Fibrosis,	2017).		In	order	for	gas	exchange	to	happen	within	the	lungs,	air	must	pass	
through	the	intersDDum	of	the	lung	to	reach	the	pulmonary	circulaDon.		Scarring	of	
the	lungs	causes	the	intersDDum	to	become	thick	and	sDﬀ,	making	this	diﬃcult.		This	
leads	to	shortness	of	breath	(Living	Well	with	Pulmonary	Fibrosis,	2017).			
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Image	obtained	from:	www.clipartpanda.com	
	
Normal	breathing	involves	two	phases,	inspira)on	and	expira)on.		InspiraDon	
involves	the	movement	of	air	into	the	lungs,	while	expiraDon	involves	the	movement	
of	air	out	of	the	lungs	(Urden	et	al.,	2010).		As	we	have	already	reviewed,	chronic	
lung	disease	can	have	a	great	impact	on	both	of	these	phases,	leading	to	shortness	of	
breath.		
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Reference:	(COPD	FoundaDon,	2017;	Living	Well	with	COPD,	2017)	
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Reference:	(Living	Well	with	COPD,	2005,	p.	11)	
	
A	common	and	eﬀecDve	strategy	used	to	decrease	and	manage	shortness	of	breath	is	
pursed-lip	breathing	(Living	Well	with	COPD,	2017;	COPD	FoundaDon,	2017).		Pursed-
lip	breathing	enables	individuals	to	have	beder	control	over	their	breathing	and	is	
helpful	in	decreasing	both	respiratory	rate	and	the	workload	associated	with	
breathing.		ExhalaDon	should	last	twice	as	long	as	inhalaDon	while	pursed-lip	
breathing.			
	
Inhale					1…2...	
Exhale					1...2...3...4...	
																																											
Pursed-lip	breathing	may	be	helpful	during	Dmes	of	exerDon	such	as	while	
performing	acDviDes	of	daily	living	or	while	exercising	(Living	Well	with	COPD;	COPD	
FoundaDon).		During	exerDon,	individuals	should	exhale	with	eﬀort.		For	example	
while	climbing	stairs	inhale	while	at	rest	or	while	standing	sDll	and	exhale	during	
eﬀort	or	while	climbing	up	a	step.			
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Reference:	(Living	Well	with	COPD,	2005,	p.	16)	
	
Changes	to	body	posi)on	and	posture	can	provide	relief	to	or	reduce	oxygen	
demands	of	various	accessory	muscles	and	improve	funcDon	of	the	diaphragm	while	
breathing	(Living	Well	with	COPD;	Canadian	Lung	AssociaDon,	2017).							
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Reference:	(Living	Well	with	COPD,	2005,	p.	16)	
	
Coughing	techniques,	for	example,	controlled	coughing	and	the	huﬃng,	can	be	
helpful	in	reducing	shortness	of	breath	and	also	assist	in	removing	sputum	from	your	
lung	(Living	Well	with	COPD;	Australia	Lung	FoundaDon,	2016).		Increased	sputum	
producDon	is	commonly	associated	with	chronic	lung	disease.		It	is	also	a	risk	factor	
for	infecDon	and	exacerbaDon.			
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Reference:	(Living	Well	with	COPD,	2005,	p.	23)	
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Image	obtained	from	www.livingwellwithCOPD.com	
	
Everyday	we	encounter	various	factors	in	the	environment	that	may	have	an	aﬀect	on	
our	breathing.		For	individuals	who	do	not	have	chronic	lung	disease	this	is	something	
that	we	o:en	do	not	even	think	about.		For	individuals	living	with	chronic	lung	disease	
these	factors	may	aggravate	symptoms	and	lead	to	an	acute	exacerba>on	of	their	
disease.			
		
Common	Environmental	Factors	include	(Living	Well	with	COPD):		
•  Indoor	and	outdoor	pollutant	such	as	cigarede	smoke,	smog,	or	dust	etc.		These	
factors	can	be	avoided	to	prevent	exacerbaDon.			
	
Both	the	RN	and	RT	working	with	the	program	are	trained	in	smoking	cessa>on	and	
can	assist	any	par>cipant	interested	in	quiDng	smoking!		
		
•  Changes	in	temperature.		Unfortunately	we	cannot	avoid	changes	in	temperature	
associated	with	weather.		We	can	dress	appropriately	in	layers	and	stay	in	air-
condiDoned	environments	when	possible.				
		
•  Respiratory	infecDons.		Frequent	handing	washing	and	receiving	a	yearly	ﬂu	shot	is	
very	important	for	individuals	living	with	chronic	lung	disease.			
13	
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Image	obtained	from	www.clipartpanda.com	
	
Smoking	is	the	leading	cause	of	chronic	lung	disease	with	approximately	50	percent	
of	smokers	developing	COPD.		Smoking	is	further	esDmated	to	account	for	ten	
percent	of	deaths	worldwide	(Laniado-Laborin,	2009).		Of	importance,	smoking	is	a	
preventable	risk	factor	for	chronic	lung	disease	(CDC,	2017).		
		
Smoking,	as	well	as	exposure	to	second-hand	smoke,	has	been	found	to	have	a	
negaDve	impact	on	overall	health	and	wellness.		Both	lead	to	the	development	of	
chronic	lung	disease	and	lung	cancer,	while	also	increasing	risk	of	cardiovascular	
disease	(CDC,	2017).		
		
One	in	ﬁve	Canadians	smoke	(Public	Health	Agency	of	Canada,	2012).		
		
Quikng	smoking	is	the	most	eﬀecDve	and	economical	treatment	for	COPD	(Laniado-
Laborin,	2009).		Adempts	to	quit	smoking,	even	if	not	successful,	can	preserve	lung	
funcDon.			
		
Quikng	smoking	is	very	diﬃcult	and	olen	requires	mulDple	adempts	and	NRT	
therapy.		Only	about	2%	of	smokers	succeed	in	quikng	smoking	without	the	help	of	
NRT	with	approximately	2/3	relapsing	in	the	ﬁrst	48	hours	(Laniado-Laborin,	2009).		
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Image	obtained	from	www.clipartpanda.com	
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	Handout	obtained	from	www.livingwellwithCOPD.com	
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Module	5:	Puffer	and	Device	Use	
		The	module	will	focus	on	providing	a	description	of	the	various	types	and	classifications	of	puffers	utilized	in	the	treatment	and	management	of	chronic	lung	disease	for	individuals.		A	demonstration	of	how	to	administer	each	puffer	type	correctly	and	a	brief	discussion	on	the	spacer	device	will	be	provided	within	the	content.			Learing	Objectives		By	the	end	of	a	group	education	session	participants	will:		10. Demonstrate	the	correct	administration	for	each	of	their	prescribed	puffers.		11. Identify	the	class	of	each	of	their	prescribed	puffers.		12. Describe	two	side	effects	of	each	of	their	prescribed	puffers.			
It	is	intended	that	the	materials	presented	within	this	module	be	utilized	during	a	one	hour	group	education	session.		Various	aids	have	been	provided	within	the	module	to	assist	with	ease	of	education	delivery.		
v Visual	Aids:	PowerPoint	presentation	with	various	pictures;	whiteboard	and	markers		
v Patient	Activity	and	Handout:	COPD	and	Asthma	Medications	handouts		
v Models:	placebo	teaching	demonstration	puffers		
v Videos:	Eight	Puffer	Instructional	Videos	and	Spacer	Instructional	Video	(links	avalible	throughout	module)	
	
	Image	obtained	from:	www.livingwellwithCOPD.com		
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Note…	this	module	contains	a	large	amount	of	information	that	is	essential	to	the	treatment	
and	management	of	chronic	lung	disease.		All	participants	could	attend	the	same	education	
session	for	this	module	rather	then	being	broken	into	two	groups.		This	will	allow	for	
additional	time	if	required	to	cover	materials.		The	physical	activity	session	for	the	day	would	
subsequently	be	slightly	shorter	in	duration.		The	Respiratory	Therapist	will	review	this	
information	during	an	education	session	covering	action	plans.			
	
 • Puffers	are	commonly	utilized	in	the	treatment	of	both	COPD	and	asthma.		Incorrect	usage	leads	to	a	decrease	in	medication	delivery,	poor	disease	control,	and	increased	incidence	of	exacerbation	and	hospitalization.		Only	about	10%	of	patients	take	their	puffers	correctly	(National	Asthma	Counsel,	2016).					Note…	Participants	diagnosed	with	pulmonary	fibrosis	will	most	likely	not	be	prescribed	puffers	and	may	choose	not	to	attend	this	group	education	session.				
Patient	Activity:		Many	patients	may	not	know	the	name	or	type	of	puffers	they	are	
prescribed	by	their	physician.		Despite	this,	patients	can	typically	identify	their	puffers	by	their	
appearance	description	of	current	puffers	available	in	Canada	for	the	treatment	of	both	COPD	
and	asthma.			
	
Instructions:	To	begin	the	group	education	session	on	Puffers	and	Device	Use,	distribute	the	
following	handouts	and	have	patients	circle	the	puffers	they	are	currently	prescribed.		The	
handout	may	then	be	helpful	to	participants	during	the	group	education	session,	since	they	
will	be	able	to	identify	their	specific	puffer	through	the	discussion.					
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Combination Inhalers
???????????????????????????
?????????????????????????????
?????
???????????????????????????
????
???????????????????????????????????
?
????
????????????????????????????????????
?????????????
??????????????????????
?????????????
????????????
(salbutamol sulphate)
100 mcg/dose
Duration: 4-6h
Company: Valeant
?????????????????
(umeclidinium bromide)
62.5 mcg/dose
Duration: 24h
Company: GSK
???????????????
(fluticasone propionate/salmeterol 
xinafoate)
100/50; 250/50; 500/50 mcg 
doses
Duration: 12h
????????????
?only the Advair? Diskus? has 
been??????????????????????? 
???????????????? ???
(ipratropium bromide/salbutamol 
sulphate)
20/100 mcg/dose
Duration: 4-6h
Company: BI
*nebules also available
???????????????????
(indacaterol maleate)
75 mcg/dose
Duration: 24h
Company: Novartis
?????????? ??
(ipratropium bromide)
20 mcg/dose
Duration: 4-6h
Company: BI
*nebules also available
?????????????????????
(terbutaline  sulphate)
0.5 mg/dose
Duration: 4-6h
Company: AZ
????????????????????
(tiotropium bromide monohydrate)
18 mcg/dose
Duration: 24h
Company: BI
??????????????
(fluticasone furoate/vilanterol 
trifenatate)
100/25 mcg/dose
Duration: 24h
Company: GSK
?????????????????
(??? ????????????????)
??? ???????
Duration: 12h
Company: ???
?????????????????
(salbutamol sulphate)
200 mcg/dose
Duration: 4-6h
Company: GSK
???????????????????
(glycopyrronium bromide)
50 mcg/dose
Duration: 24h
Company: Novartis
??????????????????????
(budesonide/formoterol fumarate)
100/6; 200/6 mcg doses
Duration: 12h
Company: AZ 
??????????????????????????
Prednisone (Apotex, Teva, Jaapharm, Pro Doc 
Ltée)
????????????????
(e.g. theophylline,?oxtriphylline, etc.)
??????????????????????????????
Daxas? (roflumilast) (Takeda)
???????????????
(umeclidinium bromide/vilanterol
trifenatate)
62.5/25 mcg/dose
Duration: 24h
Company: GSK
?????????? ??
(salbutamol sulphate)
100 mcg/dose
Duration: 4-6h
Company: GSK
?nebules and generic brands available
?????????????????
(aclidinium bromide)
400 mcg/dose
Duration: 12h
Company: AZ
????????????????????
(glycopyrronium bromide/
indacaterol maleate)
50/110 mcg/dose
Duration: 24h
Company: Novartis
?????????????????
(aclidinium bromide/formoterol 
fumarate dehydrate)
??0/12 mcg/dose
Duration: 12h
Company: AZ???????????????? ???
(olodaterol hydrochloride)
2.5 mcg/dose
Duration: 24h
Company: BI
?Approved by Health Canada but may?
???????????????????? 
?????????????? ???
(tiotropium bromide monohydrate)
2.5 mcg/dose
Duration: 24h
Company: BI
Short-Acting Bronchodilators Long-Acting Bronchodilators
?????????????????????????????????
??????????????????
???????????????????? ????????????? ?????????????
????????????????????????????????
?????????????
?????????????
www.resptrec.org 
www.lung.ca
RESPIRATORY TRAINING
& EDUCATOR COURSE
RESPTREC?
????????????
AZ - AstraZeneca Canada Inc
BI - Boehringer Ingelheim (Canada) Ltd
GSK - GlaxoSmithKline Inc
Novartis - Novartis Pharmaceuticals Canada Inc?
Takeda - Takeda Canada Inc.
Valeant - Valeant Canada
???????????????? ???
(???????????????????
????????????olodaterol 
hydrochloride)?
???????? ???????
Duration: 24h
???????????
? ???? ???????????????????????????????????????????????????????????????????????????? ????????????????????
? ????????????????????????????????????????????????????
? ??????????????????????????????????????????????????
? ?????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????
? ???????????????????????????????????? ?????????????????????????????????????????????
?????????????????????????????????
? ?????? ?????????????????????????????????? ??????????
© Copyright 201?
???????????????????
(???????????????????)
??? ???????
Duration: ??h?
Company: Novartis
Dose = one inhalation?
MDI = Metered Dose Inhaler
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
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RESPIRATORY TRAINING
& EDUCATOR COURSE
RESPTREC?
Combination Inhalers
SABA
(Short-Acting Beta2-Agonist)
Corticosteroid Corticosteroid and LABA
Corticosteroid and Long-Acting Beta2-Agonist 
LABA
(Long-acting Beta2-Agonist)
Flovent® MDI
(fluticasone propionate)
50; 125; 250 mcg doses
Duration: 12h
Company: GSK
Advair® MDI
(fluticasone propionate/salmeterol 
xinafoate)
125/25; 250/25 mcg doses 
Duration: 12h
Company: GSK
Airomir™ MDI
(salbutamol sulphate)
100 mcg/dose
Duration: 4-6h
Company: Valeant
Oxeze® Turbuhaler®
(formoterol fumarate)
6; 12 mcg doses
Duration: 12h
Company: AZ
Symbicort® Turbuhaler®
(budesonide/*formoterol fumarate)
100/6; 200/6 mcg doses 
Onset: <5m
Duration: 12h
?ompany: AZ
?????? ???????????????????????????????????
???????????????
Alvesco® MDI
(ciclesonide)
100; 200 mcg doses
Duration: 24h
Company: Takeda
Asmanex™ Twisthaler™?
(mometasone furoate)
?????200; 400 mcg doses
Duration: 24h
Company: Merck 
Flovent® Diskus®
(fluticasone propionate)
50; 100; 250, 500 mcg doses
Duration: 12h
Company: GSK
Pulmicort® Turbuhaler®
(budesonide)
100; 200; 400 mcg doses
Duration: 12h
Company: AZ
?neb also available
Bricanyl® Turbuhaler®
(terbutaline sulphate)
0.5 mg/dose
Duration: 4-6h
Company: AZ
Zenhale™ MDI
(mometasone furoate/formoterol 
fumarate) 
50/5; 100/5; 200/5 mcg doses
Duration: 12h
Company: Merck
Qvar™ MDI
(beclomethasone dipropionate)
50; 100 mcg doses
Duration: 12h
Company: Valeant
Advair® Diskus®
(fluticasone propionate/salmeterol 
xinafoate)
100/50; 250/50; 500/50 
mcg doses
Duration: 12h
Company: GSK
Ventolin® Diskus®
(salbutamol sulphate)
200 mcg/dose
Duration: 4-6h
Company: GSK
Ventolin® MDI
(salbutamol sulphate)
100 mcg/dose
Duration: 4-6h
Company: GSK
Serevent® Diskus® 
(salmeterol xinafoate)
50 mcg/dose
Duration: 12h
Company: GSK
Bronchodilators
USE REGULARLY 
**Gargle and spit after each use
USE REGULARLY 
**Gargle and spit after each use
PRN
*RESCUE MEDICATION
Onset within 5 min 
USE REGULARLY
**Never used on its own for asthma 
without an inhaled corticosteroid
www.resptrec.org  
www.lung.ca
? ???? ???????????????????????????????????????????????????????????????????????????? ????????????????????
? ??????????????????????????????????????????????????????? ???????????????
? ????????????????????????????????????????????????????
? ??????????????????????????????????????????????????
? ?????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????
? ???????????????????????????????????? ?????????????????????????????????????????????
?????????????????????????????????
? ?????? ???????????????????????????????????? ??????????
Additional Medications
Leukotriene Receptor Antagonists 
(LTRA):
Accolate®
Singulair®
Anti-IgE:
Xolair®
Corticosteroids
© Copyright 201?
Dose = one inhalation
MDI = Metered Dose Inhaler
LA???
(Long-acting ?????????????????????
USE REGULARLY
**Never used on its own for asthma 
without an inhaled corticosteroid
Spiriva® Respimat®
(tiotropium bromide monohydrate)
2.5 mcg/dose
Duration: 24h
Company: BI
Oral Corticosteroid (OCS):?
Prednisone (Apotex, Teva, Jaapharm, Pro Doc 
Ltée)
Breo™ Ellipta®
(fluticasone furoate/vilanterol 
trifenatate)
100/25?????????mcg?dose?
Duration: 24h
Company: GSK
???????®??????????®
(???????????????????)
??? ???????
Duration: ??h?
Company: Novartis
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
????????????
AZ – AstraZeneca Canada Inc
GSK – GlaxoSmithKline Inc
Merck – Merck Canada Inc
Novartis Pharmaceuticals Canada Inc?
Takeda – Takeda Canada Inc?
Valeant – Valeant Canada
???????™ Ellipta®?
(fluticasone furoate??
100??????mcg?dose?
Duration: 24h
Company: ???
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Puffer	Classifications:		
	Various	classifications	of	puffers	are	currently	available	and	utilized	in	the	treatment	and	management	of	chronic	lung	disease	including:		
	
1. Bronchodilators		Bronchodilators	dilate	the	bronchi	and	bronchioles	of	the	lungs	and	relax	surrounding	muscles	(Living	Well	with	COPD,	2017;	Australia	Lung	Foundation,	2016).		This	allows	for	decreased	resistance	within	the	airways	and	ultimately	improves	ventilation.		Bronchodilators	reduce	or	relieve	symptoms	such	as	shortness	of	breath,	wheezing,	or	tightness	in	the	chest.		Bronchodilators	can	be	utilized	to	open	the	airways	in	order	to	improve	delivery	of	other	inhaled	medications.																																																																Types	of	Bronchodilators:		
• Short-Acting:	can	provide	almost	immediate	symptom	relief	and	are	often	used	as	a	rescue	medication.				
o SAMA	(Short-Acting	Muscarinic	Antagonist)	
o SABA	(Short-Acting	Beta2-Agonist):	used	regularly	or	PRN	
• Long	Acting:	take	approximately	20	minutes	to	take	effect	and	are	often	used	as	a	maintenance	medication.				
o LAMA	(Long-Acting	Muscarinic	Antagonist)		
o LABA	(Long-Acting	Beta2-Agonist)	(Living	Well	with	COPD,	2017;	Australia	Lung	Foundation,	2016)		Side	Effects:	increased	heart	rate,	tremors,	headache,	nervousness,	and	flushing	 	 	(Living	Well	with	COPD,	2017)			
2. Corticosteroids		Corticosteroids	reduce	inflammation	and	swelling	of	the	bronchi	and	bronchioles	(Living	Well	with	COPD).		They	are	typically	used	for	symptom	management	in	combination	with	bronchodilators.				Side	Effects:	thrush,	sore	throat,	hoarse	voice,	bruising,	and	osteoporosis.			(Living	Well	with	COPD,	2017)		
Advise	participants	to	gargle	with	water	and	spit	after	using	corticosteroids	to	decrease	risk	of	
side	effects	such	as	thrush,	sore	throat,	and	hoarse	voice.							
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3. Combination	Inhalers		
	Various	combination	inhalers	are	available	and	prescribed	for	the	treatment	and	management	of	chronic	lung	disease.		There	are	combination	short-acting	bronchodilator	puffers	and	combination	long-acting	bronchodilator	and	corticosteroid	puffers.				
Puffer	Types:		
• Various	types	of	puffers	are	currently	available	and	prescribed	in	Canada	including:			
v Metered-Dose	Inhaler	(MDI)	
v Breezhaler	
v Diskus		
v Ellipta	
v HandiHaler		
v Genuair	
v Respimat		
v Turbuhaler				
• Each	puffer	is	administered	differently.		Patients	require	ongoing	education	related	to	puffer	administration,	incorporating	various	education	methods	including	verbal,	visual,	and	demonstration.		This	is	essential	in	order	to	receive	the	maximum	benefit	of	prescribed	inhaled	medications	(Yawn,	Colice,	&	Hodder,	2012).				
• Various	barriers	exist	that	lead	to	both	puffer	misuse	and	non-compliance	including:			
v Lack	of	patient	knowledge	related	to	correct	administration	and	low	health	literacy			
v Patient	physical	and	cognitive	capabilities		
v Comorbidities	leading	to	physical	limitations	such	as	tremors,	arthritis,	or	poor	vision	
v Language	barriers		
v Lack	of	healthcare	provider	knowledge	related	to	puffer	administration	leading	to	lack	of	patient	education		
v Cost	associated	with	obtaining	prescribed	puffers		 (Yawn	et	al.,	2012)		
Detailed	instructions,	obtained	from	www.livingwellwithCOPD.com,	describing	the	utilization	
and	care	of	each	type	of	puffer	will	be	provided	below	to	review	with	participants.		Link	to	an	
instructional	video	for	each	puffer	type,	obtained	from	www.sk.lung.ca,	has	also	been	provided	
in	order	to	assist	with	ease	of	demonstration	during	the	group	education	session.			
Note:	The	placebo	teaching	demonstration	puffers	could	also	be	utilized	to	further	
demonstrate	correct	puffer	use.		
	Pictures	of	each	puffer	type	below	retrieved	from	www.sk.lung.ca.			
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Metered-Dose	Inhaler:		
	
	
	 (Living	Well	with	COPD,	2016,	p.	28)	
	
	Instructional	Video:	https://sk.lung.ca/lung-diseases/inhalers/videos/metered-dose-inhaler-mdi	
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Breezhaler:	
	
(Living	Well	with	COPD,	2016,	p.	29)	
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	Image	obtained	from	www.livingwellwithCOPD.com	
	(Living	Well	with	COPD,	2016,	p.	30)		
Instructional	Video:	https://sk.lung.ca/lung-diseases/inhalers/videos/breezhaler									
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Diskus:		
			
	(Living	Well	with	COPD,	2016,	p.	31)		
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	(Living	Well	with	COPD,	2016,	p.	32)	
	
	
Instructional	Video:	https://sk.lung.ca/lung-diseases/inhalers/videos/diskus																
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Ellipta:		
		
		(Living	Well	with	COPD,	2016,	p.	33)		
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		 (Living	Well	with	COPD,	2016,	p.	34)		Instructional	Video:	https://sk.lung.ca/lung-diseases/inhalers/videos/ellipta														
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HandiHaler:		
		
	(Living	Well	with	COPD,	2016,	p.	37)		
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	(Living	Well	with	COPD,	2016,	p.	38)			
Instructional	Video:	https://sk.lung.ca/lung-diseases/inhalers/videos/handihaler															
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Genuair:		
	 	
		 (Living	Well	with	COPD,	2016,	p.	35)		
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		 (Living	Well	with	COPD,	2016,	p.	36)				
Instructional	Video:	https://sk.lung.ca/lung-diseases/inhalers/videos/genuair		
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Respimat:		
				
	(Living	Well	with	COPD,	2016,	p.	40)	
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	(Living	Well	with	COPD,	2016,	p.	41)		
	
	
Instructional	Video:	https://sk.lung.ca/lung-diseases/inhalers/videos/respimat													
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Turbuhaler:			
		
		 (Living	Well	with	COPD,	2016,	p.	39)		
Instructional	Video:	https://sk.lung.ca/lung-diseases/inhalers/videos/turbuhaler		
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Spacer	Device:		
	
Spacers	improve	medication	delivery	of	MDI’s.		Utilizing	a	spacer	assists	inhaled	medications	
to	reach	your	lungs	rather	then	ending	up	in	mouth	or	throat.				
	
	
	 (Living	Well	with	COPD,	2016,	p.	28)	
	
Instructional	Video:	https://sk.lung.ca/lung-diseases/inhalers/videos/mdi-spacer	
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Review	Key	Messages	from	previous	module.		
2	
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Reference:	(Na>onal	Asthma	Counsel,	2016)	
4	
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Pa#ent	Ac#vity:		Many	pa'ents	may	not	know	the	name	or	type	of	puﬀers	they	are	
prescribed.		Despite	this,	pa'ents	can	typically	iden'fy	their	puﬀers	by	how	they	look.		
The	following	two	handouts,	obtained	from	www.sk.lung.ca,	provide	a	visual	
descrip'on	of	current	puﬀers	available	in	Canada	for	the	treatment	of	both	COPD	and	
asthma.		To	begin	the	group	educa'on	session	on	Puﬀers	and	Device	Use,	distribute	
the	following	handouts	and	have	pa'ents	circle	the	puﬀers	they	are	currently	
prescribed.		The	handout	may	then	be	helpful	to	par'cipants	during	the	group	
educa'on	session	as	they	will	be	able	to	iden'fy	their	speciﬁc	puﬀer	as	they	are	
discussed.				
	
5	
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Image	obtained	from	www.livingwellwithCOPD.com	
	
Bronchodilators	
		
Bronchodilators	dilate	the	bronchi	and	bronchioles	of	the	lungs	and	relax	surrounding	
muscles	(Living	Well	with	COPD,	2017;	Australia	Lung	Founda>on,	2016).		This	allows	
for	decreased	resistance	within	the	airways	and	ul>mately	improves	ven>la>on.		
Bronchodilators	reduce	or	relieve	symptoms	such	as	shortness	of	breath,	wheezing,	
or	>ghtness	in	the	chest.		Bronchodilators	can	be	u>lized	to	open	the	airways	in	order	
to	improve	delivery	of	other	inhaled	medica>ons.		
																																																													
Types	of	Bronchodilators:		
Short-Ac>ng:	can	provide	almost	immediate	symptom	relief	and	are	oYen	used	as	a	
rescue	medica>on.				
SAMA	(Short-Ac>ng	Muscarinic	Antagonist)	
SABA	(Short-Ac>ng	Beta2-Agonist):	used	regularly	or	PRN	
Long	Ac>ng:	take	approximately	20	minutes	to	take	eﬀect	and	are	oYen	used	as	a	
maintenance	medica>on.				
LAMA	(Long-Ac>ng	Muscarinic	Antagonist)		
LABA	(Long-Ac>ng	Beta2-Agonist)	
(Living	Well	with	COPD;	Australia	Lung	Founda>on)	
7	
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Image	obtained	from	www.livingwellwithCOPD.com	
	
TECHNIQUE		
1.	Remove	the	cap.		
2.	Shake	the	inhaler	3-4	>mes	from	top-down	(to	mix	the	contents	well).		
3.	Tilt	your	head	slightly	back	and	exhale	normally.		
4.	Place	carefully	the	mouthpiece	within	your	teeth	and	seal	your	lips	around	it.		
5.	Begin	to	breathe	in	slowly	through	your	mouth.	Press	down	once	on	the	canister	
and	con>nue	breathing	in	slowly	(only						once	to	release	one	dose	of	medica>on).		
6.	Con>nue	to	breathe	in	slowly	and	deeply	un>l	your	lungs	are	full.		
7.	Hold	your	breath	for	5-10	seconds	or	as	long	as	is	comfortable,	so	the	medica>on	
will	have	>me	to	se`le	in	your	airways.		
8.	If	another	dose	is	required,	wait	one	minute	between	puﬀs	and	repeat	steps	2-7.		
9.	Replace	the	protec>ve	cap.		
	
Maintenance	and	Cleaning		
•		Once	a	week,	clean	the	cap	and	plas>c	container,	without	the	canister,	by	soaking	
them	in	warm,	soapy	water,	then	rinsing	and	allowing	to	air-drying.		
•		The	canister	should	be	kept	warm,	away	from	heat	sources	and	cold.	In	case	of	
exposure	to	cold,	roll	the	canister	between	the	palms	of	your	hands	to	warm	it	up.		
	
8	
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Image	obtained	from	www.livingwellwithCOPD.com	
	
TECHNIQUE		
1.	Pull	oﬀ	the	cap.		
2.	Open	inhala>on	device:	Hold	the	base	of	the	inhaler	ﬁrmly	and	>lt	the	mouthpiece	
to	open	the	inhala>on	device.		
3.	Prepare	capsule.		
4.	Insert	capsule:	Place	the	capsule	into	the	capsule	chamber.		
5.	Close	the	inhala>on	device.	You	should	hear	a	‘click’.		
6.	Pierce	the	capsule.	Do	not	press	the	piercing	bu`ons	more	than	once.		
7.	Release	the	bu`ons	fully.		
8.	Breathe	out.	Never	blow	into	the	mouthpiece.		
9.	Place	the	mouthpiece	in	your	mouth	and	close	your	lips	ﬁrmly	around	the	
mouthpiece.	Breathe	in	rapidly	but	steadily,	as							deeply	as	you	can.		
10.	Note:	As	you	breathe	in	through	the	inhala>on	device,	the	capsule	spins	around	
in	the	chamber	and	you	should	hear	a	whirring	noise.		
11.	Hold	your	breath	for	at	least	5-10	seconds	or	as	long	as	comfortably	possible	
while	removing	the	inhaler	from	your	mouth.	Then	breathe	out.	
12.	Remove	capsule:	Open	the	mouthpiece	again,	remove	the	empty	capsule	by	
>pping	it	out,	and	discard	it.	Close	the	inhala>on	device	and	replace	the	cap.	
13.	Mark	daily	dose	tracker:	Put	a	mark	in	today’s	box	if	it	helps	to	remind	you	of		
9	
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TECHNIQUE		
1.	Open:	To	open	your	inhaler	hold	the	outer	case	in	one	hand	and	put	the	thumb	of	
your	other	hand	on	the	thumb	grip.	Push	the	thumb	grip	away	from	you,	un>l	you	
hear	it	click	into	place.		
2.	Slide:	Hold	your	inhaler	with	the	mouthpiece	towards	you.	Slide	the	lever	away	
un>l	you	hear	another	click.	Your	inhaler	is	now	ready	to	use.		
3.	Exhale:	Hold	the	inhaler	away	from	your	mouth.	Breathe	out	as	far	as	is	
comfortable.	Remember	–	never	exhale	into	your	inhaler.		
4.	Inhale:	Before	you	start	to	inhale	the	dose,	read	through	this	sec>on	carefully.	
Once	you	have	fully	exhaled,	place	the	mouthpiece	to	your	mouth	and	close	your	lips	
around	it.	Breathe	in	steadily	and	deeply	through	your	mouth	un>l	a	full	breath	is	
taken.	Remove	the	inhaler	from	your	mouth.	Hold	your	breath	for	5-10	seconds	or	as	
long	as	is	comfortable.	Breathe	out	slowly.		
5.	Close:	To	close	your	inhaler,	place	your	thumb	in	the	thumb	grip,	and	slide	it	back	
un>l	you	hear	a	click.	The	lever	is	now	automa>cally	reset	for	your	next	use.	The	
counter	on	the	inhaler	indicates	how	many	doses	are	remaining.		
	
Maintenance	and	Cleaning		
•		The	device	has	a	dose	counter	which	tells	you	the	number	of	doses	remaining.	To		
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TECHNIQUE		
1.	Prepare:		
a.	When	you	take	your	inhaler	out	of	its	box	it	will	be	in	the	closed	posi>on.		
b.	Keep	the	cover	closed	un>l	you	are	ready	to	inhale	a	dose.	
c.	When	you	are	ready,	slide	the	cover	to	the	side	un>l	you	hear	one	‘click’.		
d.	The	dose	counter	will	now	count	down	by	one	number.	You	are	now	ready	to	
inhale	a	dose.		
	
2.	Inhale:		
a.	While	holding	the	inhaler	away	from	your	mouth,	breathe	out	as	far	as	it	is	
comfortable.	Remember	–	never	exhale	into	your	inhaler.		
b.	Put	the	mouthpiece	between	your	lips,	and	close	your	lips	ﬁrmly	around	it.	Don’t	
block	the	air	vent	with	your	ﬁngers.		
c.	Take	one	long,	steady,	deep	breath	in.	Hold	your	breath	for	5-10	seconds	or	as	long	
as	is	comfortable.	Remove	the	inhaler	from	your	mouth.	Breathe	out	slowly.		
	
3.	Close:		
a.  Slide	the	cover	upwards	as	far	as	it	will	go	to	cover	the	mouthpiece.		
11	
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TECHNIQUE		
1.	To	release	the	dust	cap,	press	the	green	piercing	bu`on	completely	in	and	let	go.		
2.	Open	the	dust	cap	completely	by	pulling	it	upwards,	then	open	the	mouthpiece	by	
pulling	it	upwards.		
3.	Immediately	before	use,	peel	the	aluminum	back	foil	un>l	one	capsule	if	fully	
visible.	Remove	one	capsule	from	the	blister	(do	not	expose	more	than	one	capsule).		
4.	Place	the	capsule	in	the	centre	chamber.		
5.	Close	the	mouthpiece	ﬁrmly	un>l	you	hear	a	click,	leaving	the	dust	cap	open.		
6.	Hold	the	inhaler	with	the	mouthpiece	upwards	and	press	the	green	bu`on	
completely	in	only	once,	and	release.		
[pick	up	images	from	BISO05	P012,	High	Res	images	please]		
7.	Breathe	out	completely.	Do	not	breathe	into	the	mouthpiece	at	any	>me.		
8.	Hold	the	inhaler	by	the	grey	base.	Do	not	block	the	air	intake	vents.	Raise	the	
inhaler	to	your	mouth	and	close	your	lips	>ghtly	around	the	mouthpiece.	Keep	your	
head	in	an	upright	posi>on	and	breathe	in	slowly	and	deeply	but	at	a	rate	suﬃcient	
to	hear	or	feel	the	capsule	vibrate.	Breathe	in	un>l	your	lungs	are	full;	then	hold	your	
breath	for	5-10	seconds	or	as	long	as	is	comfortable	and	at	the	same	>me	take	the	
inhaler	out	of	your	mouth.	Resume	normal	breathing.		
9.	To	ensure	complete	inhala>on	of	capsule	contents,	you	must	repeat	steps	7	and	8		
12	
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TECHNIQUE		
1.	Remove	the	protec>ve	cap	by	lightly	squeezing	the	arrows	marked	on	each	side	
and	pulling	outwards.		
2.	Hold	the	inhaler	horizontally	with	the	mouthpiece	towards	you	and	the	colored	
bu`on	facing	straight	up.		
3.	Press	the	colored	bu`on	all	the	way	down	and	release	it.	The	green	control	
window	conﬁrms	that	your	medicine	is	ready	for	inhala>on.		
4.	Breathe	out	away	from	the	inhaler.		
5.	Place	your	lips	>ghtly	around	the	mouthpiece	and	inhale	strongly	and	deeply	
through	your	mouth.	The	inhaler	signals	that	you	inhaled	correctly	by	emilng	a	
“click”	sound.	Keep	breathing	in	even	aYer	you	have	heard	the	“click”	to	be	sure	you	
get	the	full	dose.		
6.	Remove	the	inhaler	from	your	mouth	and	hold	your	breath	for	5-10	seconds	or	as	
long	as	is	comfortable,	then	breathe	out	slowly.		
7.	Make	sure	the	control	window	has	turned	to	red.	This	conﬁrms	that	you	have	
inhaled	your	full	dose	correctly.	If	the	colored	control	window	is	s>ll	green,	repeat	
inhaling	strongly	and	deeply	through	the	mouthpiece.	If	the	window	does	not	change	
to	red,	you	may	have	forgo`en	to	release	the	green	bu`on	before	inhaling,	or	may	
have	not	inhaled	correctly.	If	that	happens,	try	again.		
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TECHNIQUE		
1.	Hold	your	inhaler	upright	with	the	cap	closed.		
2.	Turn	the	clear	base	un>l	it	clicks.		
3.	Open	the	plas>c	cap	un>l	it	snaps	fully	open.		
4.	Breathe	out	slowly	and	holding	the	inhaler	level,	place	the	mouthpiece	carefully	
between	your	teeth.	Seal	your	lips	around	the	mouthpiece	without	covering	the	air	
vents.		
5.	While	taking	in	a	slow,	deep	breath,	press	the	dose	release	bu`on	and	con>nue	to	
breathe	in	slowly.		
6.	Remove	the	inhaler	from	your	mouth	and	hold	your	breath	for	about	5-	10	seconds	
or	as	long	as	is	comfortable.		
7.	Replace	the	plas>c	cap.		
	
Maintenance	and	Cleaning		
•  Important:	Before	taking	the	ﬁrst	dose,	Respimat	needs	to	be	properly	assembled	
and	prepared.	Ask	your	pharmacist	for	help	or	follow	the	instruc>ons	included	
with	the	inhaler	package.		
•  To	prepare	the	inhaler	for	ﬁrst->me	use,	hold	your	inhaler	upright	with	the	cap	
closed.	Turn	the	clear	base	-	in	the	direc>on	of	the	arrows	of	the	label	-	un>l	it		
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TECHNIQUE		
1.	Unscrew	and	liY	oﬀ	the	cover.	You	may	hear	a	ra`ling	sound.	This	is	normal;	it	is	
the	sound	of	the	drying	agent,	not	the	medica>on.		
2.	Holding	the	inhaler	upright,	turn	the	colored	grip	as	far	as	it	will	go	in	one	direc>on	
(clockwise	or	counterclockwise,	it	does	not	ma`er	which	way	you	turn	it	ﬁrst);	then	
you	must	turn	it	back	again	as	far	as	it	will	go	in	the	opposite	direc>on.	Do	not	hold	
the	mouthpiece	when	turning	the	grip.	The	click	you	hear	is	part	of	the	loading	
process.	The	inhaler	is	now	ready	to	use.		
3.	Breathe	out,	with	your	mouth	away	from	the	mouthpiece.	Then,	place	the	
mouthpiece	gently	between	your	teeth.		
4.	Now	close	your	lips	over	the	mouthpiece.	Inhale	as	deeply	and	strongly	as	you	can.	
Remove	the	inhaler	from	your	mouth	and	hold	your	breath	for	5-10	seconds	or	as	
long	as	is	comfortable.	Repeat	this	process	from	step	1	if	more	than	one	dose	has	
been	prescribed.	When	you	have	taken	the	prescribed	amount	of	maintenance	
doses,	rinse	your	mouth	with	water,	and	do	not	swallow.		
	
Maintenance	and	Cleaning		
•		Clean	the	outside	of	the	mouthpiece	once	a	week	with	a	dry	>ssue.	Never	use	
water	or	any	other	ﬂuid	when	cleaning	the	mouthpiece.	If	ﬂuid	enters	the	inhaler	it		
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Spacers	improve	medica'on	delivery	of	MDI’s.		U'lizing	a	spacer	assists	inhaled	
medica'ons	to	reach	your	lungs	rather	then	ending	up	in	mouth	or	throat.				
	
TECHNIQUE		
1.	Remove	the	caps.		
2.	Shake	the	inhaler	3-4	>mes	keeping	it	upright.		
3.	Connect	the	inhaler	to	the	spacing	device.		
4.	Tilt	your	head	slightly	back	and	breathe	out	normally.		
5.	Place	the	spacing	device	mouthpiece	carefully	between	your	teeth	and	seal	your	
lips	around	it.		
6.	Press	down	canister	once.		
7.	Breathe	in	slowly	and	deeply	through	your	mouth.		
8.	a.	Single	breath	technique:	Try	to	hold	your	breath	for	5-10	seconds	or	as	long	as	is	
comfortable.	Then	breathe	out	normally.		
b.	Tidal	volume	technique:	If	you	ﬁnd	it	diﬃcult	to	take	one	deep	breath	or	to	hold	
your	breath	for	long,	breathe	slowly	in	and	out	of	the	spacing	device,	3-4	>mes	in	a	
row.		
9.	If	you	need	more	than	one	dose,	wait	1	minute	between	puﬀs	and	repeat	steps	
2-8.	Replace	the	protec>ve	caps.		
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Module	6:	Pulmonary	Medications			 	This	module	will	provide	a	description	of	various	medications	utilized	in	the	treatment	of	chronic	lung	disease	with	the	exception	of	puffers	or	device	use.		These	medications	were	discussed	in	a	previous	module.		It	is	intended	that	the	materials	presented	within	this	module	be	utilized	during	a	one-hour	group	education	session.		A	PowerPoint	presentation	has	been	provided	within	this	module	to	assist	with	ease	of	education	delivery	in	the	group	setting.				By	the	end	of	a	group	education	session	participants	will:		1. Identify	one	goal	of	medication	therapy.			2. State	two	medications	they	take	other	than	puffers	that	treat	their	chronic	lung	disease.	3. 	Identify	one	common	side	effect	of	each	medication	they	take	for	the	treatment	of	their	chronic	lung	disease.				4. Differentiate	between	the	brand	name	and	generic	name	of	a	drug.						
It	is	intended	that	the	materials	presented	within	this	module	be	utilized	during	a	one	hour	group	education	session.		Various	aids	have	been	provided	within	the	module	to	assist	with	ease	of	education	delivery.				
v Potential	questions	for	facilitated	group	discussion			
v Visual	Aids:	PowerPoint	presentation	containing	various	pictures/graph;	whiteboard	and	markers	
v Handout:	Patient	Medication	List					
When	we	talk	about	pulmonary	medications	we	commonly	think	of	puffers	but	there	are	many	
other	types	of	medications	that	have	an	effect	on	breathing	and	the	pulmonary	system.		
Puffers	and	device	use	were	discussed	in	a	previous	module.		Today	we	are	going	to	discuss	
some	of	these	other	medications.			
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Goals	of	Medication	Therapy	Related	to	Chronic	Lung	Disease…	
	
 • Optimize	lung	function	and	slow	disease	progression		
 • Decrease	symptoms	such	as	shortness	of	breath		
 • Prevent	exacerbations		
	
	Discussion	Questions:		1. What	medications,	other	then	puffers,	do	you	currently	take	to	treat	your	chronic	lung	disease?		2. What	medications	do	you	take	when	you	have	an	exacerbation	of	your	condition?			
	Image	obtained	from	www.livingwellwithCOPD.com		
	
	
Brand	Name	Drugs	versus	Generic	Drugs		
	What’s	in	a	name?		The	nomenclature	of	medications	can	be	very	confusing.		Medications	have	a	classification,	generic	name,	and	often	one	or	more	brand	names.				Discussion	Question:	Who	knows	the	name	of	every	medication	they	take?				
• When	a	drug	or	medication,	prescription	or	over-the-counter,	is	created	by	a	pharmaceutical	company,	that	company	gains	a	patent	on	the	drug	for	a	particular	number	of	years	to	prevent	other	companies	from	producing	and	selling	the	same	drug.		When	created,	the	drug	is	given	two	names:	a	generic	name	and	a	brand	name.		The	generic	name	is	the	drugs	scientific	name	whereas	the	brand	name	is	a	name	that	is	intended	to	make	the	drug	stand	out	for	the	purpose	of	marketing.		For	example	Tylenol	is	a	brand	name	and	the	drugs	generic	name	is	Acetaminophen.		After	a	patent	expires	the	company	or	another	company	can	produce	the	same	drug	and	sell	it	by	its	generic	name.		A	generic	drug	is	required	to	be	bioequivalent		(the	same	as)	a	brand	name	drug.		A	generic	and	brand	drug	have	the	same	active	ingredient,	strength,	dose,	and	route.		The	two	may	differ	in	appearance	and	cost.		Generic	drugs	are	typically	80	to	85%	cheaper	then	brand	name	drugs.		The	company	who	created	the	brand	name	drug	had	additional	costs	associated	with	
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development,	research,	clinical	trials	etc.	(Food	and	Drug	Administration,	2016;	Depression	and	Bipolar	Support	Alliance,	2007)					
• All	drugs	or	medications	also	fall	under	one	or	more	classifications.		Classes	contain	various	drugs	that	are	similar	and	utilized	for	the	same	purpose.		They	are	not	identical.		For	example	Tylenol	or	Acetaminophen	falls	under	the	classification	of	antipyretics	and	analgesics.				
Did	you	know…	for	any	resident	on	Prince	Edward	Island	(PEI),	with	a	valid	PEI	Health	
Card,	that	does	not	have	private	drug	insurance	coverage	and	is	under	the	age	of	65,	your	
medications	may	be	covered	under	the	Generic	Drug	Program.		The	program	limits	the	cost	of	
all	eligible	generic	prescriptions	to	a	maximum	of	$19.95.	
For	more	information	or	to	apply:	https://www.princeedwardisland.ca/en/service/apply-
generic-drug-program		
	
	
	Types	of	Medications	
	
Distribute	Patient	Medication	List	Handout.			
	Within	this	module,	the	follow	medications/medication	classes	will	be	discussed:		
v Oral	anti-inflammatory		
v Antibiotics		
v Anti-anxiety	medications		
v Diuretics	
v Opioids		
v Proton	Pump	Inhibitors		
v Daxas	
v Esbriet	and	Ofev	
v Vaccines	
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Oral	Anti-Inflammatory	Medications		
• Most	common:	Prednisone																																																													
• Some	patients	with	COPD	many	be	on	a	maintenance	dose	of	an	oral	anti-inflammatory	medication	daily	and	also	have	an	increased	dose	as	part	of	their	action	plan	during	episode	of	exacerbation.		Typically	taken	in	increased	dose	for	five	to	14	days	during	exacerbation.		Individuals	with	pulmonary	fibrosis	may	take	oral	anti-inflammatory	medications	short	term	during	exacerbation.		
• Many	chronic	lung	diseases	are	associated	with	inflammation	of	the	airways.		Oral	anti-inflammatory	medications	prevent	and	reduce	inflammation	of	the	airways.		
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They	are	also	used	to:	prevent	exacerbations,	decrease	inflammation,	and	suppress	the	immune	system.			
• Used	in	the	treatment	of	both	COPD	and	pulmonary	fibrosis.		
• Common	side	effects	include:	headache,	weight	gain,	thinning	and	bruising	of	the	skin,	hair	growth,	increased	susceptibility	to	infections,	and	osteoporosis.		
• Oral	anti-inflammatory	medications	do	not	provide	a	quick	response	and	are	not	used	as	rescue	therapy.		(Australia	Lung	Foundation,	2016;	Living	Well	with	COPD,	2017)																																																
Antibiotics:		
• Used	to	treat	bacterial	respiratory	infections,	will	have	no	effect	on	viral	infections.		
• Antibiotics	are	typically	part	of	the	COPD	action	plan.		You	should	start	your	antibiotic	if	your	sputum	changes	color.		During	exacerbation	individuals	with	pulmonary	fibrosis	are	often	prescribed	antibiotics	as	well.			
• It	is	important	to	take	your	entire	prescription	even	if	you	are	feeling	better.		Stopping	your	antibiotic	before	the	last	dose	can	cause	bacterial	adapting	and	resistance	to	antibiotics.			(Australia Lung Foundation, 2016;Living	Well	with	COPD,	2017;	Living	well	with	Pulmonary	Fibrosis,	2017)		
																																																																				 	
	 Image	obtained	from	www.clipartpanda.com	
	
Anti-Anxiety	Medications:			
																																		 	Image	obtained	from	www.livingwellwithCOPD.com	
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• There	is	an	association	between	chronic	lung	disease	and	anxiety.		This	can	be	visualized	in	the	above	Anxiety-Breathlessness	Cycle.		Chronic	lung	disease	leads	to	shortness	of	breath,	shortness	of	breath	leads	to	anxiety	and	panic,	anxiety	and	panic	worsen	shortness	of	breath,	ultimately	leading	to	breathlessness	and	fatigue	as	the	cycle	continues	(Living	Well	with	COPD,	2017).				
• Most	common:	Benzodiazepines	such	as	Ativan	or	Valium	(generic	name	“pam”)		
• Benzodiazepines	work	by	slowing	down	the	nervous	system	and	helping	you	relax.		They	can	have	a	sedating	effect.		Older	adults	may	be	more	sensitive	to	the	sedating	effects.		The	most	commonly	reported	side	effect	is	drowsiness.		If	taken	regularly	this	can	lead	to	physical	dependence.		Benzodiazepines	are	typically	prescribed	to	individuals	with	chronic	lung	disease	for	the	treatment	of	insomnia,	anxiety/depression,	and	dyspnea.		Current	research	links	benzodiazepines	to	adverse	physiological	respiratory	outcomes	(Vozoris	et	al.,	2013).				
Diuretics:		
• Most	common:	Lasix	
• Used	to	treat	heart	failure,	hypertension,	renal	failure,	and	pulmonary	congestion.		
• Not	a	treatment	for	COPD	of	pulmonary	fibrosis	but	a	treatment	of	complications	of	chronic	lung	disease.		Used	as	a	rescue	treatment.		
Opioids:		
• Most	common:	Morphine		
• Typically	prescribed	for	pain.		Sometimes	prescribed	for	end	stage	lung	disease	in	low	does	to	reduce	shortness	of	breath	and	anxiety.	
• Chronic	dyspnea	and	breathlessness	experienced	at	rest	or	with	minimal	exertion,	despite	optimal	treatment,	can	be	safely	reduced	with	low	does	opioids	(Allcroft	et	al.,	2013).		The	mechanism	of	action	is	not	fully	understood	but	it	is	thought	that	opioids	diminish	the	response	to	elevated	CO2	levels	and	hypoxia,	decreasing	shortness	of	breath,	and	to	cause	vasodilation.			
	
	
Proton	Pump	Inhibitors	(PPI):		
• Most	common:	Pantoloc,	Prevacid,	Nexium	
• Gastroesophageal	reflux	disease	(GERD)	causes	acid	from	the	stomach	to	back	up	into	the	throat.		When	we	breathe	some	of	this	acid	may	enter	the	lungs	causing	damage.		The	mechanism	of	action	is	not	fully	understood	but	many	individuals	with	pulmonary	fibrosis	also	have	GERD.			
• PPI’s	reduce	the	production	of	acid	in	your	stomach	and	subsequently	protect	your	lungs.		 (Living	well	with	Pulmonary	Fibrosis)		
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Esbriet	and	Ofer	(anti-fibrotics):		
• Used	in	the	treatment	of	pulmonary	fibrosis	(a	newer	medication).			
• Do	not	repair	scar	tissue	that	has	already	formed	but	may	help	slow	the	progression	of	future	scarring.			
• Common	side	effects:	nausea,	diarrhea,	rash,	and	liver	failure			(Canadian	Pulmonary	Fibrosis	Foundation,	2017,	Living	well	with	Pulmonary	Fibrosis)			
	Image	obtained	from	www.www.livingwellwithCOPD.com	
	
Daxas	(phosphodiesterase	4	enzyme	inhibitor):		
• Used	in	the	treatment	of	COPD	(a	newer	medication)		
• Used	as	an	add	on	to	a	bronchodilator	for	the	maintenance	of	severe	COPD.		Not	used	as	a	rescue	medication	during	acute	exacerbations	
• Reduces	exacerbations	and	improves	lung	function.		
• Common	side	effects:	nausea,	diarrhea,	weight	loss,	abdominal	pain,	and	headache.		(Takeda	Pharmaceuticals	International,	2014)	
	
	
Vaccines:																															 	 	 	 	 	 																																																																											Image	obtained	from	www.clipartpanda.com	
• Flu	Vaccine																																																																																																			
o Recommended	for	individuals	with	chronic	lung	disease	yearly		
o Approximately	10-20%	of	the	population	are	infected	with	influenza	annually		
o Influenza	is	a	respiratory	infection	that	is	typically	caused	by	influenza	A	or	B	virus	occurring	in	the	fall	or	winter	months	yearly		
o The	flu	shot	does	not	cause	the	flu!!		
o Common	symptoms:	fever,	muscle	aches,	cough,	chills,	throat	irritation		
o A	complication	of	influenza	is	worsening	of	underlying	conditions	such	as	chronic	lung	disease																	(Health	PEI,	2016;	Government	of	Canada,	2015)		
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• Pneumonia	Vaccine			
o Recommended	for	individuals	with	chronic	lung	disease		
o Prevents	illness	caused	by	pneumococcus	bacteria	
o Frequency	decided	by	your	physician	and	provincial	regulations;	typically	one	dose	at	over	65	years	of	age			 (Government	of	Canada,	2015)			
																																							 	
Medication	Compliance			
Does	everyone	remember	talking	about	medication	compliance	during	Module	1?		It	was	one	
of	the	components	of	Keeping	a	Healthy	Lifestyle.			
	
Approximately	50%	of	Canadians	do	not	take	their	prescription	medications	as	
prescribed!!	Medication	non-compliance	is	the	cause	of	10%	of	all	hospital	
admissions	(Canadian	Society	of	Hospital	Pharmacists,	2017).	
	
 • Poor	medication	compliance	increases	incidence	of	hospitalizations	and	morbidity.		Improved	compliance	to	current	medications	therapies	may	in	fact	have	a	great	impact	on	overall	quality	of	life	and	well	being	than	improvement	in	medical	therapies	(Brown	&	Bussell,	2011).					
 • Compliance	to	medications	is	not	solely	the	responsibility	of	the	patient.		Healthcare	professionals	have	a	responsibly	to	provide	adequate	education	and	access.		Patient	education	is	essential	for	improvement	in	medication	compliance	(Brown	&	Bussell,	2011).						
 • Various	factors	influence	medication	compliance	including:		
 o Lack	of	understanding	of	disease	process		
 o Lack	of	involvement	in	decision	making	related	to	treatment	options		
 o Suboptimal	health	literacy		
 o Previous	experience		
 o Lack	of	motivation		
 o Low	socioeconomic	status		
 o Ineffective	communication	between	patients	and	healthcare	practitioners		
 o Inadequacies	in	recognizing	financial	burden	to	patient	
 o Limitations	surrounding	access	to	care	
 o Lack	of	health	information	technology		 (Brown	&	Bussell,	2011)	
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What	should	I	know	about	my	medications?		
	It	is	important	to	be	informed	about	the	medications	that	you	take.		You	should	know:		
v The	name	and	dose	of	each	medication	you	take	
v What	each	medication	does		
v The	time	you	should	take	each	medication	and	how	often		
v The	possible	side	effects	of	your	medications		
v What	to	do	it	you	miss	or	forget	to	take	a	dose		
v What	as	needed	or	PRN	means		
v If	the	medication	should	be	taken	with	food		
v How	other	medications	may	interfere	(US	Food	&	Drug	Administration,	2015;	Living	Well	with	COPD,	2017)				Discussion	Question:	Who	knows	all	of	these	things	about	every	medication	they	take?		
Tips:		
• Keep	a	med	list	in	your	purse,	wallet,	or	on	your	cell	phone.		
• Make	an	appointment	with	your	community	pharmacist	to	discuss	your	individual	
medications.					
 v Taking	medications	as	prescribed	optimizes	lung	function	and	slow	disease	progression		
 v Medications	can	reduce	symptoms	of	chronic	lung	disease	
 v Medications	have	a	classification,	generic	name,	and	brand	name	
 v Many	medications,	other	then	puffers,	are	used	to	treat	chronic	lung	disease	
 v Know	your	medications	–	keep	a	list	with	you	
 v About	50%	of	Canadians	do	not	take	their	medications	as	prescribed!			
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Image	obtained	from	www.LivingWellwithCOPD.com	
	
When	we	talk	about	pulmonary	medica?ons	we	commonly	think	of	puﬀers	but	there	
are	many	other	types	of	medica?ons	that	have	an	eﬀect	on	your	breathing	and	
respiratory	system.		You	have	already	learned	about	puﬀers	during	a	previous	
presenta?on.		Today	we	are	going	to	discuss	some	of	these	other	medica?ons	that	
are	u?lized	in	the	treatment	of	chronic	lung	disease.			
1	
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Image	obtained	from	www.clipartpanda.com	
2	
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Image	obtained	from	www.clipartpanda.com	
	
When	a	drug	or	medica?on,	prescrip?on	or	over-the-counter,	is	created	by	a	
pharmaceu?cal	company,	that	company	gains	a	patent	on	the	drug	for	a	par?cular	
number	of	years	to	prevent	other	companies	from	producing	and	selling	the	same	
drug.		When	created,	the	drug	is	given	two	names:	a	generic	name	and	a	brand	name.		
The	generic	name	is	the	drugs	scien?ﬁc	name	whereas	the	brand	name	is	a	name	
that	is	intended	to	make	the	drug	stand	out	for	the	purpose	of	marke?ng.		For	
example	Tylenol	is	a	brand	name	and	the	drugs	generic	name	is	Acetaminophen.		
AOer	a	patent	expires	the	company	or	another	company	can	produce	the	same	drug	
and	sell	it	by	its	generic	name.		A	generic	drug	is	required	to	be	bioequivalent		(the	
same	as)	a	brand	name	drug.		A	generic	and	brand	drug	have	the	same	ac?ve	
ingredient,	strength,	dose,	and	route.		The	two	may	diﬀer	in	appearance	and	cost.		
Generic	drugs	are	typically	80	to	85%	cheaper	then	brand	name	drugs.		The	company	
who	created	the	brand	name	drug	had	addi?onal	costs	associated	with	development,	
research,	clinical	trials	etc.	(Food	and	Drug	Administra?on,	2016;	Depression	and	
Bipolar	Support	Alliance,	2007)				
	
All	drugs	or	medica?ons	also	fall	under	one	or	more	classiﬁca?ons.		Classes	contain	
various	drugs	that	are	similar	and	u?lized	for	the	same	purpose.		They	are	not	
iden?cal.		For	example	Tylenol	or	Acetaminophen	falls	under	the	classiﬁca?on	of		
4	
		
	 248	
			
Image	obtained	from	www.clipartpanda.com	
	
Note:		All	medica?ons	have	a	beneﬁt	or	we	would	not	take	them;	they	also	all	have	
poten?al	side	eﬀects!		
	
5	
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Image	obtained	from	www.livingwellwithCOPD.com	
	
Used	for	pa?ents	with	both	COPD	and	pulmonary	ﬁbrosis.		
	
During	episodes	of	exacerba?on	or	illness	dose	may	be	increased	for	5-14	days.			
	
Oral	medica?ons	do	not	provide	quick	relief	and	are	not	used	as	a	rescue	therapy.		
	
	
6	
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Image	obtained	from	www.clipartpanda.com	
	
Used	to	treat	bacterial	respiratory	infec?ons.		An?bio?cs	have	no	eﬀect	on	viral	
infec?ons,	this	is	why	you	typically	are	instructed	to	only	start	your	an?bio?c	of	your	
COPD	ac?on	plan	if	your	sputum	changes	color.		During	exacerba?on,	individuals	with	
PF	are	oOen	also	prescribed	an?bio?c	therapy.			
	
Stopping	your	an?bio?c	before	the	last	does	can	cause	bacteria	adap?ng	and	
resistance	to	an?bio?cs.			
8	
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Generic	name	typically	ends	in	“pam”;	clonazepam,	diazepam	(Valium),	or	lorazepam	
(A?van)	
	
Cau?on:		
	
Older	adults	are	more	sensi?ve	to	the	seda?ng	eﬀects	of	benzodiazepines.		
	
Benzodiazepines	can	worsen	symptoms	of	pre-exis?ng	depression.		Can	cause	
emo?onal	blun?ng	or	numbness	and	increase	suicidal	thoughts	or	feelings.		
	
If	taken	regularly,	benzodiazepines	can	lead	to	physical	dependence.		Stopping	these	
medica?ons	quickly	can	lead	to	severe	withdrawal	symptoms	such	as	increased	
anxiety,	restlessness,	insomnia,	depression,	stomach	pain,	swea?ng,	or	in	severe	
cases	seizure.		
	
Benzodiazepines	and	alcohol	should	not	be	mixed.			
	
Benzodiazepines	are	typically	prescribed	to	individuals	with	chronic	lung	disease	for	
the	treatment	of	insomnia,	anxiety/depression,	and	dyspnea.		Current	research	links	
benzodiazepines	to	adverse	physiological	respiratory	outcomes	(Vozoris	et	al.,	2013).				
	
			
9	
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Chronic	lung	disease	can	lead	to	heart	failure	which	can	lead	to	pulmonary	
conges?on.		Essen?ally	your	heart	isn’t	pumping	properly	and	blood	enters	the	
vessels	of	your	lungs.		This	causes	SOB	to	worsen.		Diure?cs	remove	ﬂuid	through	
increased	produc?on	of	urine.				
11	
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How	morphine	works	is	not	fully	understood	but	thought	to	diminish	the	response	to	
elevated	CO2	levels	and	hypoxia,	decreasing	shortness	of	breath,	and	to	cause	
vasodila?on.		Your	heart	and	lungs	are	closely	connected.		Morphine	also	reduces	
preload,	decreasing	the	workload	of	your	heart.		If	your	heart	isn’t	working	as	hard,	
you	are	using	less	oxygen	and	therefore	less	short	of	breath.			
	
	
12	
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Newer	medica?ons.			
	
Daxas	is	also	an	oral	an?-inﬂammatory.		Used	as	an	add	on	to	a	bronchodilator	for	
the	maintenance	of	severe	COPD.		Not	used	as	a	rescue	medica?on	during	acute	
exacerba?ons.		Typically	take	1	tablet/day.		
	
Esbriet	and	Ofer	are	an?-ﬁbro?cs.		Do	not	repair	scar	?ssue	that	has	already	formed	
but	may	help	slow	the	progression	of	future	scarring.		
13	
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Inﬂuenza	is	a	respiratory	infec?on	that	is	typically	caused	by	inﬂuenza	A	and	B	viruses	
occurring	in	the	fall	and	winter	months.		
	
Approximately	10-20%	of	the	popula?on	are	infected	with	inﬂuenza	annually.		
	
The	ﬂu	shot	does	not	cause	the	ﬂu!!		
	
Symptoms	Include:		
Fever		
Muscle	aches		
Cough		
Chills		
Throat	irrita?on		
	
A	complica?on	of	inﬂuenza	is	worsening	of	underlying	condi?ons	such	as	chronic	lung	
disease.			
	
Pneumonia	vaccine	was	typically	thought	to	be	good	for	life,	new	recommenda?ons	
may	suggest	a	booster	aOer	5	years	par?cularly	for	pa?ents	who	are	
immunocompromised.	Frequency	decided	by	your	physician	and	provincial	
regula?ons;	typically	1	dose	at	over	65	years	of	age.					
15	
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Image	obtained	from	www.livingwellwithCOPD.com	
	
Compliance	is	a	word	that	is	oOen	used	in	the	medical	world.	Pa?ents	are	compliant	or	non-
compliant.	What	nurses	and	other	health	care	professionals	are	interested	in	is	why	pa?ents	
are	non-compliant?	In	other	words,	why	do	people	stop	taking	their	meds?	What	are	the	
barriers?	
	
Poor	medica?on	compliance	increases	incidence	of	hospitaliza?ons	and	morbidity.		
Improved	compliance	to	current	medica?ons	therapies	may	in	fact	have	a	great	
impact	on	overall	quality	of	life	and	well	being	than	improvement	in	medical	
therapies	(Brown	&	Bussell,	2011).			
	
Various	factors	inﬂuence	medica?on	compliance	including	(Brown	&	Bussell):		
Lack	of	understanding	of	disease	process		
Lack	of	involvement	in	decision	making	related	to	treatment	op?ons		
Subop?mal	health	literacy		
Previous	experience		
Lack	of	mo?va?on		
Low	socioeconomic	status		
Ineﬀec?ve	communica?on	between	pa?ents	and	healthcare	prac??oners		
Inadequacies	in	recognizing	ﬁnancial	burden	to	pa?ent	
Limita?ons	surrounding	access	to	care	
Lack	of	health	informa?on	technology		
	
17 
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(US	Food	&	Drug	Administra?on,	2015;	Living	Well	with	COPD,	2017)	
	
Discussion	Ques?on:	Who	knows	all	of	these	things	about	every	medica?on	they	
take	?			
	
Tips:		
	
Keep	a	med	list	in	your	purse,	wallet,	or	on	your	cell	phone.		
Make	an	appointment	with	your	community	pharmacist	to	discuss	your	individual	
medica?ons.			
19	
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http://www.gov.pe.ca/photos/original/hpei_med_list.pdf	
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Module	7:	Self-Management	&	Signs	of	an	
Acute	Exacerbation	
		This	module	will	discuss	the	concept	of	self-management.		It	will	also	highlight	the	goal	of	pulmonary	rehabilitation	in	promoting	and	developing	self-management	skills.		The	term	acute	exacerbation	will	be	described	and	common	symptoms	discussed	with	the	participants.		To	complete	the	module,	Actions	Plans	will	be	reviewed.		It	is	important	that	participants	have	an	understanding	of	how	to	properly	utilize	their	action	and	know	when	to	seek	emergency	assistance.				By	the	end	of	a	group	education	session,	participants	will:			 1. Describe	in	simple	words	the	concept	of	self-management.		2. State	the	two	most	common	symptoms	of	an	acute	exacerbation	of	chronic	lung	disease.		3. Describe	how	to	properly	utilize	their	personal	Action	Plan.				It	is	intended	that	the	materials	presented	within	this	module	be	utilized	during	a	one	hour	group	education	session.		Various	aids	have	been	provided	within	the	module	to	assist	with	ease	of	education	delivery.			
v Visual	Aids:	PowerPoint	presentation	containing	various	pictures/graph;	whiteboard	and	markers		
v Patient	Activity:	Chronic	Lung	Disease	Case	Studies		
v Handout:	“Hand	Washing”	and	“My	Personal	COPD	Action	Plan”	
v Potential	questions	for	facilitated	group	discussion				 		What	is	Self-Management?			
Many	participants	and	their	family	members	may	in	fact	already	be	participating	in	self-
management	behaviors,	but	may	not	recognize	the	term.		Facilitate	a	group	discussion	to	
answer	the	following	question.					
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Discussion	Question:	What	does	self-management	mean	to	you?			
• Self-management	refers	to	the	ability	of	an	individual	to	adequately	monitor,	provide	treatment,	and	manage	ongoing	symptoms	associated	with	chronic	disease	(Grady	&	Gough,	2014;	Coleman	&	Newton,	2005).		Self-management	moves	away	from	the	traditional	medical	model	and	enables	the	patient	to	be	responsible	for	the	day-to-day	care	of	their	disease	(Wang,	Tan,	Xiao,	&	Deng,	2017).				
• In	order	to	participate	in	self-management,	individuals	require	both	support	and	education	from	health	care	professionals	(Coleman	&	Newton).				
• Benefits	of	self-management	include	(Wang	et	al.,	2017):		
o Improves	overall	quality	of	life		
o Improves	functional	ability		
o Enhances	knowledge	and	confidence		
o Decreases	incidence	of	acute	exacerbation		
o Decreases	hospitalizations			
	
The	ultimate	goal	of	pulmonary	rehabilitation	is	to	promote	and	develop	self-management	
skills	through	relevant	education.		This	happens	in	both	the	classroom	and	gym	while	
attending	pulmonary	rehabilitation!		It	is	hoped	that	by	the	end	of	this	12-week	program	
participants	will	have	obtained	the	knowledge	and	skills	required	to	participate	in	self-
management	of	their	disease.							
	
	
	
				Image	obtained	from	www.livingwellwithCOPD.com				
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What	is	an	Acute	Exacerbation?			
• An	acute	exacerbation	is	a	flair	up	or	an	aggravation	of	the	symptoms	of	your	chronic	lung	disease	(Living	Well	with	COPD,	2017).		The	most	common	causes	of	an	exacerbation	are	respiratory	infections	and	changes	in	temperature.				
																																					 		
• One	way	to	prevent	or	reduce	risk	of	respiratory	infections	is	to	receive	recommended	vaccinations.		Other	tips	include	avoiding	people	with	known	respiratory	infections	and	frequent	hand	washing.				
• Hand	washing	removes	microorganisms	from	the	hands	and	is	the	most	effective	way	to	prevent	the	spread	of	disease	and	infection	(Infection	Prevention	and	Control	Canada,	2017).		You	should	wash	your	hands	after	being	in	contact	with	another	individual	(e.g.	shaking	hands),	each	time	you	are	in	contacting	with	secretions	or	other	body	fluids	(ex.	after	covering	your	mouth	while	coughing	or	blowing	your	nose),	and	after	performing	personal	functions	(e.g.	going	to	the	bathroom).		Effective	hand	washing	can	be	done	utilizing	soap	and	water	or	an	alcohol-based	hand	rub.		If	your	hands	are	visibly	soiled	you	should	use	soap	and	water	(Infection	Prevention	and	Control	Canada)!			
• We	talked	about	vaccines	during	the	additions	medication	module,	lets	review…		
A	handout	depicting	proper	hand	washing	technique	can	be	found	that	the	end	of	this	
module.			
	
	
Vaccines:																																	 																																																																																																																																					
• Flu	Vaccine		
o Recommended	for	individuals	with	chronic	lung	disease	yearly		
o Approximately	10-20%	of	the	population	are	infected	with	influenza	annually		
o Influenza	is	a	respiratory	infection	that	is	 	 	
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typically	caused	by	influenza	A	or	B	virus	occurring	in	the	fall	or	winter	months	yearly		
o The	flu	shot	does	not	cause	the	flu!!		
o Common	symptoms:	fever,	muscle	aches,	cough,	chills,	throat	irritation		
o A	complication	of	influenza	is	worsening	of	underlying	conditions	such	as	chronic	lung	disease		 (Health	PEI,	2016;	Government	of	Canada,	2015)	
• Pneumonia	Vaccine		
o Recommended	for	individuals	with	chronic	lung	disease		
o Prevents	illness	caused	by	pneumococcus	bacteria	
o Frequency	decided	by	your	physician	and	provincial	regulations;	typically	one	dose	at	over	65	years	of	age			 	(Government	of	Canada,	2015)	Typical	Signs	of	an	Acute	Exacerbation			
• The	two	most	common	symptoms	of	an	acute	exacerbation	of	COPD	and	Pulmonary	Fibrosis	are	increased	shortness	of	breath	and	a	change	in	your	sputum	(Living	Well	with	COPD,	2017;	Living	Well	with	Pulmonary	Fibrosis,	2017).		You	should	monitor	the	color,	volume,	and	consistency	of	your	sputum!		Other	symptoms	may	include:			
o Fever	
o Sore	throat		
o Flu-like	symptoms		
o Increased	cough	frequency			Action	Plan	Review			
In	a	previous	group	education	session	Action	Plans	were	discussed	in	detail	with	the	RT.		All	
participants	diagnosed	with	COPD	should	have	an	Action	Plan!	In	PEI	no	Action	Plan	currently	
exists	for	individuals	living	with	Pulmonary	Fibrosis.		For	those	who	do	not	have	an	Action	
Plan,	it	is	recommended	that	you	make	an	appointment	within	48	hours	to	see	your	health	
care	professional	when	you	feel	unwell	or	have	a	change	in	your	typical	symptoms	(Living	
Well	with	COPD,	2017;	Living	Well	with	Pulmonary	Fibrosis).			
	
	
Prior	to	reviewing	the	concept	of	Action	Plans,	facilitate	a	group	discussion	to	explore	the	
following	questions.				Discussion	Questions:		1. What	do	you	currently	do	when	the	symptoms	of	your	lung	disease	worsen?		2. Do	you	have	an	Action	Plan?		3. Do	you	know	how	to	use	your	Action	Plan?		4. How	do	you	know	when	to	call	911	or	go	to	the	Emergency	Room?				
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The	following	images	depict	the	components	of	a	typical	Action	Plan.	Most	participants	will	
have	similar	Action	Plans.		The	specific	medication	utilized	or	dosage	will	differ,	but	each	
Action	Plan	typically	contains	instructions	as	well	as	a	prescription	for	both	an	antibiotic	and	
oral	anti-inflammatory	drug.			
	
Note…	Throughout	the	program,	each	participant	will	meet	one-on-on	with	either	the	RN	or	
RT	to	discuss	his	or	her	personal	Action	Alan.		For	now	lets	review	Actions	Plans.			The	COPD	
Action	Plan,	utilized	in	PEI,	can	be	found	in	the	handout	section	of	this	module.					
COPD	Action	Plan:			
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	Images	obtained	from	www.livingwellwithCOPD.com	
Pulmonary	Fibrosis	Action	Plan:			
											
		
	
		
	 273	
	
		 Images	obtained	from	the	program	"Living	Well	with	Pulmonary	Fibrosis",	J.	Morisset,	D.	Nault,	A.	Savard,	M.	Sedeno,	1st	edition	(2016)	www.livingwellwithpulmonaryfibrosis.com		Participant	Activity:			
As	a	group,	lets	discuss	the	following	scenarios	and	decide	what	action	we	would	take.			
	
Note…	this	activity	is	not	to	be	utilized	as	a	form	of	evaluation	or	to	test	participants.		It	is	to	
be	used	to	facilitate	discussion	and	questions	regarding	Action	Plans.				Scenario	1:			
v Ms.	Smith…		
Ø 58	year	old	female,	diagnosed	with	COPD	approximately	20	years	ago.		
Ø Has	an	action	plan	that	includes	an	antibiotic,	prednisone,	and	an	increase	in	the	frequency	of	her	bronchodilator.		
Ø Ms.	Smith	awoke	this	morning	feeling	more	short	of	breath	then	normal.		She	was	able	to	get	dressed	but	was	unable	to	do	the	typical	household	chores	that	she	normally	does	every	morning.		
Ø Ms.	Smith	notices	she	has	been	coughing	more	than	normal	however,	her	sputum	has	not	changed	in	color,	volume,	or	consistency.			
		
	 274	
What	should	Ms.	Smith	do?			
Suggestion…	Ms.	Smith	should	avoid	common	exacerbation	triggers	and	increase	the	
frequency	of	her	bronchodilator.		They	frequency	will	be	decided	by	her	current	symptoms	and		
personal	Action	Plan.		She	should	also	continue	to	monitor	symptoms	closely!				
Ø Day	2…	Ms.	Smith	slept	poorly	overnight.		She	continues	to	have	increasing	shortness	of	breath	that	is	not	being	controlled	with	the	increased	frequency	of	her	bronchodilator.		Her	sputum	this	morning	is	yellow	in	color.				What	should	Ms.	Smith	do?			
Suggestion…	Per	her	Action	Plan,	Ms.	Smith	should	initiate	both	her	antibiotic	and	her	
prednisone.		If	after	48	hours	her	symptoms	are	not	improved,	despite	starting	treatment,	Ms.	
Smith	should	make	an	immediate	appointment	with	her	health	care	provider.		It	would	be	
important	for	her	to	also	be	aware	of	when	to	seek	help	at	the	Emergency	Room	or	call	911.				Scenario	2:			
v Mr.	Wilson…	
Ø 62	year	old	male,	diagnosed	with	Pulmonary	Fibrosis	three	year	ago.		
Ø Mr.	Wilson	does	not	have	an	Action	Plan	for	his	Pulmonary	Fibrosis.		
Ø Mr.	Wilson	has	been	feeling	unwell	for	approximately	three	days.		He	is	experiencing	increased	shortness	of	breath	and	is	coughing	up	green	sputum,	which	is	not	normal	for	him.			
Ø Mr.	Wilson	awoke	this	morning	with	extreme	shortness	of	breath.		He	was	unable	to	get	out	of	bed	and	get	dressed.		He	typically	is	independent	with	his	activities	of	daily	living.		His	wife	finds	him	to	be	slightly	confused,	which	is	also	not	normal	for	him.		He	typically	is	independent	with	his	activities	of	daily	living.				What	should	Mr.	Wilson	or	his	wife	do?			
Suggestion…	Mr.	Wilson	or	his	wife	if	he	is	unable	to	should	call	911	and	seek	help	at	the	
Emergency	Room.		His	symptoms	have	progressed	too	far	for	him	to	wait	for	an	appointment	
with	his	typical	health	care	provider.	
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v Self-management	is	the	ability	of	an	individual	to	monitor,	treat,	and	manage	symptoms	of	their	disease.		
v An	acute	exacerbation	is	a	flair	up	or	an	aggravation	of	the	symptoms	of	your	chronic	lung	disease.			
v The	two	most	common	symptoms	of	an	acute	exacerbation	are	increased	shortness	of	breath	and	a	change	in	your	sputum	
v Your	Action	Plan	is	a	key	component	to	your	self-management	plan.		It	tells	you	what	to	do	during	an	exacerbation	or	when	your	symptoms	worsen.		
v It	is	recommended	that	you	make	an	appointment	within	48	hours	to	see	your	health	care	professional	when	you	feel	unwell	or	have	a	change	in	your	typical	symptoms.				
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Image	obtained	from	www.livingwellwithCOPD.com	
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Review	Key	Messages	from	previous	module.		
	
Image	obtained	from	www.clipartpanda.com	
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Self-management	refers	to	the	ability	of	an	individual	to	adequately	monitor,	provide	
treatment,	and	manage	ongoing	symptoms	associated	with	chronic	disease	(Coleman	
&	Newton,	2005).		Self-management	moves	away	from	the	tradiMonal	medical	model	
and	enables	the	paMent	to	be	responsible	for	the	day-to-day	care	of	their	disease	
(Wang,	Tan,	Xiao,	&	Deng,	2017).			
		
In	order	to	parMcipate	in	self-management,	individuals	require	both	support	and	
educaMon	from	health	care	professionals	(Coleman	&	Newton).			
		
Beneﬁts	of	self-management	include	(Wang	et	al.,	2017):		
Improves	overall	quality	of	life		
Improves	funcMonal	ability		
Enhances	knowledge	and	conﬁdence		
Decreases	incidence	of	acute	exacerbaMon		
Decreases	hospitalizaMons		
		
When	speaking	to	the	role	of	healthcare	providers	in	the	treatment	of	chronic	lung	
disease,	90	percent	of	care	should	involve	paMent	educaMon	(Wang	et	al.,	2017)!	
	
The	ul'mate	goal	of	pulmonary	rehabilita'on	is	to	promote	and	develop	self-
management	skills	through	relevant	educa'on.		This	happens	in	both	the	classroom		
4	
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Images	from	www.livingwellwithCOPD.com	
	
An	acute	exacerbaMon	is	a	ﬂair	up	or	an	aggravaMon	of	the	symptoms	of	your	chronic	
lung	disease	(Living	Well	with	COPD,	2017).		The	most	common	causes	of	an	
exacerbaMon	are	respiratory	infecMons	and	changes	in	temperature.			
	
One	way	to	prevent	or	reduce	risk	of	respiratory	infecMons	is	to	receive	
recommended	vaccina&ons.		Other	Mps	include	avoiding	people	with	known	
respiratory	infecMons	and	frequent	hand	washing.		We	talked	about	vaccines	during	
the	addiMons	medicaMon	module,	lets	review…	
	
Vaccines:																																 		
																																																																																																																																				
Flu	Vaccine:			
Recommended	for	individuals	with	chronic	lung	disease	yearly		
Approximately	10	to	20	percent	of	the	populaMon	are	infected	with	inﬂuenza	
annually		
Inﬂuenza	is	a	respiratory	infecMon	that	is	typically	caused	by	inﬂuenza	A	or	B	
virus	occurring	in	the	fall	or	winter	months	yearly		
The	ﬂu	shot	does	not	cause	the	ﬂu!!		
Common	symptoms:	fever,	muscle	aches,	cough,	chills,	throat	irritaMon		
6	
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References:	(Living	Well	with	COPD,	Living	Well	with	Pulmonary	Fibrosis,	2017)	
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In	a	previous	group	educa'on	session	Ac'on	Plans	were	discussed	in	detail	with	the	
Respiratory	Therapist.		All	par'cipants	diagnosed	with	COPD	should	have	an	Ac'on	
Plan!	In	PEI	no	Ac'on	Plan	currently	exists	for	individuals	living	with	Pulmonary	
Fibrosis.		For	those	who	do	not	have	an	Ac'on	Plan,	it	is	recommended	that	you	make	
an	appointment	within	48	hours	to	see	your	health	care	professional	when	you	feel	
unwell	or	have	a	change	in	your	typical	symptoms	(Living	Well	with	COPD;	Living	Well	
with	Pulmonary	Fibrosis).			
	
9	
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Image	obtained	from	www.livingwellwithCOPD.com	
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Images	obtained	from	www.livingwellwithCOPD.com	
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Images	obtained	from	www.livingwellwithCOPD.com	
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This	is	what	a	COPD	acMon	plan	looks	like	in	the	Province	of	PEI.		
14	
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Images	obtained	from	the	program	"Living	Well	with	Pulmonary	Fibrosis",	J.	Morisset,	
D.	Nault,	A.	Savard,	M.	Sedeno,	1st	ediMon	(2016)	
www.livingwellwithpulmonaryﬁbrosis.com	
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Images	obtained	from	the	program	"Living	Well	with	Pulmonary	Fibrosis",	J.	Morisset,	
D.	Nault,	A.	Savard,	M.	Sedeno,	1st	ediMon	(2016)	
www.livingwellwithpulmonaryﬁbrosis.com	
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	As	a	group,	lets	discuss	the	following	scenarios	and	decide	what	ac'on	we	would	
take.			
		
Note…	this	ac'vity	is	not	to	be	u'lized	as	a	form	of	evalua'on	or	to	test	par'cipants.		
It	is	to	be	used	to	facilitate	discussion	and	ques'ons	regarding	ac'on	plans.			
	
	
Sugges'on…	Ms.	Smith	should	avoid	common	exacerba'on	triggers	and	increase	the	
frequency	of	her	bronchodilator.		She	should	also	con'nue	to	monitor	symptoms	
closely!			
17	
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Sugges'on…	Per	her	Ac'on	Plan,	Ms.	Smith	should	ini'ate	both	her	an'bio'c	and	her	
prednisone.		If	aTer	48	hours	her	symptoms	are	not	improved,	despite	star'ng	
treatment,	Ms.	Smith	should	make	an	immediate	appointment	with	her	health	care	
provider.		It	would	be	important	for	her	to	also	be	aware	of	when	to	seek	help	at	the	
emergency	room	or	call	911.			
	
18	
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Sugges'on…	Mr.	Wilson	or	his	wife	if	he	is	unable	to	should	call	911	and	seek	help	at	
the	emergency	room.		His	symptoms	have	progressed	too	far	for	him	to	wait	for	an	
appointment	with	his	typical	health	care	provider.			
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Image	obtained	from	www.clipartpanda.com	
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White-Pharmacist      Yellow-Patient      Pink-Physician      Goldenrod-Educator 
 
                  
                Name:    ______________________________________  Date of Birth:________________________ PHN: ____________________        Date: _______________ 
 
Feeling Worse (not MY normal) 
My sputum has changed for at least 2 
days:                         Yes        No    
                            OR  
I am more short of breath than usual 
for at least 2 days   Yes        No   
 
 
x I feel short of breath when I: 
 
x My sleep is: 
 
 
  
 
My Personal COPD Action Plan                                          This Personal COPD Action Plan is valid for 1 year. 
                     
Feeling Good (MY normal breathing) 
x My sputum is: ________________ 
x I cough more when I: __________ 
___________________________ 
x I feel short of breath when I: ____ 
___________________________ 
x My sleep is: _______________ 
 
 
Feeling MUCH Worse 
x NO improvement after 48 hours of 
taking COPD flare-up medication 
x Drowsy and confused 
x Chest pain or pressure 
 
You Are In Control 
x Continue taking daily medication 
x Avoid Triggers: ________________ 
                                ________________ 
                                ________________ 
x Continue daily activity 
 
 
If I checked YES to one or both I will 
 
x Take daily medication and start 
prescription for COPD flare-up 
x Call one of my Health Care Contacts 
_____________________________ 
_____________________________ 
_____________________________ 
x I will pace myself and practice 
pursed lip breathing 
 
                                    
 
  
Take Action NOW              
x Go directly to the nearest 
emergency room 
x Bring your action plan with you 
x Home Oxygen  ___ at rest 
                         ___ with exertion 
 
PRESCRIPTIONS FOR COPD FLARE-UP 
If your SPUTUM changes from your normal color for 2 days : 
Prescription #1 Start Antibiotic     
 
Dose: ______   #Pills:   _____    Frequency:  ______    Days: ____ 
Refills: _______ 
 
If repeating antibiotic within 3 months use the following instead 
Prescription #2 Start Antibiotic  
 
Dose: ______   #Pills:   _____    Frequency:  ______    Days: ____ 
Refills: _______ 
 
Prescription #3 ____________________ 
When more SHORT OF BREATH than usual 
Take ______   puffs of  _________________    up to a maximum 
of _______   times a day as needed.                    
Refills: _______ 
 
If  SHORTNESS OF BREATH DOES NOT IMPROVE: 
Prescription #4 Start PREDNISONE                         
Dose: ______   #Pills:   _____    Frequency:  ______    Days: ____ 
Refills: _______ 
 
_______________________________           _____________ 
Physician/NP Name                                                      License                
 
_______________________________          ______________ 
Signature                                                                           Date 
 
Follow up with your doctor within 2 days after using any 
prescriptions for a COPD flare-up 
 
**Pharmacist please retain on patient file to be filled as needed. 
 
16HPE15-44661
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Module	8:	Navigating	the	Health	Care	
System	and	Tests	and	Interventions		
The	health	care	system	is	complex	and	often	challenging	to	navigate.		This	module	will	provide	information	regarding	various	aspects	of	the	health	care	system,	provide	tips	for	navigation,	and	describe	various	tests	and	interventions	that	patients	commonly	encounter	during	the	diagnosis,	treatment,	and	management	of	chronic	lung	disease.		Throughout	the	module	the	roles	of	various	health	care	professionals	will	be	discussed.		Individuals	Goals	of	Care	should	be	addressed	at	every	health	care	encounter,	but	this	is	often	not	the	case.		Patients	and	families	are	often	faced	with	making	these	decisions	at	times	of	acute	injury/disease	or	crisis.		The	Goals	of	Care	options,	R,	M,	and	C	will	be	discussed	and	described.		Drug	plans,	as	well	as	additional	health	care	resources,	available	to	residents	of	PEI,	will	be	identified	in	the	content.				By	the	end	of	a	group	education	session	participants	will:		1. Explain	the	roles	of	various	health	care	professionals.		2. State	a	basic	definition	of	each	Goal	of	Care	(R,	M,	and	C).		3. Identify	two	tips	helpful	in	optimizing	health	care	appointments.		4. Be	aware	that	there	are	provincially	funded	drugs	plans	available	to	residents	of	PEI.			5. Identify	a	health	care	resource	available	to	residents	of	PEI.			6. Simply	describe	common	tests	utilized	in	the	diagnosis	and	treatment	of	their	chronic	lung	disease.					It	is	intended	that	the	materials	presented	within	this	module	be	utilized	during	a	one	hour	group	education	session.		Various	aids	have	been	provided	within	the	module	to	assist	with	ease	of	education	delivery.			
v Visual	Aids:	PowerPoint	presentation;	whiteboard	and	markers		
v Potential	questions	for	facilitated	group	discussion		
v Video:	What	is	Spirometry	avaliable	at:	https://www.youtube.com/watch?v=LeXgXKIyRA0						
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Understanding	the	Role	of	Various	Health	Care	Professionals			
• Various	healthcare	professionals	make	up	the	multidisciplinary	team	that	provides	care	to	patients	both	in	the	hospital	and	community	setting.		These	professionals	have	varying	education	levels,	specialties,	scopes	of	practice,	and	therefore	different	responsibilities	to	the	patient.		Sometimes	it	is	difficult	for	patients	to	understand	the	role	of	all	of	these	professionals	or	to	even	distinguish	between	them.				
• Multidisciplinary	teams	improve	patient	outcomes	and	satisfaction.		They	also	decrease	lengths	of	hospital	stays	and	in	turn	health	care	costs,	while	improving	the	job	satisfaction	of	health	care	providers	(Epstein,	2014).				Team	members	may	include:		
v Respirologist		
v Thoracic	or	Transplant	Surgeon		
v Family	Physician		
v Internal	Medicine	
v Nurse	Practitioner		
v Registered	Nurse		
v Licensed	Practical	Nurse		
v Resident	Care	Worker		
v Respiratory	Therapist		
v Pharmacist		
v Physiotherapist		
v Occupational	Therapist	
v Registered	Dietician		
v Psychologist		
v Social	Worker	
v Spiritual	Care	Worker		
v Students		
																											 	Image	obtained	from	www.clipartpanda.com	
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The	Pulmonary	Rehabilitation	Program	is	an	example	of	a	multidisciplinary	team.		Working	
day	to	day	with	the	program	is	a	RN,	RT,	and	PT.		The	Medical	Director	for	the	program	is	a	
Respirologist	and	works	within	the	Internal	Medicine	Department.		Guest	speakers	for	the	
program	include	a	Registered	Dietician,	SW,	Psychologist,	Spiritual	Care	Worker,	and	OT.		This	
team	approach	to	the	program	helps	to	ensure	that	the	program	best	meets	the	needs	of	all	
participants	and	is	holistic.					Discussion	Questions:		1. Can	you	share	your	hospital	experience?		What	do	you	remember	most?				2. Was	your	experience	positive	or	negative?		3. Did	you	feel	that	your	family	was	included	within	your	multidisciplinary	team?	4. Were	you	able	to	identify	the	profession	of	each	healthcare	worker	that	you	encountered	or	did	they	all	look	the	same?		5. Did	the	language	that	healthcare	providers	use	confuse	you?			6. Do	you	find	tests	and	interventions	confusing?			
Goals	of	Care	
	
• Traditionally	in	the	hospital	setting	the	concept	Goals	of	Care	may	have	been	referred	to	as	Code	Status.		
• Goals	of	Care	provide	instruction	to	healthcare	providers	in	relation	to	your	wishes	and	ultimately	guide	the	treatment	you	will	receive	(Government	of	Prince	Edward	Island).			
• Goals	of	Care	should	ideally	be	discussed	with	loved	ones,	family,	and	friends	on	an	ongoing	bases.		A	time	of	acute	illness	or	emergency	is	often	a	difficult	time	to	address	goals	of	care.						In	PEI	Goals	of	Care	are	defined	by	the	following:				
	Image	created	utilizing	definitions	obtained	from	Government	of	Prince	Edward	Island	(2016).					Goals	of	Care	should	be	addressed	with	patients	at	every	health	care	encounter!
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Later	in	the	program	we	will	be	doing	an	entire	education	session	on	advance	care	planning.		
We	will	further	discuss	Goals	of	Care	during	this	session.				
		
How	do	I	make	the	most	of	my	Health	Care	Appointments?		
	
Health	care	appointment	can	be	overwhelming,	confusing,	and	frustrating.		Patients	often	
identify	that	they	feel	rushed	during	their	appointments	and	rarely	get	all	issues	addressed	
during	the	allotted	time.			
	
	
Helpful	Tips	(Harvard	Health	Publications,	2017):		Image	obtained	from	www.clipartpanda.com	
	
v Be	prepared		
Ø Arrive	to	your	appointment	on	time	and	make	a	list	of	questions	to	have	addressed	before	you	arrive.			
v Identify	symptoms	
Ø Your	health	care	professional	can	not	diagnosis	or	treat	a	problem	they	don’t	know	you	have.		Be	specific	and	concise.		
v Ask	questions		
Ø Don’t	be	afraid	to	ask	questions.		If	you	do	not	understand	information	that	your	health	care	provider	is	giving	ask	for	clarification.		Health	care	providers	have	a	responsibility	to	ensure	you	are	adequately	informed	and	to	involve	you	as	an	active	participant	in	your	care.			
v Bring	a	friend		
Ø Appointments	can	be	confusing	and	we	rarely	hear	everything	that	is	said.		Four	ears	are	always	better	than	two!		
v Bring	an	updated	medication	list		
Ø This	will	save	time	if	your	health	care	provider	asks	you	what	medications	you	take.			
v Get	a	recap	
Ø Ask	for	a	quick	repeat	of	important	information.		Make	sure	you	know	the	plan	for	follow	up.		Advocate	for	yourself,	as	your	health	care	professional	may	not!			
	
Drug	Plans			
FYI…	Various	drug	plans	are	available	to	residents	of	PEI.		Those	most	relevant	to	the	
pulmonary	rehabilitation	population	will	be	discussed.		A	full	list	and	additional	information	
can	be	found	at:		https://www.princeedwardisland.ca/en/information/health-pei/drug-
programs	
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		Obtained	from	www.livingwellwithCOPD.com				
v Generic	Drug	Program:	the	program	is	for	individuals	under	the	age	of	65	who	do	not	have	private	healthcare	insurance.		The	program	limits	the	cost	per	prescription	to	$19.95	for	medications	listed	within	the	provincial	formulary.		Note:	does	not	cover	diabetic	drugs	or	narcotics		
v Seniors	Drug	Program:	the	program	is	for	individuals	over	the	age	of	65.		You	will	pay	$15.94	per	prescription	for	medications	listed	within	the	provincial	formulary.		All	additional	cost	will	be	covered.		You	will	be	automatically	enrolled	at	the	age	of	65.					`	
v Catastrophic	Drug	Program:	program	caps	annual	cost	of	prescription	medications,	listed	within	the	provincial	formulary,	based	on	your	household	income.					
v Home	Oxygen	Program:	subsidizes	up	to	50	percent	of	the	cost	of	prescribed	oxygen	to	a	maximum	of	$200	per	month.		There	are	clinical	requirements	you	must	meet	to	be	eligible.					
v Quit	Smoking	Drug	Program:	the	program	will	pay	$75	per	year	towards	the	cost	of	approved	smoking	cessation	medications.		
	
v Financial	Assistance	Drug	Program:	the	program	covers	the	cost	of	all	prescription	and	non-prescription	medications,	listed	within	the	provincial	formulary,	for	individuals	approved	for	Social	Assistance.		 (Government	of	Prince	Edward	Island)		
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Additional	Resources	
	
FYI…	There	are	resources	available	to	residents	of	PEI	who	have	difficulty	navigating	the	
healthcare	system	or	need	advice.			
		
v Patient	Navigator:	Health	PEI	recognizes	that	the	health	care	system	is	often	confusing	and	difficult	to	navigate.		The	patient	navigator	works	within	Health	PEI	and	is	available	to	assist	patients,	families,	and	caregivers.			The	patient	navigator	can	provide	information,	support,	coordinate,	and	connect	individuals	to	the	right	health	care	professional	based	on	their	individual	needs	(Government	of	Prince	Edward	Island,	2016).		
Ø Contact	at:		Toll	free:		1-844-882-3141			Telephone:		(902)	620-3418	Email:		patientnavigator@gov.pe.ca	Website:	https://www.princeedwardisland.ca/en/information/health-pei/patient-navigator		
v 811:	Provides	access	to	a	Registered	Nurse	24	hours	per	day,	365	days	per	year.		This	is	not	an	emergency	service.		It	provides	access	to	a	registered	nurse	who	can	provide	information,	advise,	and	guidance	regarding	available	healthcare	services	(Government	of	Prince	Edward	Island).			
Ø Contact	at:		Telephone:	811		Website:	https://www.princeedwardisland.ca/en/information/health-pei/811-telehealth			
Important	note…	Health	PEI	recommends	that	individuals	seek	care	in	an	Emergency	Room	or	call	911	in	the	following	situations	(Government	of	Prince	Edward	Island):		
v Experiencing	chest	discomfort	of	tightness		
v Atypical	shortness	of	breath		
v Prolonged	headache	or	dizziness				
Various	tests	and	interventions	are	utilized	in	the	diagnosis,	treatment,	and	management	of	
chronic	lung	disease.		Often	times	these	tests	can	be	scary,	overwhelming,	and	confusing.		
Spirometry	
v Useful	in	the	diagnosis	of	chronic	lung	diseases	such	as	COPD	and	asthma.		It	is	also	utilized	to	monitor	lung	function	and	disease	progression.				Spirometry	measures	how	much	air	you	can	blow	out	and	how	fast	(Canadian	Lung	Association,	2017).				
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Watch	the	following	video	to	see	how	spirometry	is	conducted…		Video:	What	is	Spirometry?		https://www.youtube.com/watch?v=LeXgXKIyRA0		
v Various	measurement	are	obtained	during	Spirometry	testing	including	(Australia	Lung	Foundation,	2016):		
o Forced	Expiratory	Volume	in	one	second	(FEV1)	
§ The	maximal	amount	of	air	that	can	be	blown	out	from	the	lungs	in	one	second.	
o Forced	Vital	Capacity	(FVC)	
§ The	maximal	amount	of	air	that	can	be	blown	out	forcefully	in	one	entire	breath.				
Participants	of	Pulmonary	Rehabilitation	complete	spirometry	during	their	initial	assessment	
and	at	the	completion	of	the	program.								
Bronchoscopy	
v A	test	that	is	conducted	by	a	Respirologist.		A	flexible	tube	with	a	light	and	camera	is	inserted	through	your	mouth	or	nose	to	the	bronchi	of	your	lungs.		During	the	test,	the	Respirologist	can	collect	tissue	or	fluid	samples	to	be	sent	to	the	lab	for	assessment.		A	bronchoscope	is	helpful	in	the	diagnosis	and	treatment	of	various	chronic	lung	diseases	(Canadian	Lung	Association).			
v A	bronchoscope	is	considered	safe	but	is	an	invasive	test.		It	typically	takes	30	to	60	minutes	to	complete.		You	are	typically	sedated	for	a	bronchoscope,	told	not	to	eat	or	drink	prior	to	the	test,	and	may	be	told	not	to	take	certain	medications	(Canadian	Lung	Association).		
v Risks	include:	bleeding,	pneumothorax	(collapsed	lung),	infections,	and	allergic	reaction	to	medications.								
																																								 	 Image	obtained	from	www.lung.ca		
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Chest	X-ray		
v Provides	a	visual	depiction	of	damage	to	your	lungs	(Canadian	Lung	Association).				
v Non-invasive	test	but	does	provide	exposure	to	radiation		
																																																														 		 Image	obtained	from	www.clipartpanda.com		
Oximetry	
v Commonly	known	as	SP02	level	or	monitoring	
v Estimates	the	oxygen	saturation	of	your	blood	with	a	finger	or	ear	probe.		Oximetry	is	non-invasive,	has	no	risks,	and	provides	an	almost	instant	result	(Living	Well	with	COPD,	2017;	Canadian	Lung	Association)		
v Oximetry	is	not	always	accurate.		If	a	reading	does	not	match	the	presentation	of	the	patient	check	the	equipment	or	try	another	oximeter.			
This	is	assessed	during	each	visit	to	the	Pulmonary	Rehabilitation	Program	when	we	perform	
oximetry	with	your	initial	vital	signs	and	while	you	are	exercising	in	the	gym.						
Arterial	Blood	Gas	(ABG)		
v Measures	the	amount	of	oxygen	and	carbon	dioxide	in	your	blood.		A	needle	is	used	to	obtain	a	small	amount	of	blood	from	an	artery,	typically	in	your	wrist	(Living	Well	with	COPD,	2017).			
v Specially	trained	Registered	Nurses	and	Respiratory	Therapists	can	draw	ABG’s.		An	ABG	does	not	give	an	instant	result	like	Oximetry.		The	sample	must	be	sent	to	the	lab	to	be	analyzed.		Individuals	on	home	oxygen	will	have	an	initial	ABG	drawn	and	have	the	test	repeated	in	three	months.		This	test	is	also	utilized	frequently	in	emergency	rooms	and	critical	care	units	for	individuals	with	chronic	lung	disease	during	exacerbation.				
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v Multidisciplinary	teams,	made	up	of	various	healthcare	professionals,	improve	patient	outcomes	and	satisfaction.			
v Goals	of	Care	provide	instruction	to	healthcare	providers	about	your	wishes	and	guide	the	treatment	you	will	receive.		
v To	make	the	most	of	your	healthcare	appointments	be	prepared,	identify	symptoms,	ask	questions,	bring	a	friend,	bring	an	updated	medication	list,	and	get	a	recap.			
v Resources	available	to	residents	of	PEI	who	have	difficulty	navigating	the	healthcare	system	or	need	advice	include	the	patient	navigator	and	811.			
v Tests	and	interventions	can	be	scary,	overwhelming,	and	confusing.		
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Review	Key	Messages	from	previous	module.		
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Image	obtained	from	www.clipartpanda.com	
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Image	obtained	from	Image	obtained	from	www.clipartpanda.com	
		
Various	healthcare	professionals	make	up	the	mulAdisciplinary	team	that	provides	
care	to	paAents	both	in	the	hospital	and	community	seBng.		These	professionals	
have	varying	educaAon	levels,	specialAes,	and	scopes	of	pracAce	and	therefore	
varying	responsibiliAes	to	the	paAent.		SomeAmes	it	is	diﬃcult	for	paAents	to	
understand	the	role	of	all	of	theses	professionals	or	to	even	disAnguish	between	
them.				
	
MulAdisciplinary	teams	improve	paAent	outcomes	and	saAsfacAon,	decrease	lengths	
of	hospital	stays	and	in	turn	health	care	costs,	and	improve	the	job	saAsfacAon	of	
health	care	providers	(Epstein,	2014).			
	
The	Pulmonary	Rehabilita2on	Program	is	an	example	of	a	mul2disciplinary	team.		
Working	day	to	day	with	the	program	is	a	Registered	Nurse,	Respiratory	Therapist,	
and	Physiotherapist.		The	medical	director	for	the	program	is	a	Respirologist	and	
works	within	the	Internal	Medicine	Department.		Guest	speakers	for	the	program	
include	a	Registered	Die2cian,	Social	Worker,	Psychologist,	Spiritual	Care	Worker,	and	
Occupa2onal	Therapist.		This	team	approach	to	the	program	helps	to	ensure	that	the	
program	best	meets	the	needs	of	all	par2cipants	and	is	holis2c.				
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Image	obtained	from	hNp://familiesusa.org/share-your-story,	copyright	permission	
not	required	per	website.			
	
Discussion	QuesAons:		
1.  Can	you	share	your	hospital	experience?		What	do	you	remember	most?				
2.  Was	your	experience	posiAve	or	negaAve?		
3.  Did	you	feel	that	your	family	was	included	within	your	mulAdisciplinary	team?	
4.  Were	you	able	to	idenAfy	the	profession	of	each	healthcare	worker	that	you	
encountered	or	did	they	all	look	the	same?		
5.  Did	the	language	that	healthcare	providers	use	confuse	you?			
6.  Do	you	know	the	name	and	purpose	of	every	test	you	had	done?		
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Image	created	uAlizing	deﬁniAons	obtained	from	Government	of	Prince	Edward	
Island	(2016).				
	
TradiAonally	in	the	hospital	seBng	the	concept	Goals	of	Care	may	have	been	referred	
to	as	Code	Status.		
	
Goals	of	Care	provide	instrucAon	to	healthcare	providers	in	relaAons	to	your	wishes	
and	ulAmately	guide	the	treatment	you	will	receive	(Government	of	Prince	Edward	
Island).			
	
Goals	of	Care	should	ideally	be	discussed	with	family,	friends,	and	loved	ones	on	an	
ongoing	bases.		A	Ame	of	acute	illness	or	emergency	is	o_en	a	diﬃcult	Ame	to	
address	goals	of	care.				
	
Later	in	the	program	we	will	be	doing	an	en2re	educa2on	session	on	advance	care	
planning.		We	will	further	discuss	Goals	of	Care	during	this	session.				
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Health	care	appointment	can	be	overwhelming,	confusing,	and	frustra2ng.		Pa2ents	
oJen	iden2fy	that	they	feel	rushed	during	their	appointments	and	rarely	get	all	issues	
addressed	during	the	alloKed	2me.			
	
Helpful	Tips	(Harvard	University,	2017):		
•  Be	prepared		
Arrive	to	your	appointment	on	Ame	and	make	a	list	of	quesAons	to	have	
addressed	before	you	arrive.			
•  IdenAfy	symptoms	
Your	health	care	professional	can	not	diagnosis	or	treat	a	problem	they	don’t	
know	you	have.		Be	speciﬁc	and	concise.		
•  Ask	quesAons		
Don’t	be	afraid	to	ask	quesAons.		If	you	do	not	understand	informaAon	that	
your	health	care	provider	is	giving	ask	for	clariﬁcaAon.		Health	care	providers	
have	a	responsibility	to	ensure	you	are	adequately	informed	and	to	involve	
you	as	an	acAve	parAcipant	in	your	care.			
•  Bring	a	friend		
Appointments	can	be	confusing	and	we	rarely	hear	everything	that	is	said.		
Four	ears	are	always	beNer	than	two!		
•  Bring	an	updated	medicaAon	list		
This	will	save	Ame	if	your	health	care	provider	asks	you	what	medicaAons	you		
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Image	obtained	from	www.livingwellwithCOPD.com	
	
Various	Drug	Plans	are	available	to	resident	of	PEI	including	(Government	of	Prince	
Edward	Island,	2016):		
	
Generic	Drug	Program:	the	program	is	for	individuals	under	the	age	of	65	who	do	not	
have	private	healthcare	insurance.		The	program	limits	the	cost	per	prescripAon	to	
$19.95	for	medicaAons	listed	with	the	provincial	formulary.		Note:	does	not	cover	
diabeAc	drugs	or	narcoAcs	
		
Seniors	Drug	Program:	the	program	is	for	individuals	over	the	age	of	65.		You	will	pay	
$15.94	per	prescripAon	for	medicaAons	listed	within	the	provincial	formulary.		All	
addiAonal	cost	will	be	covered.		You	will	be	automaAcally	enrolled	at	the	age	of	65.		
			`	
Catastrophic	Drug	Program:	program	caps	annual	cost	of	prescripAon	medicaAons,	
listed	within	the	provincial	formulary,	based	on	your	household	income.				
		
Home	Oxygen	Program:	subsidizes	up	to	50	percent	of	the	cost	of	prescribed	oxygen	
to	a	maximum	of	$200	per	month.		There	are	clinical	requirements	you	must	meet	to	
be	eligible.				
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Reference:	(Government	of	Prince	Edward	Island,	2016)		
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Spirometry:		
•  Useful	in	the	diagnosis	of	chronic	lung	diseases	such	as	COPD	and	asthma	and	is	
also	uAlized	to	monitor	lung	funcAon	and	disease	progression.				Spirometry	
measures	how	much	air	you	can	blow	out	and	how	fast.			
	
A	link	to	a	vide,	obtained	from	www.lung.ca,	depicAng	spirometry	is	found	above		
		
•  Various	measurement	are	obtained	during	Spirometry	tesAng	including	(Australia	
Lung	FoundaAon,	2016):		
Forced	Expiratory	Volume	in	one	second	(FEV1):	The	maximal	amount	of	air	
that	can	be	blown	out	from	the	lungs	in	one	second.	
Forced	Vital	Capacity	(FVC):	The	maximal	amount	of	air	that	can	be	blown	out	
forcefully	in	one	enAre	breath.		
	
Par2cipants	of	Pulmonary	Rehabilita2on	complete	spirometry	during	their	ini2al	
assessment	and	at	the	comple2on	of	the	program.							
	
Bronchoscopy	
•  A	test	that	is	conducted	by	a	Respirologist.		A	ﬂexible	tube	with	a	light	and	camera	
is	inserted	through	your	mouth	or	nose	to	the	bronchi	of	your	lungs.		During	the	
test,	the	Respirologist	can	collect	Assue	or	ﬂuid	samples	to	be	sent	to	the	lab	for		
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Image	obtained	from	www.clipartpanda.com	
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Module	9:	Stress,	Anxiety,	and/or	
Depression			It	is	recognized	that	there	is	an	association	between	chronic	lung	disease	and	stress,	depression,	and	anxiety	(Kunik	et	al.,	2005).		This	module	will	introduce	the	concepts	of	stress,	depression,	and	anxiety	and	provide	participants	an	opportunity	to	share	their	personal	experience	or	story.		The	Anxiety-Breathlessness	Cycle	will	be	introduced	as	well	as	various	coping	strategies.				
By	the	end	of	a	group	education	session	participants	will:		1. Identify	the	three	domains	of	health.		2. Simply	explain	the	Anxiety-Breathlessness	Cycle.		3. Identify	two	strategies	to	assist	with	stress,	depression,	and	anxiety.		
 Share	their	personal	impact	of	chronic	lung	disease.			It	is	intended	that	the	materials	presented	within	this	module	be	utilized	during	a	one	hour	group	education	session.		Various	aids	have	been	provided	within	the	module	to	assist	with	ease	of	education	delivery.			
v Visual	Aids:	PowerPoint	presentation;	whiteboard	and	markers		
v Potential	questions	for	facilitated	group	discussion		
v Handout:	Test	your	Confidence	Level	in	Managing	your	Stress	and	Anxiety		
v Video:	“Pursed	Lip	Breathing”	avaliable	at	https://www.youtube.com/watch?v=7kpJ0QlRss4		
	
• The	reality	of	living	with	lung	disease	is	burdensome	and	debilitating	to	individuals	with	these	conditions	(World	Health	Organization,	2007).		As	we	know,	lung	disease	is	a	chronic	disease	associated	with	symptoms	that	gradually	progress	over	time.		How	does	this	reality	impact	our	overall	health?									
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What	is	Health?			
• The	World	Health	Organization	(WHO)	(1948)	defines	health	as	“a	state	of	complete	physical,	mental,	and	social	well-being	and	not	merely	the	absence	of	disease”	(para.	1).					
• Health	is	holistic	and	encompasses	three	domains:					
		
Patients	often	identify	that	health	care	professionals	do	not	address	the	mental	health	or	
emotional	aspect	of	their	overall	well-being.		This	module	will	provide	an	opportunity	to	first	
address	the	significance	of	stress	and	anxiety	and	allow	participants	to	share	their	personal	
experience	or	story.		Facilitate	a	group	discussion	to	address	the	following	questions.								Discussion	Questions:		1. How	did	you	feel	when	you	were	diagnosed	with	chronic	lung	disease?	2. Have	those	feelings	changed	over	time?																																																																																																																																						 Obtained	from	www.clipartpanda.com			Stress		What	is	Stress?		
• Stress	is	a	response	to	a	situation,	typically	a	real	or	perceived	threat.		
• We	experience	stress	as	a	result	of	both	good	and	bad	things	that	happen	to	us.		
• Stress	can	be	good!		I	can	be	utilized	as	a	form	of	motivation.		
• Stress	can	also	effect	us	negatively,	leading	to:		
v Avoidance		
v Difficulty	concentrating	
Health	
Physical	
Mental	Social	
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v Sleep	disturbances		
v Increased	heart	rate		
v Headaches		 (Canadian	Mental	Health	Association,	2017)		
• Chronic	lung	disease	presents	additional	challenges.		There	are	various	reactions	to	stress	that	have	an	impact	on	our	overall	ability	to	cope	such	as	fear,	anxiety,	or	panic	(Living	Well	with	COPD,	2017).				Depression			
Stress	and	the	various	associated	reactions	may	lead	to	depression	if	not	paired	with	effective	
coping.			
	
• Depression	is	characterized	by	ongoing	feelings	of	sadness,	worthlessness,	worrying,	or	withdrawal,	and	is	caused	by	a	chemical	imbalance.		
• There	is	a	link	between	how	we	feel	emotionally	and	feel	physically!		
• Depression	is	not	having	a	bad	day	or	feeling	sad.		Without	appropriate	treatment	and	support,	depression	will	not	go	away.		
• Many	symptoms	of	depression	are	similar	to	those	of	lung	disease	including:		
v Sleep	disturbances		
v Fatigue	
v Moving	slower	
v Withdrawing	from	activities		
v Difficulty	remembering	or	concentrating	
v Loss	of	appetite	 (Canadian	Mental	Health	Association,	2017)			
• Depression	is	under	diagnosed	and	under	treated	in	individuals	living	with	chronic	lung	disease.			
• Depression	and	anxiety	increase	incidence	of	acute	exacerbation.		(Australian	Lung	Foundation,	n.d;	Living	Well	with	COPD,	2017)		
																			 	Obtained	from	www.clipartpanda.com			
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It	is	essential	to	seek	emergency	help	if	you	are	experiencing	
thoughts	of	suicide	or	self	harm.		Anxiety	and	Chronic	Lung	Disease			
• The	main	symptom	of	chronic	lung	disease	is	typically	shortness	of	breath	(SOB).		SOB	may	cause	anxiety	or	panic	attacks.			Anxiety	causes	your	to	breathe	faster,	which	in	turn	increases	your	anxiety	and	SOB	(Doyle	et	al.,	2013).				
• This	may	cause	individuals	with	chronic	lung	disease	to	avoid	activity	due	to	fear	and	anxiety	associated	with	SOB.		The	less	activity	we	do	the	less	in	shape	we	are,	also	causing	SOB.		This	may	also	increase	social	isolation.		The	uncertainty	of	being	able	to	climb	stairs	or	walk	a	long	distance	creates	anxiety,	resulting	in	avoidance	of	social	situations	(Living	Well	with	COPD,	2017).		This	cycle	is	depicted	in	the	following	picture	obtained	from	www.livingwellwithCOPD.com.		
																																											 		
• Various	strategies	can	be	utilized	to	break	the	Anxiety-Breathlessness	Cycle	including	(COPD	Foundation,	2017):		
v Learn	to	relax	
v Recognize,	examine,	and	face	you	fears	
v Solve	one	problem	at	a	time	and	don’t	worry	about	future	events		
v Plan	actions	in	advance		
v Do	things	you	enjoy	and	enjoy	humor			
v Maintain	a	positive	attitude			
v Seek	help	when	needed		
		 329	
	
• The	impact	of	anxiety	on	chronic	lung	disease	has	been	linked	to	greater	disability,	increased	frequency	of	hospital	admissions	for	acute	exacerbations,	and	increased	breathlessness	(Doyle	et	al.,	2013;	Australia	Lung	Foundation,	n.d).				
• A	review	of	22	published	studies	between	1999	and	2009	found	that	the	prevalence	of	anxiety	symptoms	ranged	from	6%	to	74%	among	individuals	diagnosed	with	chronic	lung	disease.		Clinical	anxiety	was	experience	by	up	to	55%	of	individuals	with	COPD	(Australia	Lung	Foundation,	n.d).		
• Similarly,	a	research	study	by	Kunik	et	al.	(2005)	identified	that	80%	of	individuals	with	chronic	lung	disease	screen	positive	for	anxiety	and/or	depression.			Common	Signs	of	anxiety	include	(Canadian	Mental	Health	Association,	2017):		
v Tightening	of	the	chest		
v Increased	heart	rate		
v Shortness	of	breath		
v Nausea		
v Fear	
v Hot	and	cold	flashes		
v Excessive	worrying		
v Sleep	disturbances				
• It	is	important	to	note	that	the	treatment	for	anxiety	and	depression	is	complex	and	varies	among	individuals.		The	different	side	effects	of	medications	used	in	the	treatment	and	management	of	chronic	lung	disease	may	also	have	an	impact	on	and	individual’s	mental	or	emotional	health	(Kunik	et	al.,	2005;	Australia	Lung	Association,	n.d).				
• Using	breathing	techniques	such	as	pursed	lip	breathing	will	help	manage	both	anxiety	and	SOB	(Borge	et	al.,	2014).																
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	Lets	review	pursed-lip	breathing:			
	
	(Living	Well	with	COPD,	2005,	p.	11)			Video:	“Pursed	Lip	Breathing”	available	at	https://www.youtube.com/watch?v=7kpJ0QlRss4			
Pulmonary	Rehabilitation	is	recognized	as	beneficial	for	individuals	with	chronic	lung	disease	
who	are	experiencing	anxiety	and	depression	since	it	provides	psychosocial	support.		It	has	
been	shown	to	be	helpful	with	symptom	management	and	to	improve	overall	mood	(Australia	
Lung	Association,	n.d).						Coping	with	Chronic	Lung	Disease		
• Effective	coping,	associated	with	chronic	lung	disease,	requires	ongoing	physical,	cognitive,	and	emotional	adjustments	as	individuals	experience	disease	progression.		Possible	adjustments	may	include:		
v Physical:	managing	shortness	of	breath	or	other	symptoms	associated	with	lung	disease,	inability	to	participate	in	activities,	environmental	conditions,	or	managing	new	medical	equipment.		
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v Cognitive:	changes	to	self-esteem,	learning	new	skills,	planning	for	the	future,	acceptance	of	limitations		
v Emotional:	anger,	grief,	denial,	or	fear																																					
																														 	
	
	
FYI…	Often	physical	or	cognitive	adjustments	are	easier	then	emotional	adjustments!	
	
Activity:		Distribute	handout	Test	your	Confidence	Level	in	Managing	your	Stress	and	Anxiety		Discussion	Questions:		1. Did	you	have	to	make	any	adjustment	in	your	life	after	you	were	diagnosed	with	lung	disease?		2. Is	this	an	ongoing	process	as	your	disease	progresses?				
Provide	an	opportunity	for	participants	and	family	members	to	share	their	personal	
experience	or	story.		They	following	discussion	may	be	helpful	to	facilitate	discussion	if	
required.					Discussion	Questions:		1. What	situations	cause	you	to	experience	stress	or	anxiety?	2. How	does	stress	or	anxiety	affect	your	breathing?		3. What	strategies	do	you	use	to	cope	with	stress	and	anxiety?	4. Do	you	think	that	health	care	providers	adequately	address	your	emotional	needs	that	are	associated	with	chronic	lung	disease?		5. Do	your	family	and	friends	understand	the	impact	of	your	disease	and	the	associated	emotions?	
	
	
Available	Resources		
• The	Pulmonary	Rehabilitation	Team		
• Friends	and	Family	Members	
• Primary	Care	Provider	such	as	Family	Doctor	or	Nurse	Practitioner	
Physical		
Cognitive	Emotionl	
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• Community	Mental	Health	Services	across	PEI	
• Hospital	Emergency	Department		
v Health	is	a	“state	of	complete	physical,	mental,	and	social	well-being	and	not	merely	the	absence	of	disease”.		
v 80%	of	individuals	with	chronic	lung	disease	screen	positive	for	anxiety	and/or	depression.		You	are	not	alone!	
v Using	breathing	techniques	such	as	pursed	lip	breathing	will	help	manage	both	anxiety	and	SOB.		
v Depression	and	anxiety	increase	incidence	of	acute	exacerbation.	
v It	is	essential	to	seek	emergency	help	if	you	are	experiencing	thoughts	of	suicide	or	self	harm.																																		
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Review	Key	Messages	from	previous	module.		
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The	World	Health	OrganizaDon	(WHO)	(1948)	deﬁnes	health	as	“a	state	of	complete	
physical,	mental,	and	social	well-being	and	not	merely	the	absence	of	disease”	(para.	
1)			
	
Pa#ents	o*en	iden#fy	that	health	care	professionals	do	not	address	the	mental	
health	or	emo#onal	aspect	of	their	overall	well-being.		This	module	will	provide	an	
opportunity	to	ﬁrst	address	the	signiﬁcance	of	stress	and	anxiety	and	allow	
par#cipants	to	share	their	personal	experience	or	story.		Facilitate	a	group	discussion	
to	address	the	following	ques#ons.				
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Image	obtained	from	www.clipartpanda.com	
	
5	
		 338	
Image	obtained	from	www.clipartpanda.com	
	
What	is	Stress?		
	
Stress	is	a	response	to	a	situaDon,	typically	a	real	or	perceived	threat.		
	
We	experience	stress	as	a	result	of	both	good	and	bad	things	that	happen	to	us.		
	
Stress	can	be	good!		I	can	be	uDlized	as	a	form	of	moDvaDon.		
	
Stress	can	also	eﬀect	us	negaDvely,	leading	to:		
•  Avoidance		
•  Diﬃculty	concentraDng	
•  Sleep	disturbances		
•  Increased	heart	rate		
•  Headaches		
(Canadian	Mental	Health	AssociaDon,	2017)	
	
Chronic	lung	disease	presents	addiDonal	challenges.		There	are	various	reacDons	to	
stress	that	have	an	impact	on	our	overall	ability	to	cope	such	as	fear,	anxiety,	or	panic	
(Living	Well	with	COPD,	2017).			
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References:		(Canadian	Mental	Health	AssociaDon,	2017;	Australian	Lung	FoundaDon,	
n.d;	Living	Well	with	COPD)	
	
Depression	is	not	having	a	bad	day	or	feeling	sad.		Without	appropriate	treatment	
and	support,	depression	will	not	go	away.		
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Image	obtained	from	www.clipartpanda.com	
	
Reference:	(Canadian	Mental	Health	AssociaDon,	2017)		
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Image	obtained	from	www.livingwellwithCOPD.com	
	
The	main	symptom	of	chronic	lung	disease	is	typically	shortness	of	breath	(SOB).		SOB	
may	cause	anxiety	or	panic	abacks.			Anxiety	causes	your	to	breathe	faster,	which	in	
turn	increases	your	anxiety	and	SOB	(Doyle	et	al.,	2013).			
		
This	may	cause	individuals	with	chronic	lung	disease	to	avoid	acDvity	due	to	fear	and	
anxiety	associated	with	SOB.		The	less	acDvity	we	do	the	less	in	shape	we	are,	also	
causing	SOB.		This	may	also	increase	social	isolaDon.		The	uncertainty	of	being	able	to	
climb	stairs	or	walk	a	long	distance	creates	anxiety,	resulDng	in	avoidance	of	social	
situaDons	(Living	Well	with	COPD,	2017).		This	cycle	is	depicted	in	the	following	
picture	obtained	from	www.livingwellwithCOPD.com.	
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Reference:	(Living	Well	with	COPD)	
	
It	is	important	to	note	that	the	treatment	for	anxiety	and	depression	is	complex	and	
varies	among	individuals.		The	diﬀerent	side	eﬀects	of	medicaDons	used	in	the	
treatment	and	management	of	chronic	lung	disease	may	also	have	an	impact	on	and	
individual’s	mental	or	emoDonal	health	(Australia	Lung	AssociaDon,	n.d).			
	
Pulmonary	Rehabilita#on	is	recognized	as	beneﬁcial	for	individuals	with	chronic	lung	
disease	who	are	experiencing	anxiety	and	depression	as	it	provides	psychosocial	
support.		It	has	been	shown	to	be	helpful	with	symptom	management	and	to	improve	
overall	mood	(Australia	Lung	Associa#on,	n.d).					
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Image	obtained	from	www.clipartpanda.com	
	
Reference:	(Living	Well	with	COPD)	
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Reference:	(Living	Well	with	COPD,	2005,	p.	11)	
	
Using	breathing	techniques	such	as	pursed	lip	breathing	will	help	manage	both	
anxiety	and	SOB	(Living	Well	with	COPD).			
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The	impact	of	anxiety	on	chronic	lung	disease	has	been	linked	to	greater	disability,	
increased	frequency	of	hospital	admissions	for	acute	exacerbaDons,	and	increased	
breathlessness	(Doyle	et	al.,	2013;	Australia	Lung	FoundaDon,	n.d).			
		
A	review	of	22	published	studies	between	1999	and	2009	found	that	the	prevalence	
of	anxiety	symptoms	ranged	from	6%	to	74%	among	individuals	diagnosed	with	
chronic	lung	disease.		Clinical	anxiety	was	experience	by	up	to	55%	of	individuals	with	
COPD	(Australia	Lung	FoundaDon,	n.d).	
		
Similarly,	a	research	study	by	Kunik	et	al.	(2005)	idenDﬁed	that	80%	of	individuals	
with	chronic	lung	disease	screen	posiDve	for	anxiety	and/or	depression.		
	
14	
		 347	
Image	obtained	from	hbp://familiesusa.org/share-your-story,	copyright	permission	
not	required	per	website.			
	
Discussion	QuesDons:		
1.  What	situaDons	cause	you	to	experience	stress	or	anxiety?	
2.  How	does	stress	or	anxiety	aﬀect	your	breathing?		
3.  What	strategies	do	you	use	to	cope	with	stress	and	anxiety?	
4.  Do	you	think	that	health	care	providers	adequately	address	your	emoDonal	needs	
that	are	associated	with	chronic	lung	disease?		
5.  Do	your	family	and	friends	understand	the	impact	of	your	disease	and	the	
associated	emoDons?	
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Physical:	managing	shortness	of	breath	or	other	symptoms	associated	with	lung	
disease,	inability	to	parDcipate	in	acDviDes,	environmental	condiDons,	or	managing	
new	medical	equipment.		
	
CogniDve:	changes	to	self-esteem,	learning	new	skills,	planning	for	the	future,	
acceptance	of	limitaDons		
	
EmoDonal:	anger,	grief,	denial,	or	fear		
	
FYI…	O*en	physical	or	cogni#ve	adjustments	are	easier	then	emo#onal	adjustments!	
		
Ac#vity:		Distribute	handout	Test	your	Conﬁdence	Level	in	Managing	your	Stress	and	
Anxiety	
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Image	obtained	from	www.clipartpanda.com	
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	Obtained	from	www.livingwellwithCOPD.com			
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Module	10:	Moving	Forward			This	module	completes	the	12-week	Pulmonary	Rehabilitation	Program.		We	will	look	back	and	reflect	on	what	each	participant	has	achieved	and	discuss	moving	forward.		The	module	will	begin	by	reviewing	and	reflecting	on	personal	SMART	goals	developed	by	participants	during	module	1.		Time	will	then	be	allotted	for	participants	to	complete	five	out-take	surveys	and	a	program	evaluation	form.		Throughout	the	program,	Summary	Reports	are	completed	on	each	participant	that	contain	both	intake	and	out-take	data.		This	report	is	then	sent	to	the	participant’s	referring	and	family	physician	to	close	the	communication	loop.					By	the	end	of	a	group	education	session	participants	will:		1. Review	and	reflect	on	personal	SMART	goals	developed	in	Module	1.		2. Complete	five	outtake	surveys.		3. Review	their	personal	Summary	Report.		4. Complete	a	program	evaluation	form.			It	is	intended	that	the	materials	presented	within	this	module	be	utilized	during	a	one	hour	group	education	session.		Various	aids	have	been	provided	within	the	module	to	assist	with	ease	of	education	delivery.			
v Visual	Aids:	whiteboard	and	markers		
v Potential	questions	for	facilitated	group	discussion		
v Surveys:			
o Lung	Information	Needs	Questionnaire		
o Pulmonary	Rehabilitation	Program	Survey		
o Patient	Health	Questionnaire	(PHQ-4)	
o Self-Efficacy	for	Managing	Chronic	Disease	6-item	Scale	
o COPD	Assessment	Test	(CAT)		
v Patient	Summary	Reports		
v Program	Evaluation	Form				Congratulations!		You	have	successfully	completed	the	Provincial	Pulmonary	Rehabilitation	Program.						
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SMART	Goal	Review/Reflection			
						 			
On	the	first	day	of	the	program	participants	all	created	three	personalized	SMART	goals	to	
achieve	by	the	end	of	the	program.		Distribute	copy	of	SMART	goals	to	participants	in	order	for	
them	to	review	and	reflect	on	their	personal	goals.		Facilitate	a	group	discussion.				Discussion	Questions:		1. Did	you	achieve	your	goals?		2. Did	your	goals	change	as	your	progressed	through	the	program?		3. Do	you	have	new	goals	now	that	you	have	completed	the	program?			
There	may	be	some	participants	who	did	not	achieve	their	goals	and	that	is	ok.		Lets	focus	on	
what	we	did	achieve	during	the	last	12	weeks.		This	provides	an	opportunity	for	self-reflection	
for	participants	as	well.			Discussion	Question:	Why	did	I	know	achieve	my	goals?									Outtake	Surveys			During	intake	assessment	all	participants	filled	out	the	following	surveys:		
v Lung	Information	Needs	Questionnaire		
v Pulmonary	Rehabilitation	Program	Survey		
v Patient	Health	Questionnaire	(PHQ-4)	
v Self-Efficacy	for	Managing	Chronic	Disease	6-item	Scale	
v COPD	Assessment	Test	(CAT)			Now	that	you	have	completed	the	program,	we	will	now	take	15	to	20	minutes	and	fill	out	the	same	surveys.		The	results	of	each	survey	will	become	part	of	your	summary	report!		Each	survey	can	be	found	in	the	handout	section	of	this	module.							
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	Summary	Reports		
During	the	Pulmonary	Rehabilitation	Program	various	outcomes	measures	are	collected	from	
the	participants.		The	Pulmonary	Rehabilitation	Team	developed	the	following	Summary	
Report	as	a	tool	to	manage	and	share	collected	data.		A	Summary	Report	is	completed	for	each	
participant,	and	sent	to	his	or	her	physician	or	nurse	practitioner.		A	folder	has	been	created	
for	each	patient	with	a	program	completion	certificate	and	their	personal	Summary	Report.		
Review	each	section	of	the	report	with	participants.							
	Discussion	Question:	Does	anyone	have	any	additional	questions	about	their	Summary	Reports?	
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The	following	chart	was	developed	by	the	Provincial	Cardiac	and	Pulmonary	Team.		It	is	sent	
with	each	summery	report	as	a	guide	for	interpreting	data	contained	within	each	report.				
Measure	 Description	 Interpretation	
BODE	Index	 The	BODE	index	is	a	multidimensional	scoring	system	and	capacity	index	used	to	predict	4	year	outcomes	for	people	diagnosed	with	COPD	.	The	BODE	score	is	calculated	using	body	mass	index	(BMI),	airflow	obstruction	(FEV1),	dyspnea	rating	using	the	MRC	scale,	and	results	from	a	6	minute	walk	test	(6MWT).		
0-2 = 80%   4 year predicted survival rate              
5-6 = 57%   4 year predicted survival rate 
3-4 = 67%    4 year predicted survival rate                 
7-10 = 18%  4 year predicted survival rate 
	
CAT		 The	CAT	is	a	simple	but	highly	valid	questionnaire.	It	provides	a	reliable	measure	of	health	status	in	COPD	patients	and	assists	patients	and	health	care	professionals	in	quantifying	the	impact	of	COPD	on	patients’	health,	wellbeing	and	daily	life.	
	
<10=	Low	Impact:	most	days	are	good,	but	COPD	causes	a	few	problems	and	stops	people	doing	one	or	two	things	that	they	would	like	to	do.		10-20=	Medium	Impact:	COPD	is	one	of	the	most	important	problems	that	they	have.	>20=	High	Impact:	COPD	stops	them	from	doing	most	things	that	they	want	to	do.		>30=	Very	High	Impact:	Their	condition	stops	them	from	doing	everything	they	want	to	do	and	they	never	have	any	good	days.	 	
Health	
Literacy	
Questionnaire	
This	is	a	3	item	questionnaire	which	screens	for	an	individual’s	level	of	self-reported	difficulty	with	understanding	information	or	performing	reading	tasks	they	encounter	in	the	health	care	setting.	
Scores	range	from	3-15	with	higher	scores	indicting	higher	subjective	health	literacy.	
	
LINQ		 The	Lung	Information	Needs	Questionnaire	is	a	self-completed	questionnaire	that	measures	the	information	needs	of	patients	with	chronic	obstructive	pulmonary	disease	(COPD)	and	other	chronic	lung	diseases.	LINQ	is	designed	to	help	clinicians	identify	which	patients	would	benefit	from	lung	information	and	the	type	of	information	an	individual	patient	needs.	This	questionnaire	can	also	be	used	to	evaluate	the	impact	of	an	intervention,	including	pulmonary	rehabilitation,	for	research	and	audit	purpose.	
The	minimum	score	(low	information	needs)	is	0	and	maximum	score	(high	information	needs)	is	25		
	
PHQ-4		 The	Patient	Health	Questionnaire	for	Depression	and	Anxiety	(PHQ-4)	was	developed	to	allow	for	a	very	brief	and	accurate	measurement	to	screen	for	depression	and	anxiety.	
Normal	(0-2)	Mild	(3-5)	Moderate	(6-8)	Severe	(9-12)	
Self-Efficacy	
Scale	
This	6-item	scale	is	used	to	identify	how	confident	a	patient	feels	in	managing	their	chronic	disease.	It	covers	several	domains	that	are	common	across	many	chronic	diseases:	symptom	control,	role	function,	emotional	functioning	and	communication	with	health	care	providers.	
Scores	range	from	1	to	10,	with	1	correlating	with	low	self-	efficacy	and	10	correlating	with	high	self-efficacy	in	managing	chronic	disease.		 	
		Program	Evaluation:	Distribute	and	have	participants	complete	a	Program	Evaluation	form.		
Conclude	session	with	an	open	discussion	related	to	program	evaluation,	outcomes,	or	general	
comments.		
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Image	obtained	from	www.clipartpanda.com	
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On	the	ﬁrst	day	of	the	program	par2cipants	all	created	three	personalized	smart	
goals	to	achieve	by	the	end	of	the	program.		Distribute	copy	of	SMART	goals	to	
par2cipants	in	order	for	them	to	review	and	reﬂect	on	their	personal	goals.		Facilitate	
a	group	discussion.			
		
Discussion	Ques<ons:		
Did	you	achieve	your	goals?		
Did	your	goals	change	as	your	progressed	through	the	program?		
Do	you	have	new	goals	now	that	you	have	completed	the	program?		
		
There	may	be	some	par2cipants	who	did	not	achieve	their	goals	and	that	is	ok.		Lets	
focus	on	what	we	did	achieve	during	the	last	12	weeks.		This	provides	an	opportunity	
for	self-reﬂec2on	for	par2cipants	as	well.		
		
Discussion	Ques<on:	Why	did	I	know	achieve	my	goals?						
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Image	obtained	from	hEp://www.clipartpanda.com	
	
During	intake	assessment	all	par<cipants	ﬁlled	out	the	following	surveys:		
•  Lung	Informa<on	Needs	Ques<onnaire		
•  Pulmonary	Rehabilita<on	Program	Survey		
•  Pa<ent	Health	Ques<onnaire	(PHQ-4)	
•  Self-Eﬃcacy	for	Managing	Chronic	Disease	6-item	Scale	
•  COPD	Assessment	Test	(CAT)		
		
Now	that	you	have	completed	the	program,	we	will	now	take	15	to	20	minutes	and	
ﬁll	out	the	same	surveys.		The	results	of	each	survey	will	become	part	of	your	
summary	report!		Each	survey	can	be	found	in	the	handout	sec<on	of	this	module.			
	
A	chart,	developed	by	the	Provincial	Cardiac	and	Pulmonary	Team,	is	located	within	
the	associated	module	and	can	be	used	to	provide	a	descrip2on	for	each	survey.		
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Image	obtained	from	hEp://www.clipartpanda.com	
	
Have	par<cipants	complete	a	program	evalua<on	form.			
	
Open	discussion	to	discuss	feedback	on	the	program.			
7	
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0 1 2 3 4 5X
Your name: Today’s date:
How is your COPD?Take the COPDAssessmentTest™ (CAT)
This questionnaire will help you and your healthcare professional measure the impact COPD (Chronic Obstructive
Pulmonary Disease) is having on your wellbeing and daily life.Your answers, and test score, can be used by you and
your healthcare professional to help improve the management of your COPD and get the greatest benefit from treatment.
For each item below, place a mark (X) in the box that best describes you currently. Be sure to only select one response
for each question.
Example: I am very happy I am very sad
TOTAL
SCORE
SCORE
COPDAssessmentTest and CAT logo is a trademark of the GlaxoSmithKline group of companies.
© 2009 GlaxoSmithKline. All rights reserved.
I never cough 0 1 2 3 4 5
0 1 2 3 4 5
0 1 2 3 4 5
0 1 2 3 4 5
0 1 2 3 4 5
0 1 2 3 4 5
0 1 2 3 4 5
0 1 2 3 4 5
I cough all the time
I have no phlegm (mucus)
inmychest at all
My chest is completely
full of phlegm (mucus)
My chest does not
feel tight at all
My chest feels
very tight
When I walk up a hill or
one flight of stairs I am
not breathless
When I walk up a hill or
one flight of stairs I am
very breathless
I am not limited doing
any activities at home
I am very limited doing
activities at home
I am confident leaving
my home despite my
lung condition
I amnotatall confident
leavingmyhomebecause
ofmylung condition
I sleep soundly
I don’t sleep soundly
because ofmy lung
condition
I have lots of energy I have no energy at all
COPD As essment Test and the CAT logo is  trade mark f the GlaxoSmithKline group of companies.
© 2 09 GlaxoSmithKline group of companies. All rights reserved.
Last Updated: February 24, 2012
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Pulmonary	Rehabilitation	Program				Dear	Participant:		The	following	questions	will	help	us	better	understand	health	literacy	levels	of	participants	in	the	program.		Health	literacy	refers	to	the	ability	to	read	and	understand	health	information.			1.	 “How	often	do	you	have	problems	learning	about	your	medical	condition	because	of	difficulty	understanding	written	information”		
☐		Always	
☐		Often	
☐		Sometimes		
☐		Occasionally			
☐		Never					2.	 “How	confident	are	you	filling	out	medical	forms	by	yourself?		
☐		Not	at	all	
☐		A	little	bit	
☐		Somewhat	
☐		Quite	a	bit	
☐		Extremely				3.	 “How	often	do	you	have	someone	help	you	read	hospital	materials?”	
☐		Always	
☐		Often	
☐		Sometimes		
☐		Occasionally			
☐		Never				 Thank-you	for	completing	this	survey!		*	From	Chew	et	al.	(2004,	2008)	
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LINQ 
Lung Information Needs Questionnaire 
1 
2 
3 
4 
Do you know the name of your lung disease? 
YES 
NO 
Has  a  doctor  or  nurse  told  you  how  this  disease  affects  your 
lungs? 
YES 
NO 
Has a doctor or nurse told you what is likely to happen in the 
future? 
YES 
NO 
Which of the following statements best describes what will 
happen to you over the next few years?  TICK ONE ONLY 
Now that my disease is being treated, I will probably 
get better 
Now that my disease is being treated, I will probably 
stay the same 
I will get worse 
I have no idea
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LINQ 
Lung Information Needs Questionnaire 
5 
6 
7 
8 
Has a doctor or nurse explained the reason for taking your 
inhalers or medicines? 
YES 
NO 
Do you try to take your inhalers or medicines exactly as you 
have been instructed by a doctor or nurse? 
YES 
NO 
Are you satisfied with the information doctors and nurses have 
given you about your inhalers or medicines?  TICK ONE ONLY 
I understand everything I need to know 
I understand what I have been told but I would like to 
know more 
I am slightly confused about my medicines 
I am very confused about my medicines 
What sentence best describes what you have been told to do if 
your breathing gets worse (e.g., take two puffs instead of one)? 
TICK ONE ONLY 
I have been told what to do and the doctor/nurse has 
given me written instructions 
I have been told but it is not written on paper 
I haven't been told but I know what to do 
I haven't been told and I don’t know what to do
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LINQ 
Lung Information Needs Questionnaire 
9 
10 
11 
12 
Have you been told when you should call an ambulance if your 
breathing worsens?  TICK ONE ONLY 
I have been told what to do and the doctor/nurse has 
given me written instructions 
I have been told but it isn't written on paper 
I haven't been told but I know what to do 
I haven't been told and I am uncertain when an 
ambulance should be called 
What best describes you?  TICK ONE ONLY 
Never smoked (go to question 13) 
Used to smoke but don't now (go to question 13) 
Still smoking (go to question 11) 
Has a doctor or nurse advised you to give up smoking? 
YES 
NO 
Has a doctor or nurse offered to help you to give up smoking 
(e.g., given you nicotine gum or patches or referral to a 
Smoking Cessation clinic)? 
YES 
NO
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LINQ 
Lung Information Needs Questionnaire 
13 
14 
15 
16 
Have you been told by a doctor or nurse to try to do some 
physical activity (e.g., walking, brisk walking and other forms of 
exercise)? 
YES 
NO 
Has a doctor or nurse told you how much physical activity (e.g., 
walking, brisk walking and other forms of exercise) you should 
do? 
Yes and I know what to do 
Yes but I am unsure what to do 
Yes but I am unable to do it 
No 
How much physical activity do you do? 
As little as possible 
I make an effort 
I push myself as much as I can 
What have doctors or nurses told you about your diet or eating? 
(please tick all that apply) 
Nothing 
Lose or gain weight 
Eat healthy food 
Eat several small meals per day 
"(e.g., 6 small meals per day instead of 3 large ones)"
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LINQ 
Lung Information Needs Questionnaire 
17 
18 
19 
20 
Have you any questions or comments about your lung disease? 
"If so, write them in the space below" 
Do you live on your own? 
YES 
NO 
Sex  (delete one)  Male  Female 
In which year were you born?  19 _ _
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Patient Health Questionnaire (PHQ-4) 
 
Name: ____________________________________ 
Due Date/ Delivery Date: __________________ 
Today’s Date:  _____________________________ 
  
 
Over the past 2 weeks 
have you been bothered 
by these problems? 
Not at all 
Several 
days 
More days 
than not 
Nearly 
every day 
 
 
Feeling nervous, anxious, 
or on edge 
0 1 2 3  
 
Not being able to stop or 
control worrying 
0 1 2 3 
 
 
Feeling down, depressed, 
or hopeless 
0 1 2 3 
 
 
Little interest or pleasure in 
doing things 
0 1 2 3 
 
The thought of harming myself has occurred to me (circle one)          No Yes 
 
Administered by (initial):  
 
MD 
 
CMA 
 
Self 
 
 
TOTAL 
 
Notes: 
 
 
 
 
 
                                                                   Reviewing provider:      
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SATISFACTION	Survey	Pulmonary	Rehab	Program		Dear	Participant:		Health	PEI	is	committed	to	providing	the	highest	possible	quality	of	care	to	our	clients.	In	order	to	help	us	do	that,	we	are	asking	for	your	feedback	on	your	experience	with	the	Pulmonary	Rehab	Program.	We	are	interested	in	what	worked	well	and	where	we	can	make	improvements.		We	value	your	input.	Please	be	assured	your	responses	will	be	held	in	the	strictest	of	confidence.	Answers	will	be	grouped	so	that	no	one	individual	can	be	identified.		For	each	item,	check	the	box	that	most	closely	reflects	your	experience.		You	can	skip	any	question	you	don’t	want	to	answer.			1.	How	would	you	rate	your	overall	experience	with	the	Pulmonary	Rehab	Program?	
 
 
 2.	a)	Was	the	time	of	the	day	chosen	for	the	program	satisfactory?							ο	Yes									ο	No													If	not,	what	would	be	a	better	time?	_____________________________________										b)	Was	the	physical	setting	for	the	education	sessions	satisfactory?		ο	Yes									ο	No												If	not,	what	would	make	it	better?	______________________________________											c)	Was	the	physical	setting	for	the	exercise	satisfactory?																			ο	Yes									ο	No													If	not,	what	would	make	it	better?	_______________________________________												d)	Was	the	length	of	the	program	(12	weeks)	appropriate?											ο	Yes									ο	No														If	not,	what	would	you	recommend?	_____________________________________							3.	Do	you	believe	the	Pulmonary	Rehab	Program	has	helped	you	make	positive	changes	toward	physical	activity?												ο	Yes									ο	No																			
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4.	Do	you	believe	the	Pulmonary	Rehab	Program	has	helped	you	make	positive	changes	toward	healthy	eating?																ο	Yes									ο	No																			5.		Do	you	believe	the	Pulmonary	Rehab	Program	has	helped	improve	your	quality	of	life?																																																	ο	Yes									ο	No																																																																																																																																																																																																																 	 	 							6.	On	a	scale	of	1	to	5,	how	confident	are	you	that	you	can	maintain	any	lifestyle	changes				(healthy	eating	or	increased	physical	activity)	you	made	during	the	program	once	the	weekly	classes	are	complete?														1										2										3										4										5											Not	at	all																																																						extremely											Confident																																																					Confident		7.	Please	comment	on	what	education	topics	you	found	to	be	the	most	helpful?					_______________________________________________________________________ 
 
_______________________________________________________________________ 
 
_______________________________________________________________________ 	8.	Are	there	any	changes	you	would	recommend	to	the	education	classes?		
_______________________________________________________________________ 
 
_______________________________________________________________________ 
 
_______________________________________________________________________ 	9.	Would	you	recommend	this	program	to	someone	else?									ο	Yes									ο	No								
 
 10.	What	did	you	find	the	most	valuable?			
_______________________________________________________________________ 
 
_______________________________________________________________________ 
 	11.	What	changes	would	you	recommend?		
_______________________________________________________________________ 
 
_______________________________________________________________________ 
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_______________________________________________________________________		12.	Additional	Comments:			
_______________________________________________________________________ 
 
_______________________________________________________________________ 
 
_______________________________________________________________________			 													Thank	You																																												 																																				
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